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Investigations  of the  prevalence  of antibiotic  resistance  genes  and  their  genetic 
supports are essential  for our understanding of the mechanisms of resistance, and 
their transfer.
I his study  investigated the prevalence of tetracycline and erythromycin resistance 
in  the  Gram  positive  aerobic  cultivable  portion,  and  the  total  oral  and  faecal 
microbiota  of  six  European  countries.  Only  Gram  positive  isolates  were 
investigated  as  they  represent  a  distinct  phylogenetic  group.  Furthermore,  this 
project was part of a larger European-wide study on the biology of Gram positive 
organisms.
A collection of 123  tetracycline and/or erythromycin resistant  isolates was made, 
and  through  macroarray  analysis  the  most  common  let  genes  were  found  to  be 
tct(M). tet{()) and tet{ W) in the aerobic oral  flora, and tet{M). tet(O) and tet(Q) in 
the aerobic faecal flora. Three isolates did not hybridise to any probes on the array.
In  order  to  investigate  the  contribution  of the  whole  metagenome  to  antibiotic 
resistance,  total  extracted  DNA  was  analysed  on  the  macroarray  and  12  BAG 
libraries were constructed. The most common let genes in the oral microbiota were 
tci(M). tet(Q) and ief(30); and were tet( W). tet(()). tet(Q) and tet(32) in the faecal 
metagenome.I he BAC libraries were evaluated for efficiency of cloning microbial DNA. and to 
ensure they were representative of each microbiota, by end-sequence analysis. The 
libraries were screened  on  tetracycline.  32  resistant clones were  found, only  four 
of  these  were  stable.  One.  NFtetCl.  contained  tet(O).  The  entire  insert  was 
sequenced to determine its support, it was shown to contain orfs with similarity to 
tnpl' from  In4451.  and to or/6   from Tn916 and cpp2 from  the /e/(0)-harbouring 
( ampylohacter coli plasmid pCC31.
C  lone  SFtetCIO  harboured  PCR  analysis  illustrated  it  was  flanked  by
sequences  with  homology  to  those  flanking  /e/(M)  in  Tn916.  however,  ini  from 
Tn916 did  not amplify with  specific  primers.  Clones  IStetCl  and  FRStetCll  did 
not  hybridise  to  any  probes  on  the  array.  These  harbour either  novel  or  rare  let 
genes.  Clone  IStetC" 1   was  subcloned  and  found  to  harbour  a  putatitve  natural 
chimera of two tetracycline resistance plasmids: pRSB107 and pR64.
This study  thus provides  further evidence of the  prevalence of antibiotic resistant 
bacteria in the human Gastrointestinal (GI) tract, and the difference in prevalence 
of  tetrcycline  resistance  determinants  in  the  aerobic  cultivable  flora  and  total 
microbiota.
Furthermore, it illustrates how antibiotic resistance genes are contained on mobile 
genetic  elements  which  are  mosaic  in  structure  having  undergone  evolutionary 
changes in which functional modules are exchanged.
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Introduction
231.1  Bacteria, Disease and Treatment
1.1.1  The Discovery of Antibiotics
By the late  1800s it was generally accepted that bacteria and other microbes were 
the cause of various diseases. A phenomenon which at that time was known as the 
'germ theory of disease' (Brock et al..  2002). As a result, biologists dedicated time 
in  the  search  for  chemicals  that  would  kill  these  bacteria  without  having  toxic 
effects  on  the  human  host.  In  1888.  the  blue  pigment  pyocyanase.  released  by 
Bacillus pyocyaneus was found to stop the growth of other bacteria in the culture, 
this is now recognised as the first report of an antibiotic. Unfortunately pyocyanase 
proved to be unstable when isolated and toxic to animals (Gaby et al..  1945)
In  1929 Alexander Flemming  famously discovered  penicillin when  bacterial  agar 
plates  contaminated  with  moulds  showed  areas  of growth  inhibition  around  the 
mould colonies (Fraenkel,  1998: Chain et al..  2005).  Flemming illustrated that the 
peniciIlium moulds produced a small compound which was able to diffuse through 
the agar and lyse the bacteria (Fraenkel.  1998).
Since  then,  numerous  antibiotic  compounds  have  been  isolated  from  both  fungi 
and prokaryotes, and subsequent chemical modifications of certain antibiotics have 
resulted  in  semi-synthetic  derivatives  (Hopvvood  &  Chater.  1980:  Monaghan  & 
Barrett. 2006).
Antibiotics  may  be  either  bacteriostatic  or  bacteriocidal  (Brock  et  al.,  2002). 
Bacteriostatic  antibiotics  such  as  the  sulphonamides.  tetracyclines, 
choloramphenicol,  erythromycin  and  trimethoprim  do  not  kill  cells,  but  prevent 
growth by  a variety of mechanisms, therefore if the antibiotic is removed growth
24will  resume.  Bacteriocidal agents kill the organism. These include the penicillins, 
cephalosporins and aminoglycosides (Brock et al..  2002). Antibiotics may target a 
single  species,  having a  narrow spectrum of activity, or be potent against a wide 
variety of bacteria (broad-spectrum activity) (Pow ledge. 2004).
1.1.1.2  Classes of Antibiotics
1.1.1.2.1  Macrolides
1.1.1.2.1.1  Structure and Background
Macrolides  are  made  up  of  14-  (erythromycin  and  clarithromycin).  15- 
(azithromycin)  and  16-  (josamycin.  spiramycin  and  tylosin)  membered  lactones 
covalently  attached  via  glycosidic  bonds  to amino  or neutral  sugars  (Figure  1.1) 
(Bryskier et al..  1993: reviewed in Roberts et al..  1999b).
Frythromycin  was  the  first  macrolide  antibiotic  discovered,  a  product  of 
Saccharopolvspora ervthraea. and was introduced to the clinic  in  1952 (reviewed 
in Roberts. 2002). It is used in the treatment of respiratory tract infections in adults 
and  children,  in  bone  and  soft  tissue  infections  and  in  specific  cases  of sexually 
transmitted  diseases  including  chlamydia  and  syphilis  (Goldman  &  Scaglione. 
2004).
25Figure 1.1: Molecular Structure of Erythromycin (Taken from Vester, 2001)
By  1953  resistance  had  been  detected  in  staphylococcal  isolates  (reviewed  in 
Roberts,  2002)  worldwide.  In  general,  erythromycin  is  much  more  effective 
against Gram positive bacteria than Gram negatives.
The other macrolides are all derivatives with synthetic substitutions on the lactone 
ring.  These synthetic  molecules confer improved stability and  penetration of the 
drug and are less likely to interact with other antibiotics (Goldman & Scaglione, 
2004).
1.1.1.2.1.2  Mode of Action
The uncharged form of macrolides is capable of crossing the membrane by passive 
diffusion (there  is no evidence  for a membrane carrier, the use of energy  or the 
proton motive force) (Hancock & Bell.  1988; Goldman & Kadam.  1989; reviewed 
in Goldman & Scaglione, 2004). Entrance of the protonated form of macrolides is 
restricted due to strong ionic hydrogen bonding with water (Bosnar et al, 2005). 
Only  one  erythromycin  molecule  binds  to  each  50S  subunit.  The  macrolide 
binding site is situated at the base of a deep cleft in the ribosome that allows theexit of transcribed proteins  from the  large subunit (Weisblum,  1995;  Poehlsgaard 
et al..  2002).  The  binding  site  is  in  close proximity to  where the aminoacyl  and 
peptidyl  ends of the  tRNAs become aligned  to  catalyse the  formation of peptide 
bonds,  therefore  binding  blocks  the  translation  reaction  of the  polypeptide chain 
elongation (Vester & Douthvvaite. 2001).
1.1.1.2.2  Tetracyclines
1.1.1.2.2.1  Structure and Background
Tetracyclines were discovered  in  the  1940s.  They  are  broad  spectrum  antibiotics 
and are used clinically in the treatment of atypical pneumonia, cholera, periodontal 
infection, acne and many other genital, local and systemic infections (Brodersen et 
al..  2000). They have also been used in agriculture as grovvlh promoters (reviewed 
in Chopra & Roberts. 2001). Streptomvces aurqfaciens, Sm.  viriclqfaciens and Sm. 
rimosus  all  produce  tetracyclines,  in  addition  Sm.  aurqfaciens  and  Sm.  rimosus 
produce chlortetracycline and oxytetracycline to help out compete neighbours and 
as defense mechanisms (rev iewed in Nelson,  1999).
Second  and  third  generation  tetracyclines;  doxycycline and  minocycline  (Chopra 
&  Roberts.  2001).  and  glycyclines  (Bronson  &  Barrett.  2001).  respectively,  are 
semi-synthetic  derivatives  which  are  also  used  clinically  in  dermatology  (acne, 
rosacea and perioral dermatitis) (Maibach.  1991).
Tetracyclines are constructed of linear  fused  tetracyclic  nucleus rings to  which a 
v  ariety of functional groups are attached as shown in Figure 1.2.
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Figure 1.2: Molecular structure of tetracycline, outlining sites at which modifications of the 
drug occur, and the area critical for activity (www.gsbs.utmb.edu).
Each of the rings in the fused nucleus must be six membered and carboxylic (with 
one exception: 6-thiatetracycline which has a sulphur atom at position 6 of the C 
ring) (reviewed in Chopra & Roberts, 2001). The antimicrobial and pharmokinetic 
properties of tetracyclines are strongly influenced by their chelation of metal ions 
(Broderson  et  al.,  2000)  which  occurs  at  positions  1, 2,  3,  11  and  12  (amongst 
others)  (Blackwood,  1985).  The  cation  metal  ion-tetracycline  complex  aids 
transfer across the outer membrane (through the effect of the Donnan potential (the 
electrical  potential  difference across the  membrane)  on  the complex) and  is  the 
probable active drug species that binds to the ribosome (reviewed in Levy, 1984).
1.1.1.2.2.2  Mode of Action
Tetracycline  molecules  are  attracted  to  the  cell  by  Donnan  potential  across  the 
outer membrane (Schnappinger &  Hillen,  1996).  They  enter bacteria by  passive 
diffusion,  traversing  the  bacterial  membrane  of Gram  negative  bacteria  through
28OmpF  and  OmpC  porin  channels  as  a  positively  charged  cation-tetracycline 
complex (reviewed in Chopra & Roberts, 2001; Lambs et al..  1988). This results in 
an accumulation of molecule in the periplasm. The cation complex dissociates and 
the neutral tetracycline can then diffuse through the cytoplasmic membrane due to 
its lipophilic nature (reviewed in Chopra & Roberts. 2001).
Neutral  tetracycline  molecules  transfer  across  Gram  positive  membranes  in  an 
action driven by the proton motive force (Nikaido & Thanassi,  1993).
Chelation  of the  antibiotic  occurs  in  the  cytoplasm  due  to  the  relatively  high 
concentration  of  metal  ions  within  the  cell.  This  (most-likely)  magnesium- 
tetracycline complex then binds with the 30S ribosomal subunit at one of various 
sites preventing protein synthesis (Lambs et al..  1988). All of these sites are on or 
in  close  proximity  to  aminoacyl-tRNA  binding  site  (Figure  1.3)  (reviewed  in 
Chopra  &  Roberts.  2001;  Buck  et  al..  1990).  The  binding  of  the  tetracycline 
sterically interferes with the aa-tRNA binding. There are up to six sites on the 30S 
subunit at which a tetracycline molecule can bind, but only two are actually within 
the A site (the ‘primary site' and the ‘tet-1' site) (Versalovic et al..  1997; reviewed 
in Brodersen et al..  2000).
W  ithin  the  primary  site  the  tetracyclines  do  not  bond  with  bases,  but  with  the 
sugar-phosphate  backbone  (Brodersen  et  al..  2000).  This  relative  lack  of 
specificity  is  thought  to  be  the  reason  why  tetracyclines  have  such  a  broad 
spectrum of activity.
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Figure 1.3: The primary tetracycline binding site (A site region) with rings A. B, C, and D of
the fused-ring system and possible interactions with the  16S rRNA. The shaded area represents the 
positions on the tetracycline molecule that can be modified without affecting the hydonaphthacene 
nucleus without interefering w ith its inhibitory action, (taken from Hlavka et al.,  1985).
1.1.2  The Rise of Antibiotic Resistant Bacteria
Soon  after the  discovery  and  clinical  use  of antibiotics,  resistance  was detected 
(Table 1.1).
30Antibiotic Year
discovered
First resistant strain Reference / Reviewed 
in
Penicillin 1929 early  1940s, 
Streptococcus sp.
Schneierson,  1948.
‘Protonsil Red’ 
Sulphonamide
1932 1946,
Streptococcus sp.
Alexander et al., 
1956.
Aminoglycoside 1944 1949,
Enterococcus sp.
Scott,  1949.
Chloramphenicol 1947 1950,
Salmonella sp.
Corda, 1950.
Chlortetracycline/
oxytetracycline
1949 1953.
Shigella sp.
Bryson & Demerec, 
1950.
Macrolides 1952 1952-53,
Staphylococcus spp.
Pattee & Baldwin, 
1962.
Vancomycin 1956 1986,
Enterococcus spp.
Koelbl & Catlin, 
1986.
Table 1.1  : The discovery of antibiotics and dates of first resistances.
Today  resistance  to  antibiotics  and  other  pharmaceuticals  is  one  of  the  main 
concerns for the healthcare sector, costing the NHS millions of pounds every year 
(Livermore,  1994) and limiting current and  future therapeutic choices.  Resistance 
to antibiotics in pathogenic bacteria is associated with increased rates of mortality 
and morbidity (Austin et al.. 1999; Williams, 2001).
In  response,  repeated  warnings  have  been  given  about  the  development  of 
resistance  and  the  related  threats  to  the  clinical  effectiveness  of antibiotics  by 
various  governing  bodies  (Degener,  1999;  McCaig,  1995;  Hoiby,  2000;  Fish, 
1995), and there have been many reports calling for the implementation of polices 
on  the  use  of  antibiotics  (Stratchounski  et  al.,  2005;  Bronzwaer  et  al.,  2004,2002a,b;  Casewell  et  al..  2003;  Hooton  et  al.,  2001;  Cizman  et  al.,  2004)  in  an 
attempt to limit resistance.
1.1.2.1  Antibiotic Resistant Bacteria
Iable  1.1  illustrates how quickly bacteria have been in responding to the selective 
pressures exerted in the clinical setting. These resistances have also quickly spread 
to the community and now resistant bacteria have been isolated from almost every 
environment investigated (Barbosa et al..  2000; Kummerer et al.,  2004).
1.1.2.1.1  In Clinical Environments
Hospitals  offer  an  environment  conducive  to  the  development  and  spread  of 
antibiotic  resistance.  Heavy  exposure  to  antimicrobial  agents  provide  a  strong 
selective  pressure,  and  a  high  population  density  offers  greater opportunities  for 
spread  compared  to  other  environments  (Tenover.  1996).  Consequently,  the 
emergence  of  nosocomial  infections  caused  by  multidrug-resistant  bacteria  is 
increasingly  reported.  Examples  include  MRSA  strains,  most  of  which  are 
resistant  to  all  antibiotics  with  the  exception  of glycopeptides  (Tenover.  2004; 
Khan et al..  2000;  Moore &  Lindsay.  2002).  Until  recently vancomycin  has been 
used as a last line of defense against MRSA infections, however, recent decreased 
susceptibilities  to  vancomycin  have  been  reported  in  Japan  and  the  USA 
(Hiramatsu,  1997),  and  UK  (Woodford.  2000).  In  addition,  enterococci  are 
intrinsically  resistant  to several  commonly  used  antibiotics and  have  been  shown 
able to acquire resistance to all  currently available antibiotics either by mutations
32or by transfer of mobile genetic  elements (Zirakzadeh &  Patel, 2006;  Mascini  & 
Bonten, 2005).
In  the developed  world,  up to  60% of hospital-acquired  infections are caused  by 
VRH and MSRA (Morris et al..  1995). They can cause a broad range of symptoms 
depending  on  the  site  of  infection,  but  are  commonly  associated  with  wound 
infections or more seriously, blood infections (Garnier et al.. 2000a).
1.1.2.1.2  In The Community
In  the  community,  the  most  common  infections  caused  by  antibiotic  resistant 
bacteria  are  by  pathogens  that  cause  respiratory  and  gastrointestinal  infections 
(Table  1.2).  Some  of these  bacteria  are  likely  to  have  spread  from  hospitals  or 
farms  where the  high  use  of antibiotics  has  produced  a strong  selective pressure 
(Smith  et  al..  2005).  They  then  emerge  upon  sporadic  use  of antibiotics  by  out 
patients,  and  remain  due  to  incorrect  administration  of the  drugs  (Austin  et  al.. 
1999).  Following  their  establishment  they  may  spread  amongst  the  population 
(Witte. 2004).
In  addition,  some  multi-drug  resistant  pathogens  have  developed  in  the 
community.  These  include  CA-MRSA  (community  aquired-MRSA)  which 
exhibits different  PFGH  and  MLST  profiles  to  those  strains  which  developed  in 
hospitals,  and  which  is emerging as  a  major public  health concern (Witte.  2004; 
Drews et al..  2006).
33Pathogen Disease Antibiotic for 
treatment
Resistance
Phenotype
Reference
Streptococcus
pneumoniae
Pneumonia.
Meningitis
Penicillin/
Erythromycin
PenR.
ErmR. TetR. 
CmpR, TriR
Felmingham 
et al., 2002 
Diaz-Meija et 
al., 2002 
Gay & 
Stephens 
2001
Montanari et 
al., 2003 
Perez- 
Trallero 
2001a. 2001b
Streptococcus
pyogenes
Respiratory
tract
infections
Penicillin ErmR Farrell et al., 
2006
Seisseria
meningitides
Meningitis Penicillin ErmR. PenR Florez et al., 
1997
Haemophilus
influenzae
Influenza Penicillin PenR. Johnson et 
al., 2006
\  tor  axe I  la 
catarrhal  is
Respiratory
tract
infections
Penicillin PenR.
AmpR
Fung et al., 
1994
Walker et al., 
2000
Salmonella
typhimurium
Gastroenteritis Fluoroquinolone FlrR Izumiya et 
al.,  2005
C  'ampylohacter 
jejuni
Gastroenteritis Erythromycin ErmR W Yan et al., 
1991
Vaishnavi & 
Kaur, 2005
Table  I. 2: Common antibiotic-resistant community pathogens.  Resistance phenotypes:  Pen. 
penicillin: erm. erythronncin: tet. tetracycline: cmp. chloramphenicol: tri. trimethoprim- 
sulfonamide.
1.1.2.1.3  In Agriculture
The wide-spread use of antibiotics in agriculture as growth promoters has resulted 
in the rise of antibiotic resistant bacteria in  farms (van den  Bogaard et al.,  2000). 
These can then spread to the community and lead to transfer of resistance genes to 
pathogens (as discussed above) (Smith et al.,  2005). A commonly cited example is 
the use of avoparcin as a growth promoter in cattle farming. Avoparcin resistance
34genes  were  soon  found  in  bovine  commensals,  and  studies  have  shown  that 
resistance  has  spread  to  the  commensal  organisms  of the  farmers  (Smith  et  al, 
2005: Casewell et al,  2003;  Wegener et al,  1999).  Such findings have led to the 
banning of the  use of most antibiotics  for this  purpose  in  most of the developed 
world (Casewell et al,  2003). however, the use of some tetracyclines, ionophores 
and glycolipids remains legal (Butaye et al, 2001).
1.1.2.2  The Relationship Between Antibiotic Use and Resistance.
One of the  major causes of increasing  antibiotic  resistance  is  increased  selective 
pressure i.e.  increased volume of drug use (Austin et al..  1999).  Evidence for the 
relationship between  antibiotic  use and  resistance  is widely  documented  and can 
be  referred  to  in  terms of geographical  and chronological  trends (Baquero  et  al, 
2002; Mueller et al,  2006).
Figure  1.4 illustrates the effect of increased use of antibiotics as growth promoters 
in  chicken  broilers  in  Denmark  before  their  ban.  and  the  subsequent  decrease 
following this ban.
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Figure  1.4  :  The  use  of  antimicrobials  virginiamycin  (A)  and  avilamycin  (B)  in  Danish 
farming as growth promoters, and the levels of resistance to virginiamycin (A) and avilamycin (B) 
in  enterococcal  isolates  taken  from  chicken  broilers between  the  years  1994 -  2000.  Data  taken 
from Aarestrup et al., 2001
In  this  case a decrease  in  resistance  is  observed  when  the  selective  pressure  is 
removed.  Presumably  because the carriage of resistance  is costly  to the cell and 
therefore  is  lost  in  the  majority  of the  population  (Austin  et  al.,  1999).  The 
sensitive strains can then out-compete resistant strains (Dahlberg & Chao, 2003). 
This pattern  has also  been  seen  in similar cases since the  EU  ban of the use of
36avoparcin,  tylosin,  and  spiramycin  as  growth  promoters  (Bywater  et  al.,  2005, 
Aarestrup et al..  2001).
Examples  have  also  been  observed  in  clinical  settings  such  as  in  a  New  York 
hospital  where  the  phasing out  of certain  classes  of cephalosporins  resulted  in  a 
significant  decrease  in  the  rates  of  resistance  amongst  Klebsiella  spp.  isolates 
(Rahal et al.,  1908).  Similarly, a study in Iceland based around the clinical  use of 
penicillin  and  its  associated  rates  of  resistance  in  pneumonococci  has  shown 
significant  decreases  in  resistance  only  occur  when  corresponding  decreases  in 
drug use were made (Austin et al..  1999).
1.1.2.2.1  Persistence of Resistance.
Despite the above examples,  it  is widely reported that antibiotic  resistance genes 
exist  in  a  host even  in  the absence of a selective pressure (Guillemot &  Carbon, 
1999). Many proteins encoded by resistance genes target essential macromolecules 
such as the ribosome.  DNA  gyrase.  RNA  polymerase or the cell  wall  (Tenson & 
Mankin. 2006). Such targets usually have deleterious effects resulting in decreased 
bacterial  fitness  (increased  energy costs,  reduced  growth  rate)  (Maisnier-Patin  et 
al..  2002).  However,  in  some cases the  fitness costs associated with carriage of a 
resistance determinant are compensated  for with a mutation (N  Luo et al.,  2005). 
One such example is in streptomycin resistant Escherichia coli which was found to 
undergo  second  site  mutations  that  compensate  for  some  of the  fitness  costs  of 
rpsL  mutations  (which  confer  streptomycin  resistance)  over  500  generations 
(Bouma &  Lenski.  1988;  Lenski  et al.,  1991).  Such mutations convey a selective 
advantage  over the  original  sensitive  strains  (which  are  then  out  competed),  and
37virtually preclude the evolved resistant lineages from reverting to drug sensitivity 
(Schrag et al..  1997).
Selection  will  also  favour  resistant  strains  with  enhanced  survival  ability  or 
virulence (Livermore,  1993), such as those which harbour resistance determinants 
linked  to  genes  that  confer a  favourable  phenotype  such  as tetracycline  resistant 
infantile colonic E.  coli in which strains which carry tet(A) and tet(B) more often 
contain  the  genes  for  P  fimbriae  compared  to  tetracycline  susceptible  strains 
(Karami et al.. 2006: Krulwich et al..  2005).
1.1.3  Types of Resistance
1.1.3.1  Intrinsic and Acquired Resistance
1.1.3.1.1  Defining Resistance
Resistance is considered if a bacterium is not susceptible to a drug, or if it possible 
to demonstrate a mechanism for resistance in vitro (Degener.  1999).
Resistance to antibiotics is caused by a variety of mechanisms (Livermore. 2003):
1). Presence of an enzyme that inactivates the antibiotic.
2).  Presence  of an  alternative  enzyme  to  that  which  is  being  acted  upon  by  the 
antibiotic.
3). Mutation in the antibiotic's target site preventing or reducing binding.
4). Change in the target site caused by another protein.
5). Posttranscriptional or posttranslational modification of the antibiotic's target.
6). Reduced uptake i.e. permeability barrier.
7). Active efflux of the antibiotic.
8). Compensatory over-production of the target.
38As with all genes,  it  is commonly considered that two resistance genes are of the 
same  class  if  the  exhibit  >80%  similarity  in  their  amino  acid  sequence,  and 
different if <80% (Levy et al..  1999).
1.1.3.1.2  Intrinsic Resistance
Intrinsic resistance is defined as that which is present in all the members of a given 
species or genus (Nelson,  1999).
Many clinically important Gram negative bacteria exhibit intrinsic  resistance to a 
number of different antibiotics (Kumar & Schweizer. 2005). In Gram negatives the 
outer  membrane  lipopolysaccharide  is  much  less  fluid  than  the  inner  membrane 
and charged molecules have been shown to permeate the outer membrane at up to 
100 times  less  than  the  rate of the  usual  phospholipid  bi-lavers (Nikaido.  1994). 
Thus hydrophobic  antibiotics are  unable to easily  cross  into the cell.  In addition, 
the  porins  used  to  translocate  essential  nutrients  in  Gram  negatives  use  an 
extremely narrow  aqueous diffusion channel (7-10 A in E.  coli) and are lined with 
charged amino acid residues that prevent the entry of antibiotics this way (Nikaido.
1994).  In P.  aeruginosa. the passage of P-lactams is prevented due to the absence 
of these  'classical'  porins  and  the  presence  of a  low  affinity  porin  (Parr  et  al.. 
1987).  In addition, in P.  aeruginosa the up regulation of the MexAB-OprM operon 
is  responsible  for  the  activation  of a  multidrug  resistance  pump  that  is  always 
expressed to some degree as part of the excretion of the quorum  sensor mediator 
homoserine  lactone  (Xiha-Zarifi  et  al..  1999).  T  his  is  an  example  of genetically 
mediated  intrinsic  resistance  (Li  et  al..  1994)  and  the  over-expression  of such 
pumps  can  significantly  raise  MICs.  In  this  case,  the  MIC  of P.  aeruginosa  to
39carbenicillin has been reported to be up to 2000 times higher than that of a mutant 
with no efflux pump (Nikaido,  1998).
In  Gram  positive  bacteria,  the  outer  peptidoglycan  layer  appears  to  offer  little 
resistance  to  the  diffusion  of  antibiotics  (Schnappinger  &  Hillen,  1996).  One 
exception  are  the  Mycobacteria  since,  in  addition  to  a  peptidoglycan  layer  they 
also posses an outer lipid bi-layer of high order and thus lower fluidity, to prevent 
the  diffusion  of antibiotics  (Philalay  et  al.,  2004;  Nguyen  &  Tompson.  2006). 
However,  efflux  systems  of  Gram-positive  organisms  belonging  to  the  MFS. 
SMR, or ABC  families confer resistance to weakly  lipophilic agents and organic 
cations (Nikaido.  1994; Putman et al., 2000; van Veen & Konings,  1998).
1.1.3.1.3 Acquired Resistance
Acquired  resistance  is  present  only  in  certain  isolates  of  a  species  or  genus 
(Salyers & Amabile-Cuevas.  1997).
1.1.3.1.4 Origin of Antibiotic Resistance Genes
The origin of antibiotic resistance genes in pathogenic bacteria is  unclear.  Use of 
antibiotics  in  a  clinical  setting  has  only  been  widespread  in  the  last  -60  years 
(Livermore.  2004b).  therefore  it  is  highly  unlikely  that  spontaneous  mutation  is 
responsible  for  the  creation  of genes  which  confer  resistance  via  mechanisms 
which  require  the  cooperative  action  of  several  proteins.  In  contrast,  efflux  of 
antibiotics  may  be  conferred  by  the  mutation  of  existing  export  mechanisms 
(Paulsen et al.,  1996).
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inhibit their corresponding antibiotic (Wiener et al.,  1998). The first identification 
of these  self-protecting mechanisms  was  in Streptomyces sp.  and  soon  led to the 
hypothesis  that  resistance  was  at  least  in  part  due  to  the  dissemination  of genes 
from  these  organisms  (Davies, 1994a,  1994b).  Sequence  analyses  have  since
confirmed  this  theory  (Wiener et  al.,  1998;  Zilhao  et  al.,  1988) identifying
Streptomyces sp. as the original hosts of neomycin acetyltransferase (Sm. fratliae): 
viomycin phosphotransferases {Sm.  vinaceus): vancomycin resistance determinant 
vanA  {Sm.  coelicolor)  (Gamier et  al..  2000);  ribosomal  methylases  conveying
resistance  to  thiostrepton  {Sm.  azureus)  and  MLS  antibiotics  {Sm.  erythreus)
(Thompson et  al..  1982).  In addition,  beta-lactams are thought to be spread  from 
beta-lactam-producing  organisms  such  as  filamentous  fungi  and  actinomycetes 
(Liras & Martin. 2006).
1.1.3.1.5  The Role of Mutations in the Emergence of Resistance.
Mutation is one of the major contributors to antibiotic resistance in bacteria via the 
production of changes  in existing drug targets  (Hooper,  2001) or through effects 
on the  regulatory  systems (Barbosa &  Levy,  2000).  This results  in a decrease  in 
the  affinity  of  the  antibiotic  for  the  targets,  for  example  emerging  linezoid 
resistance in enterococci  is due to the mutational modification of the domain V of 
the 23S rRNA gene which contains the antibiotic binding site (Livermore,  1993). 
Furthermore,  it  is  a  key  process  in  refining existing  resistance  genes,  potentially 
increasing the  MIC  (Pillai  et al..  2001).  as  is the case  for quinolone resistance  in 
clinical  isolates  of .S ’   pneumoniae:  those  with  substitutions  at  Ser79  (to  Phe)  in
41ParC and Ser81  (to Phe) in GyrA were found to have the highest MICs (Broskey et 
al.,  2000).  In addition, the  MICs of fluroquinolone resistant C. jejuni and C.  coli 
were  tound  to  be  increased  by  up  to  128-fold  with  point  mutations  of gyrA  at 
codon 86 (Ihr-Ile) (Ge et al.. 2005).
1.1.3.1.6  Co-Selection of Resistant Determinants
In  addition  to  the  consequences  of  a  direct  selective  pressure,  the  use  of 
macrolides.  including  erythromycin  and  sulfamethoxazole-trimethoprim  are  also 
associated  with  selection  of tetracycline resistance  (Nielsen et  al.,  2004).  Such a 
phenomenon  is termed co-selection.  Co-selection occurs when antibiotic resistant 
determinants  are  linked  together  by  their  carriage  on  the  same  mobile  genetic 
element  leading to the development of multidrug-resistant strains (Nielsen et  al., 
2004;  Tenover.  2004;  Khan  et  al.,  2000).  The  modular  structure  of  genetic 
elements  lends  itself well  to  this  phenomenon  (Section  1.2.4)  (Shapiro  et  al., 
2005).  MRSA  (resistant  to  glycopeptides.  macrolides.  aminoglycosides, 
tetracycline, rifampin, sulfonamides and pefloxacin. with reduced susceptibility to 
fusidic acid and fosfomycin) and VRT (resistant to aminoglycosides, vancomycin 
and teicoplanin) are examples of pathogenic bacteria that exhibit cross-resistance 
(Carias et al..  1098; Moore & Lindsay. 2002; Bonten. 2001).
In addition, there is also a growing body of evidence that shows that resistance to 
toxic  metals,  such  as  mercury,  is  linked  to  antibiotic  resistance  determinants 
through  either  co-existance  on  the  same  genetic  element  (Davis  et  al.,  2005)  or 
cross-resistance (resistance to metals and antibiotics being conferred  by  the same 
resistance determinant - often an efflux pump) (Baker-Austin et al.,  2006).
421.1.3.2  Resistance to Different Classes of Antibiotics
1.1.3.2.1  Macrolides
1.1.3.2.1.1  Classification of Macrolide Resistance
Macrolides are inhibitors of protein synthesis and are bacteriostatic (Roberts et al.. 
1999b).  Gram  negative  bacteria  are  usually  intrinsically  resistant  to  these 
antibiotics due to the low permeability of their membranes to the drugs (reviewed 
in LeClercq & Courvalin,  1991).
Three mechanisms of resistance to macrolides have been reported so far.
The methylases modify the 23S rRNA subunit at a site universal to all macrolide 
targets (reviewed in Roberts et al..  1999b) this also confers cross-resistance to the 
*MLSb'  antibiotics,  including  lincosamides  and  streptogramin  B;  chemically 
distinct, hydrophobic compounds which bind at the same site in the 50S ribosomal 
subunit (Vester & Douthwaite. 2001).  These genes do not convey resistance to the 
streptogramin A-type antibiotics.
In  contrast,  some  erythromycin  resistance  determinants  which  encode  efflux 
pumps,  and  those  that  encode enzymatic  inactivation  systems  (see  Table  1.3) do 
not have the MLS phenotype of resistance (Vester & Douthwaite. 2001).
Those  isolates  carrying  only  m e fgenes  are  typically  described  as  exhibiting  the 
*M'  phenotype  (Macrolide resistance) and remain susceptible to lincosamide and 
streptogramin B (reviewed in Roberts et al.,  1999b). msr (macrolide streptogramin 
resistance) genes confer resistance to the streptogramin B antibiotics in addition to 
the macrolides but remain susceptible to clindamycin (MS phenotype) (Johnston et 
al.  1998).
431.1.3.2.1.2  Resistance Mechanisms
1.1.3.2.1.2.1  Methylases
Macrolides dissociate the  peptidyl-tRNA  molecule  from the  ribosome during the 
early stages of elongation, thus preventing protein synthesis resulting in a lack of 
functional  ribosomes  within  the  cell  (reviewed  in  Vester,  2001;  Roberts  et  al., 
1999b).  In  1953,  the  first  resistance  to  this  drug  was  reported  due  to  the  post- 
transcriptional  modification  of the  23S  rRNA  by  adenine-A^-methyltransferase 
which  adds  a  methyl  group  to  a  specific  adenine  in  the  23S  rRNA  moiety,  an 
important residue in the binding of MLSb antibiotics (Vester, 2001). A number of 
enzymes exist in different genera and are responsible for unique modifications and 
variations  in  MIC  amongst  species.  In  the  case  of E.  coli  modifications  to  the 
A2058  adenine  confer  the  highest  level  of  resistance  (reviewed  in  Weisblum,
1995).  In S.  pneumoniae  the  A2059  adenine  is  modified  causing  relatively  low- 
level resistance, and in //. pylori the A2057 residue is methlyated conferring low- 
level  resistance  to  14-membered  macrolides.  but  no  resistance  to  16-membered 
lactones  (reviewed  in  Weisblum,  1995).  Methylases  have  been  catalogued  using 
the erm  designation  for methylases (Erythromycin  Ribosome  Methylation) (Fluit 
et al.,  2001)
The erm alphabet was  first described  in detail  by  Marylin  Roberts et al.  in  1999.
I he  review  brought  into  line  all  previous descriptions  of resistance  mediated  by 
methlytransferases  which  had  been  confusing  and  had  incidences  of the  same 
designation being given to unrelated genes, and different names being given to the 
same gene.
44The erm genes are summarised in Table 1.3.
Mode of 
Action
Gene Genera in which the gene is commonly found
Methylases erm(A) Actinobacillus, Staphylococcus, Streptococcus
erm(B) Abiotrophia, Actinobacillus, Bacteroides, Campylobacter, 
Clostridium, Escherichia, Enterococcus, Fusobacterium, 
Haemophilus, Klebsiella, Neisseria, Pediococcus, 
Peptostreptococcus, Prevotella, Staphylococcus, 
Streptococcus,  Wolinella
erm(C) Actinobacillus. Bacillus,  Campylobacter, Eubacterium, 
Haemophilus, Lactobacillus, Neisseria, Peptostreptococcus, 
Staphylococcus, Streptococcus,  Wolinella
erm(D) Bacillus
erm(E) Streptomyces
erm( F) Actinobacillus, Actinomyces, Bacteroides, Clostridium, 
Eubacterium , Fusobacterium, Gardnerella, Haemophilus, 
Neisseria, Porphyromonas, Prevotella, Peptostreptococcus, 
Selenomonas, Streptococcus,  Treponema,  Veillonella, 
Wolinella
erm( G) Bacillus, Bacteroides
erm{ H) Streptomyces
erm{ I) Streptomyces
erm(N) Streptomyces
erm( O) Streptomyces
erm(Q) Actinobacillus, Campylobacter, Clostridium, Streptococcus, 
Wolinella
erm(R) Aeromicrobium
erm( S) Streptomyces
erm{ T) Lactobacillus
erm(V) Streptomyces
erm{\) Streptomyces
erm( W) Micromonospora
erm(X) Corynebacterium
erm(Y) Staphylococcus
Clr Streptomyces
ATP-Binding
Transporters
msr(A) Staphylococcus
vxa( A) Staphylococcus
vgaiB) Staphxlococcus
Major
Facilitator
Superfamily
Transporters
mef{ A) Corynebacterium, Enterococcus, Micrococcus, 
Staphylococcus, Streptococcus
lmr{ A) Streptomyces
Esterases
ere( A) Enterobacter, Escherichia, Klebsiella, Citrobacter
ere{ B) Escherichia, Klebsiella, Proteus
Hydrolases
v ^ A ) Enterococcus, Staphylococcus
vv?MB) Staphylococcus
Transferases
vat( A)-(C) Staphylococcus
45vat{DHE) Enterococcus
Phosphory lases
mph(A), 
mph{ B)
Escherichia
mphl Staphylococcus
Table 1.3:  Erythromycin  resistance determinants and their hosts (updated from Roberts.  1999: 
Cooper,  1996; Cousin et al. 2003;).
Other  methylase  genes  including  tlr{D),  m<Jm(A)  and  others  (see  Table  1.3)  all 
offer resistance to  16-membered ring macrolides, however,  these genes have not 
yet been found outside their antibiotic producing host (reviewed in Roberts et al., 
1999b).
As a result of these investigations, the synthesis of novel macrolides has focused 
on  the  development  of  drugs  that  target  ribosomes  that  have  already  been 
methylated at A2058 (LeClercq et al., 2002).
1.1.3.2.1.2.2  Efflux genes
A further mechanism of macrolide resistance is the efflux of the antibiotic from the 
cell  by  pumps  in the  cellular membrane  (reviewed  in  Roberts et al.,  1999b).  At 
present there are three classes of pumps in Gram positive cocci: the mef,  msr and 
vga classes.
Macrolide efflux {mef) genes are commonly found on conjugative elements in the 
chromosome which  are capable of intergeneric transfer (Luna et al,  1999).  The 
best characterised m ef genes, mefA and mefE were isolated from Sm. pyogenes and 
Sm.  pneumoniae,  respectively  (Clancy  et  al,  1996;  Arpin  et  al,  1999).  These 
genes convey the M phenotype. The encoded pumps have homology to the major 
facilitator  superfamily  (MFS)  of efflux  proteins  (LeClercq,  2002).  They  exhibit
4690% DNA homology and 91% amino acid homology to each other, thus are now 
considered to be in a single class: mef  [A) (reviewed in Klaasen & Mouton, 2005). 
The mechanism of transport of the antibiotic across the membrane is via secondary 
active transport (transfer of molecules using the advantage of a previously existing 
concentration  gradient,  therefore  no  ATP  is  required).  mef(A)  is  in  the  DHA3 
(DrugdT  antiporter-3)  family,  which  use  a  proton  gradient  as  the  driving  force 
(reviewed in Roberts et al.,  1999b).
The msr (macrolide streptogramin  resistance)  genes are  putative  members of the 
ABC  transporter  superfamily  and  convey  the  MS  phenotype  (Reynolds  et  al, 
2003: reviewed in Roberts et al,  1999b). The most common genes in this class are 
msr  A  and  msrB  which  were  both  found  in  Staphylococcus  aureus  isolates 
(Reynolds  et  al.,  2003)  and  are  both  primary  active  transporters  of the  drug  El 
(drug exporter  1) family. ABC transporters involved in drug efflux use ATP as an 
energy  source  (Van  Bambeke.  2000).  The  efflux  machinery  contains  two  ATP 
binding cassettes. Upon hydrolysis and antibiotic binding a conformational change 
occurs  in  the  hydrophobic  membrane  spanning  domains  exporting  the  antibiotic 
resulting in export of the drug (Garmory. 2004: Reynolds et al.,  2003).
The third class of efflux pumps consists of the vga (virginiamycin factor A) genes 
also identified in staphylococci (Allignet & El Solh.  1997). These confer resistance 
to the streptogramin A antibiotics (reviewed in Roberts et al.,  1999b).
In  addition,  a  further  efflux  pump  providing  resistance  to  lincosamide  only  has 
been  described  in  Sm.  lincolnensis.  encoded  by  the  ImrA  gene  (reviewed  in 
Roberts et al.,  1999b).
471.1.3.2.1.2.3  Other mechanisms
Other mechanisms of resistance against the individual antibiotic classes also exist 
including  enzymes  that  hydrolyse  streptogramin  B  (encoded  by  vgb  and  vgAB). 
and  those  that  modify  streptogramin  A  antibiotics  by  the  addition  of an  acetyl 
group (encoded by vat. vat B, vatC. sat A and satG) (Nakajima.  1999).  Macrolides 
can also be affected  by enzymatic  inactivation.  Hydrolysis of the  lactone  ring of 
the macrocyclic nucleus by EreA and EreB (Leclerq, 2002). and the addition of a 
phosphate on the 2'-hydroxyl-group of the amino sugar by the type I (MphA) and 
type  II  phosphotransferases  have  been  reported  in  Enterobacteriacaea  and  S. 
aureus (reviewed  in  Roberts et al..  1999b:  Ounissi  &  Courvalin,  1985; Arthur et 
aL  1986).
1.1.3.2.1.2.4  Regulation of Resistance
Inducible expression of the erm genes can occur in the presence of erythromycin, 
and  in  some  cases  lincosamides  or  streptogramin  B  (Weisblum.  1995).  This  is 
dependent on altered  secondary structure upstream of the gene in the presence of 
the  antibiotic  in a mechanism  involving translational  attenuation (Gryczan et  al., 
1980; Werckenthin et al..  1999; reviewed in Weisblum 1995).
1.1.3.2.2  Tetracyclines
1.1.3.2.2.1  C lassification of Resistance
Resistance to tetracyclines has developed over time with significant increases only 
apparent  since their wide  use  in clinical  and environmental  settings (reviewed  in 
Chopra  &  Roberts,  2001).  Tetracycline  resistance  can  be  mediated  through  a
48variety of mechanisms. Ribosomal protection and efflux of the drug across the cell 
membrane are common.  However, enzymatic inactivation has also been reported, 
and some genes have yet to be assigned a mechanism (reviewed in Roberts, 2005). 
Genes encoding resistance are all designated tet. for tetracycline resistance unlike 
the  macrolide  resistance  genes  which  have  different  designations  according  to 
resistance mechanism (Levy et al.,  1999).
The  increasing number of tet genes has  meant that the method of nomenclature 
using the letters of the alphabet is insufficient and numbers from 30 onwards are 
now used for novel genes, otr (oxytetracycline resistance) genes also exist. These 
are  used  to  designate  those  genes  first  identified  in  oxytetracycline  producing 
organisms,  however,  there  is  no  inherent  difference  between  tetracycline  and 
oxytetracycline resistance genes (reviewed in Chopra and Roberts. 2001; Speer et 
al.,  1992).
To  date  23  efflux  genes  (20 tet genes.  2  otr genes and  1   ter gene  (tetracycline 
resistance  gene  from  a  tetracycline-producing  Streptomyces  sp.);  11  Ribosomal 
Protection Protein (RPP) genes (10 tet genes,  1   otr gene); three enzymatic (all tet 
genes) and one gene of unknown mechanism (tet(U)) have been reported (Table 
1.4).
Class of 
tetracycline 
resistance 
gene
Gene Genera where the gene is commonly found
Ribosomal
protective
proteins
Eikenella, K  ingel  I  a, Neisseria, B  act  ero  ides, Fusobacterium, 
Haemophilus,  Veillonella, Pasteurel  la, Abiotrophia, Arcanobacterium, 
Bacillus, Butyrivihrio, Gemella, Mycoplasma,  Ureaplasma, 
Actinomyces, Aerococcus, Bifidobacterium, Gardnerella, 
Corynebacterium,  Eubacterium, Bacillus, Listeria, Staphylococcus, 
Clostridium, Peptostreptococcus, Eneterococcus, Streptococcus, 
Acinetobacter, Afipia, Enterobacter, Erysipelothrix, Escherichia, 
Klebsiella, Lactobacillus, Lactococcus, Microbacterium, Mitsuokella, 
Mycobacterium, Neisseria, Prevotella, Porphyromonas, Ralstonia,
49M O ) 
tetB{?)
M Q )
tet( S) 
M  T) 
M  W)
M  32) 
M  36)
Photobacterium, Pseudomonas, Selenomonas, Streptomyces,  Vibrio 
Campylobacter, Butyrivivrio, Aerococcus, Lactobacillus, Mobilunocus, 
Staphylococcus, Peptostreptococcus, Enterococcus, Streptococcus, 
Megasphaera, Neisseria 
Clostridium
Capnocytophaga, Prevotella, Mitsuokella, Selenomonas, 
Porphyromonas, Bacteroides,  Veillonella, Garnerella, Lactobacillus, 
Mobiluncus, Eubacterium, Clostridium, Peptostreptococcus, Neisseria 
Listeria, Enterococcus, Streptococcus, Streptococcus,  Veillonella 
Streptococcus
Butyrivibrio, Mitsukella, Selenomonas, Porphyromonas, Fusobacterium, 
Bifidobacterium, Actinomyces, Aranobacterium, Bacillus, Clostridium, 
Lactobacillus, Mitsuokella, Megasphaera, Neisseria, Prevotella, 
Porphyromonas, Roseburia, Selenomonas, Streptococcus, Streptomyces, 
Veillonella 
Clostridium
Bacteroides, Clostridium, Lactobacillus
Inactivating M X ) Bacteroides
enzymes M 37) Unknown
Efflux pumps tet(A) Edwardsiella, Plesiomonas, Proteus, Pseudomonas, Serratia, 
Citrobacter, Klebsiella, Shigella, Salmonella, Aeromonas,  Vibrio, 
Escherichia, Acinetobacter, Haemophilus,  Veillonella
M B) Eminia, Moraxella, Pantoea,  Treponema, Providencia, Plesiomonas, 
Enterobacter, Marheimia, Proteus, Serratia, Citrobacter, Klebsiella, 
Shigella, Salmonella, Aeromonas,  Vibrio, Escherichia, Haemophilus
tet(C) Enterobacter, Proteus, Pseudomonas, Serratia, Citrobacter, Klebsiella, 
Shigella, Salmonella,  Vibrio, Escherichia, Aeromonas, Chlamydia
M  D) Yersinia, Edwardsiella, Pleisomonas, Enterobacter, Citrobacter, 
Klebsiella, Shigella, Salmonella, Aeromonas,  Vibrio, Eschericia, 
Pasteurella, Alteromonas
M E) Aeromonas, Alcaligenes, Escherichia, Providencia. Pseudomonas, 
Vibrio
tet( F) unknown
M G ) Escherichia, Marheimia, Pasteurella, Providencia, Pseudomonas, 
Salmonella,  Vibrio
M H ) Acinetobacter, Actinobacillus, Marheimia, Moraxella, Pasteurella
tet(  I) Escherichia, Providencia
M J) Proteus
M K ) Eubacterium, Haemophilus, Norcardia, Bacillus, Listeria, 
Staphylococcus, Clostridium, Peptostreptococcus, Enterococcus, 
Streptococcus, My cobacterium, Streptomyces, Lactobacillus, Norcardia, 
Streptomyces
/e/(L) Fusobacterium,  Veillonella, Actinomyces, Bacillus, Listeria, 
Staphylococcus, Clostridium, Peptostreptococcus, Enterococcus, 
Streptococcus, Mycobacterium, Streptomyces, Actinobacillus, 
Morganella, Norcardia, Salmonella,  Veillonella
/e//J(P) Clostridium
M V ) Mycobacterium
M Y ) Escherichia
M Z) Corynebacterium
M 30) Agrobacterium
M 33) Corynebacterium
I n ­
dependent
resistance
7W(34) Aeromonas, Pseudomonas, Serratia,  Vibrio
Unknown
mechanism
M U ) Enterococcus
Table  1.4  :  Tetracycline  resistance determinants and  their  host  ranges (adapted 
from Roberts, 2005; Guardabassi et al., 2000).
501.1.3.2.2.2  Resistance Mechanisms
1.1.3.2.2.2.1  Efflux Genes
The efflux genes are well characterised. The protein products belong to the major 
facilitator  superfamily  (MFS)  and  are  membrane  associated  proteins  of 
approximately 6 kDa (Guay et al..  1993). The N-terminal halves of MFS proteins 
show a high degree of homology to each other and have been implicated in proton 
translocation,  whereas the  C-terminal  halves  differ due to  their  predicted  role  in 
substrate recognition (Paulsen et al..  1996). For transport to occur, the tetracycline 
molecule  needs to  be  part of a metal-tetracycline  complex.  Mg2^  ions have  been 
implicated as the divalent cation required (Yamaguchi et al..  1991).
Part of the antibiotic binding site is in the transmembrane helix 4. which fluctuates 
between high and low fidelity states (Hirai et al..  2003; Allard & Bertrand,  1993). 
The binding of the drug induces a conformational change in the gating site which 
opens and closes with the affinity change of the binding site (Hirai  et  al.,  2003). 
The H*  transfer site is where the external proton will bind, the affinity of which is 
also probably affected by the opening and closing of the gate (Yamaguchi et al., 
1991).
1.1.3.2.2.2.2  Ribosomal Protection Protein Genes
The Ribosomal  Protection Proteins (RPPs) are all approximately 72.5 kDa soluble 
cytoplasmic proteins (reviewed in Roberts. 2003; Taylor & Chau.  1996).  I he most 
common  tet  genes  encoding  RPPs  are  /e/(M).  tet(O)  and  tet(W)  which  encode 
proteins  of approximately  650  amino  acids  (reviewed  in  Roberts.  1996;  Burdet, 
1991).  The  amino  acid  sequences  of  these  proteins  are  all  closely  related  to
51translational  elongation  factors  (Aminov  et  al.,  2001;  Connell  et  al.,  2003b; 
reviewed  in  Taylor  &  Chau,  1996).  In  particular,  their  N-terminal  regions  are 
similar  to  the  GTPases  of  EF-Tu  and  EF-G  (Sanchez-Pescador  et  al..  1988; 
Kjeldgaard  &  Nyborg.  1992).  EF-G  is  a  translocase  which  catalyses  the 
translocation  step  of  protein  synthesis  involving  a  ribosomal  conformational 
change  in  order  to  move  the  mRNA  molecule  (Spahn  et  al..  2001).  EF-Tu  is 
involved  in  the  delivery  of the  aa-tRNA  to  the  A  site  through  the  hydrolysis  of 
GTP  (Spahn  et  al.,  2001).  It  is  believed  that  the  RPPs  have  evolved  from  the 
elongation factors to function in the presence of tetracycline (Connell et al.. 2003).
Tet(M) and Tet(O) dislodge the tetracycline molecule from the A site to free it for 
the aa-tRNA to enter (Dantley  et  al..  1998)  (Figure  1.5).  Tet(O) primarily  binds 
with the ribosome at helix 34 of the  16S subunit (Spahn et al.,  2001) producing a 
conformational  disturbance  and  causing  the  dissociation  of  the  tetracycline 
molecule  resulting  in  a  return  to  the  ribosomal  elongation  cycle  (Connell  et  al., 
2002).  Once Tet(O) has  itself dissociated  from the ribosome the entry of the  EF- 
Tu-GTP-aa-tRNA  complex  into  the  A  site  is  permitted.  However,  the  Tet(O) 
induced  conformation  persists  after  it  has  left  the  ribosome  to  prevent  the 
rebinding of tetracycline molecules (Connell et al.. 2003a).
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Figure  1.5  :  Comparison of the binding site of Tet(O) (A) and  tetracycline (B).  Diagram shows a 
ribbon model of the 16SrRNA molecule (colour coded: Yellow, helix  18; cyan, helix 31; pink, helix 34; 
blue, protein SI2) and Tet(O) or tetracycline (green). Tet(0) binds in close proximity to the tetracycline 
binding site, interacting with helix 34 and helix  18 of the  16S rRNA. Tetracycline binding is primarily 
at  helices  34  and  31  therefore  it  is  likely  that  Tet(0)  displaces  tetracycline  molecules  by  a  local 
disturbance of helix 34.
Small diagram shows the position of tet(O) with regard to the whole  16S rRNA molecule (taken from
1.1.3.2.2.2.3  Enzy matic Inactivation and Genes of Unknown Function
tet(X)  encodes  an  NADP-requiring  oxidoreductase  of 43.7  kDa  that  inactivates 
tetracycline  (Speer  et  al.,  1991).  It  was  originally  isolated  from  Bacteroides 
fragalis from Tn435J and Tn4400, however, since the enzyme requires oxygen to 
function, it has only been found to convey resistance in aerobically grown E.  coli 
(Speer et al.,  1991).
tet(U) conveys a low-level MIC to both tetracycline and minocycline (reviewed in 
Roberts,  2003).  It  encodes  a  11.8  kDa  protein  which  has  some  similarity  (21% 
amino acid similarity) to tet{M) at the carboxy terminus, however, this does not 
include  the  GTP  binding  domain  (Ridenhour  et  al.  ,  1996).  Because  of this 
similarity it is thought to be RPP-like. Little else is known about tet(\3) which was
53discovered in an Entercoccus faecium  isolate on the pKOlO plasmid (reviewed in 
Roberts et al.,  1991; Ridenhour et al..  1996).
1.1.3.2.2.2.4 Additional Tetracycline Resistance Genoty pes
In  Seisseria gonorrhoeae  resistance  can  also  be  mediated  by  mutations  in  three 
endogenous genes (mtrR, penB.  tet-2) (Hu et al..  2005). mtrR mutation results  in 
over expression of a non-specific efflux pump, and penB mutation gives a mutated 
porin  IB  leading  to decreased  entry  of tetracycline  into  the  bacterium,  and  tet-2 
mutation  results  in  a  mutant  ribosomal  protein  S10  causing  a  reduction  in  the 
binding of the drug (Hu et al., 2005).
In addition,  mutations in the rrn genes of H.  pylori offer a degree of tetracycline 
resistance associated with reduced binding of the drug to the primary site (Nonaka 
et al. 2005; Dailidiene et al.. 2002; De Stasio et al..  1989; Heuer et al..  1987).
1.1.3.2.2.2.5 Regulation of Resistance
In the absence of tetracycline a repressor protein  is present as a homodimer that 
binds  to  the  tandemly  orientated  tet  operators,  blocking  transcription  (Su  et  al.. 
1992;  Orth  et  al.,  2000).  In  the  presence  of  a  tetracycline-Mg2 +   complex 
expression  ensues  due  to  a  conformational  change  in  the  repressor  homodimer 
brought  about  through  its  binding  with  the  tetracycline  complex  (Figure  1.6) 
allowing the binding of RNA polymerase to the operator (Blake et al..  2003).
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Figure 1.6 : Repressor mediated regulation of the efflux type of 
tetracycline resisatnce genes (www.nsml .utdallas.edu)
tetK and tetL  do not  have associated cognate repressor proteins.  tet(L) plasmid- 
based resistance is regulated in a similar way to that of the erm genes i.e. through 
translational attenuation (Stasinopolous, 1998).
The  RPP genes are also believed to be regulated by the presence of tetracycline 
(Burdett,  1991),  with  the  upstream  regions of the  genes  implicated  due  to  their 
homology  within  classes  (Wang  &  Taylor,  1991;  reviewed  in  Roberts,  1996). 
Northern blot analyses have detailed transcripts of varying lengths (short and long)
55of this region and numerous stem-loop structures have been identified indicating a 
potential transcriptional attenuator (Su et al.,  1992).
1.1.3.4  The need for Further Investigation
Studies  aimed  at  reporting  mechanisms  of antibiotic  resistance  and  their genetic 
supports  are  hugely  important  in  order to  stay  one  step  ahead  of the  pathogens. 
Comprehension  should  precede  action  in  order  to  ensure  the  action  taken  is 
appropriate. It is therefore vital that studies such as the current work be undertaken 
to  improve  our  understanding  of  the  mechanisms  of  antibiotic  resistance  that 
predominate in certain environments.
561.2  Dissemination of Antibiotic Resistance Genes
1.2.1  Antibiotic Resistance and the Discovery of Bacterial Gene Exchange
At the beginning of the  1950s when the potential of antibiotics was only just being 
realised  it  was  believed  that  resistance  would  not  become  a  problem.  It  was 
thought  mutation  rates  were  not  high  enough,  and  no  consideration  was  given 
regarding the ability of bacteria to exchange genetic information (Rice. 2000).
Tatum  and  Lederberg  published  evidence  for  genetic  exchange  in  1947.  Their 
studies  on  mixed  cultures  of  E.  coli  mutants  had  unexpectedly  revealed  that, 
having  ruled  out  spontaneous  mutantion  and  transformation  of  DNA  from  the 
culture  medium,  some  form  of  bacterial  'sexual  exchange'  had  occurred  to 
complement the mutants under investigation (Tatum & Lederberg. 1947).
Since then, the evidence for horizontal  gene transfer has been both observational 
and circumstantial (Kurland et al.,  2003: reviewed in Burrus et al.,  2002: Chen et 
al.,  2005).  Many  experiments  have  demonstrated  the  transfer  of  resistance 
phenotypes  and  specific  mobile  elements  between  different  bacteria  or  the 
transformation  of bacteria  with  exogenous  DNA  (Wang  et  al.,  2002;  Guiney  & 
Hasegawa  1992).  Additional  evidence  for  horizontal  gene  transfer  comes  from 
analysis of the DNA sequences of microbial genomes (Hall et al.,  2005). Differing 
G+C  content  and  codon  usage  patterns  within  a  genome  can  point  to  DNA  of 
foreign  origin  (reviewed  in  Lawrence  &  Ochman,  1997).  Horizontal  gene 
exchange can account  for a significant amount of a bacterium's genome (Philippe 
& Douady. 2003; reviewed in Joan Curcio & Derbyshire, 2003). The percentage of 
genes  within  a  genome  that  appear  to  have  been  horizontally  transferred  varies 
from  -1.5 -   14.5  %;  for example, horizontally transferred genes account for  1.56
57%  of the  Borrelia  burgdorferi  genome  (Garcia-Vallve  et  al.  2000),  11  %  of the 
genome of Clostridium difficile strain 630 (Sebaithia et al.,  2006), and  14.47 % of 
the B.  subtilis genome (Garcia-Vallve et al.. 2000) thus demonstrating the role that 
genetic exchange has had in bacterial evolution.
It  is  now  known  that  the  increase  in  antibiotic  resistance  is  mostly  due  to  the 
transfer of determinants  throughout  a  population,  across  both  species and  genera, 
followed by clonal expansion (Dutta et al..  2002; Gill et al.,  2005).  In addition, the 
concern  about  the  'predicted  phenomenon'  of  multiple  resistance  is  no  longer 
unfounded due to the ability to concentrate multiple resistance determinants within 
a  circumscribed  mobile  genetic  region  (reviewed  in  Kurland  et  al.,  2003;  Gill  et 
al..  2005; Sekiguchi et al..  2005).
1.2.2  Mechanisms of Horizontal Gene Transfer
There  are  three  mechanisms  of horizontal  gene  transfer  (HGT),  all  of which  are 
responsible  for  the  spread  of  antibiotic  resistance.  They  are  transformation, 
conjugation and transduction.
1.2.2.1  Transformation
Bacterial  transformation  is  the  process  by  which  cells  take  up  'naked', 
extracellular  DNA  from  their  surrounding  environment,  and  the  heritable 
incorporation of the  DNA into the host genome (reviewed  in  Dubnau,  1999).  This 
may  include  chromosomal  DNA  which  is  incorporated  into  the  chromosome  by 
homologous  recombination  (Ochman  et  al.,  2000).  or  plasmid  DNA  which,  if it
58contains  an  origin  of replication that  is  recognised  by the host  DNA  polymerase, 
will replicate independently (Daley et al..  1998; Thomas & Neilsen 2005).
A bacterium's ability to take up DNA is termed  ‘competence'.  In the environment, 
many  factors  are  linked  with  the  development  of competence  including  nutrient 
availability,  pH,  temperature  and  calcium  concentration  (Bott  and  Wilson.  1968). 
It  occurs  naturally  in  some  bacteria  (including  Streptococcus  mutcms,  S. 
pneumonia,  S.  gonorrheae.  Actinobacillus  spp.,  Legionella pneumophila,  and  B. 
subtilis)  at  a  specific  stage of their  life  cycle  (Stone &  Kwaik,  1999;  Soloman  & 
Grossman,  1996).
The  process  enables  the  bacterium  to  acquire  novel  genes  encouraging  variation 
and  contributing  to  evolution  (reviewed  in  Dubnau,  1999).  Conversely, 
recombination  of  the  DNA  taken  up  may  disrupt  functional  genes  or  activate 
defective  prophage  leading to the death of the cell  (reviewed  in Chen &  Dubnau. 
2004).  In  addition,  the  supplementary  metabolic  load  conferred  by  plasmids  may 
cause selection against the transformants  in the environment (reviewed  in Chen & 
Dubnau, 2004).
Transformation  is also a means of acquisition of nutrients and nucleotides for use 
in  replication  for  certain  bacteria  (B.  subtilis.  Streptococcus  spp.,  Acinetobacter 
calcoaceticus,  Haemophilus  spp.  and  Neisseria  spp.)  (reviewed  in  Lorenz  & 
Wackernagel.  1994).  and  rates of DNA  uptake  have  been  observed to  increase  in 
conditions  of nutrient  limitation  (Lorenz  &  Wackernagel.  1991;  Page  &  Sadoff. 
1976)
The uptake of DNA  into a bacterial cell begins with its binding and proceeds with 
its  transport  into  the  cytoplasm.  Two  main  mechanisms  for these  processes  have
59been  described,  one  for  Gram  positive  organisms,  the  other  for  Gram  negative 
organisms.
1.2.2.1.1  In Gram positive Organisms
In  Gram  positive bacteria double stranded  DNA  forms a non-covalent association 
with  a  specific  DNA  binding  site  on  the  cell  surface  (S.  pneumoniae  have 
approximately  30-80  of  these  binding  sites  per  cell).  Single  stranded  and 
glycosylated  DNAs  do  not  bind.  Immediately  after  binding  the  cell  surface 
receptor  employs  endonuclease  activity  to  introduce  single  strand  breaks  in  the 
DNA approximately 6 kb apart (reviwed in Dubnau.  1999). Transfer into the cell is 
energy dependent and is initiated by subsequent double strand breaks. Once inside 
the cell  the  single  stranded  DNA complexes with a  19.5  kDa protein to  protect  it 
from  nucleases  (reviewed  in  Dubnau.  1991).  The  non-transported  strand  is 
degraded.
1.2.2.1.2 InG  ram negatives
In  various Gram  negative systems the binding of both double stranded  and  single 
stranded  DNAs  occurs,  but  is  limited  to  DNA  homologous  to  host  DNA  in  the 
systems  studied  (reviewed  in  Dubnau.  1999).  This  homology  facilitates  the 
binding  to  a  receptor  protein  via  a  recognition  sequence.  Once  bound  the  DNA 
becomes  DNase  sensitive  and  is  taken  up  in  a  *transformasome\  a  membrane 
vesicle which apparently  forms where the inner and outer membranes  fuse, before 
it is released as a single stranded molecule into the cytoplasm (in some species, the 
remaining  strand  is degraded  as  in  Gram  positive  bacteria)  (reviewed  in  Dubnau.
601999;  Dreiseikelmann.  1994).  Within  the  transformasome  the  DNA  is  protected 
from restriction and nuceolytic enzymes.
The  integration  of  DNA  into  the  chromosome  is  similar  in  both  systems.  It 
integrates  into  homologous  regions,  catalysed  by  a  RecA-like  protein,  to  form  a 
heteroduplex  by  the displacement of the complimentary  resident strand (reviewed 
in  Dubnau.  1999).  Before  replication  any  mismatches  are  repaired.  This 
mechanism  of repairing  only  small  stretches  of  DNA  mismatches  suggests  that 
intra-genera  transfer  is  preferential  at  homologous,  conserved  loci  (Majewski  & 
Cohan.  1999).
1.2.2.2  Transduction
Transduction  is  the  movement  of  DNA  from  one  bacterium  to  another  using 
bacteriophage  as  a  vector  (Ubukata  et  al.,  1975;  Witte.  2004;  Weinbauer.  2004; 
Weinbauer  &  Rassoulzadegan.  2004).  This  may  be  'generalised'  which  is  the 
incorporation of non-bacteriophage DNA. which may be chromosomal or plasmid, 
into the phage head with subsequent transfer to another bacterium, or 'specialised' 
which describes the incorporation of chromosomal  DNA adjacent to the integrated 
phage in a transfer event (Canchaya et al.,  2003; Witte, 2004).
Transduction  is  a  significant  process  in  HOT.  It  has  been  estimated  that  phage 
mediate  the  transfer  of between  102 :>   -   1()2X   Kb  of DNA  per  year  in  the  world's 
oceans (Rohwer & Hdwards, 2002).
The mechanism of transduction requires cells to be sensitive to the infecting phage 
(Canchaya  et  al.,  2004),  however,  unlike  conjugation  cell-to-cell  contact  is  not
61required  since  the  phage  particle  can  persist  in  the  environment  as  they  are 
resistant to  many physical  and chemical  agents (reviewed  in  Lorenz,  1994;  Witte,
2004).
1.2.2.3 Conjugation
Conjugation is the movement of DNA  from one bacterium to another in a process 
that involves stable cell-to-cell contact (Figure  1.7) and metabolically active donor 
and  recipient  strains  for  the  associated  replication  of  DNA  molecules 
(Ankenbauer.  1997;  Christie &  Vogel. 2000; reviewed in Grohmann et al.,  2003). 
In  Gram  negative  bacteria  physical  contact  is  by  the  sex  pilus.  an  extracellular 
filament  (Figure  1.7)  (Lanka  &  Wilkins,  1995;  Christie  &  Vogel,  2000).  The 
means  of establishing  cell-to-cell  contact  in  Gram  positive  bacteria has  yet  to  be 
established  however there  is no evidence  for the  involvement of pili  (reviewed  in 
Grohmann  et  al.,  2003).  Among  the  mechanisms  of HGT  conjugation  offers  the 
broadest  host  range  (reviewed  in  Lederberg  et  al.,  1986).  It  not  only  mediates 
DNA  transfer between  bacterial  genera,  but also  between  bacteria and eukaryotes 
including  between  Agrohacterium  and  various  plants  (Ti  plasmid)  (Bevan  & 
Chilton.  1982) and between bacteria and Saccharomyces sp. (for example, transfer 
of pAY205 and pAY201  from E.  coli to S.  cerexisiae (Nishikawa et al..  1992); and 
transfer of pHK2  from  E.  coli to  Kluyxeromyces /actis  (Dayman  &  Bolen,  1993)) 
(Heinemann & Sprague.  1989).
62Figure 1.7: Electron micrograph of Cram negative sex pilus formation during conjugation
(www.agen.ufl.edu).
In Gram negative bacteria the pilus retracts to bring the cells into close contact, or 
mediates  contact  through  non-specific  hydrophobic  reactions  (Figure  1.7) 
(Christie, 2001).  In the majority of Gram positive bacteria the means of achieving 
cell  contact has  yet  to  be determined,  although  in  some  species  mating  pairs are 
formed by the production of aggregating substances (Maas et al.,  1998).
Conjugation  results  in  the  movement  of  a  number  of different  mobile  genetic 
elements  (reviewed  in  Vogel  &  Christie,  2000;  Grohmann  et al.,  2003;  Christie, 
2001;  Mullany  et  al.,  2002).  Conjugative  plasmids  and  conjugative  transposons 
encode  all  the  proteins  required  for their own  transfer (Mullany  et al.,  2002).  In 
addition,  they  can  mobilise co-resident  plasmids,  and  transposons either  in  trans 
(by  providing the  mating  apparatus)  (Flannagan  &  Clewell,  1991),  or  in  cis  (by 
formation of a co-integrate)(Ankenbauer,  1997).1.2.2.3.1  Mobile Elements
1.2.2.3.1.1  Insertion Sequences
Insertion  Sequences  (IS)  elements  are  small  (-2.5  kb),  phenotypically  cryptic 
sequences  of DNA  which  are  capable  of inserting  into  multiple  sites  of a  target 
molecule  (reviewed  in  Mahillon  &  Chandler,  1998).  They  generally  consist  of a 
gene  encoding  a  transposase  and  are  delineated  by  terminal  inverted  repeats 
(reviewed  in  Mahillon  &  Chandler,  1998).  The  two  terminal  repeats  are 
recombinationally-active  DNA.  and  are  involved  in  the  transposition  of  some 
elements (Derbyshire et al..  1987;  Johnson  &  Reznikoff.  1983).  The  Tpase binds 
to the terminal repeats and the C terminal-end processes integration of the element 
in  the  host  chromosome  (Machida  &  Machida.  1989;  reviewed  in  Mahillon  & 
Chandler,  1998). The integration of two copies of the same element either side of a 
chromosomal  gene can result in the formation of a composite element (an element 
composed  of two  or  more  other  elements),  for  example  /e/(M)  is  contained  on 
Tn5i(V5  which  is  a  composite  element  of Tn5J<V/  flanked  by  copies  of  IS/2/6 
(reviewed by Rice et al..  2002).
1.2.2.3.1.2 Integrons
Integrons  (Figure  1.8)  are  non-conjugative  elements  composed  of  a  65  bp 
integration site for the capture of gene cassettes, a promoter and an integrase gene, 
inti,  which  catalyses  the  orientation-specific  integration  of gene cassettes  by  site- 
specific  recombination  (reviewed  in  Ploy  et  al.,  2000;  Bennett,  1999;  Collis  & 
Hall,  1992;  Nield  et  al..  2001).  The  gene  cassettes  may  include  an  antibiotic 
resistance  genes  resulting  in  the  formation  of  a  multidrug  resistance  structure 
driven by the integron promoter (Collis &  Hall,  1995;  Rowe-Magnus et al..  2002;
64Partridge  et  al.,  2000).  Integrons  are  sometimes  contained  within  transposable 
elements,  allowing  them  to  move  to  conjugative  elements  thus  permitting  their 
spread (Di Conza et al., 2005; Raadstroem et al.,  1991).
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Figure  1.8:  Diagram  of a  class  1   integron  and  associated  gene  cassette  acquisition.  Circularised 
gene cassettes  insert  at  the attl  site.  P|  and  P2  are  integron  associated  promoters.  Pjn l  is the  integrase 
gene promoter. 5’-CS and 3’-CS refer to the strand direction of the host and indicate the orientation  in 
which  the  integron  inserts.  The  qacEJl  and  suit  genes  confer  resistance  to  quaternary'  ammonium 
compounds and sulfonamides, respectively (taken from Fluit & Schmitz,  1999).
1.2.2.3.1.3 Plasmids
Plasmids are usually double stranded circular DNAs, that contain their own origin 
of replication,  oriT,  thus  replicate  independently  from  the  host  genome  and  may 
exist  as  multiple  copies  within  one  host  (reviewed  in  Grohmann  et  al.,  2003). 
Conjugative  plasmids  harbour  all  the  genes  necessary  for  their  transfer  to  a 
recipient cell (Willetts & Wilkins, 1984; reviewed in Grohmann et al.,  2003).
65For the  IncP  transfer  system  of the  broad  host  range  plasmid  pRP4,  initiation  of 
transfer  begins  with  a  protein  complex  known  as  the  relaxosome  (a  mutliprotein 
complex  constisting  of both  plasmid-encoded  and  chromosome-encoded  proteins 
(Furste,  1987))  binding  to  the  plasmid  oriT  (Climo  et  al.,  1996).  The  DNA 
relaxases of the relaxosome have a helicase activ ity and catalyse the unwinding of 
the  DNA  in  an  energy  dependent  manner  reliant  on  the  hydrolysis  of  ATP 
(Grohmann  et  al.,  2003).  It  then  nicks  the  strand  to  be  transferred,  and  initiates 
rolling-circle  replication  of  the  remaining  donor  strand  (Llosa  et  al.,  2002; 
reviewed  in  Grohmann  et  al.,  2003).  The  relaxosome  remains  attached  to  the 
transferring  strand  and  interacts  with  the  transfer  machinery  (Llosa  et  al.,  2002; 
reviewed  in  Lanka  &  Wilkins,  1995).  Upon  arrival  at  the  mating  channel  the 
relaxosome interacts with the C-terminus of a coupling protein which mediates the 
transfer of the  DNA  through  the  mating  channel  in  an  energy-dependent  manner 
(Llosa  et  al.,  2002).  The  Tral  proteins  remain  bound  to  the  5'  plasmid  terminus 
and are transferred with the DNA to protect the DNA  from exonucleolytic activity 
(Llosa et al.,  2002; reviewed in Grohmann et al.,  2003).  Once in the recipient, the 
single  stranded  DNA  is  replicated,  resulting  in  a  complete  plasmid  (reviewed  in 
Grohmann et al.,  2003; Christie. 2001).
Many  conjugative/mobilisable  plasmids  have  been  found  to  harbour  antibiotic 
resistance genes (Walters.  1999).  some of which are detailed  in Table  1.5  and are 
implicated in the spread of resistance amongst pathogenic and commensal bacteria.
66Plasmid Hosts Resistance Genes Reference
pK214 Laetococcus lactis CmpR, SmR.TetR. 
MLS
Perreten et al.,  1997
pIP501 E. faecal is ErmR. CmpR, KanR. 
TypR. RoxR, NeoR. 
SmR. ClmR, LinR. 
AzR, ClaR.
Teuber et al.,  2003.
pAMpl S.  agalacliae,  E. 
faecalis, S.  lactis,  C. 
acetobutvlicum
CmpR, MLS Yu etaL   1986
pRE25 E. faecalis CmpR. MLS Teuber et al..  2003
pSK41 S. aureus BlmR. GmR, KanR, 
NeoR, TobR
Firth et al.,  2000
pGOl S.  aureus BlmR, GmR. KanR, 
NeoR. TobR, TmpR
Thomas Jr. et al..  1989
pCFlO E. faecalis TetR Mori et al.,  1988
pAM180 C.  acetobutvlicum TetR. ErmR Bertram et al.,  1989
pMGl S.  aureus, S. 
epidermidis
MupR Bastos et al.,  1999
PMLE300 L. fermentum ErmR Gfeller et al.,  2003
Table  1.5:  Conjugative  plasmids  conferring  antibiotic  resistance  from  unicellular  Gram- 
positive bacteria.
Abbreviations:  Az.  azithromycin;  Blm.  bleomycin;  Cla,  clarithromycin;Clm.  clindamycin;  Cmp. 
chloramphenicol;  Erm.  erythromycin;  Gm.  gentamycin;  Kan.  kanamycin;  Lin.  lincomycin;  MLS. 
macrolide,  lincosamide.  streptogramin  B  antibiotics;  Neo.  neomycin;  Sm.  streptomycin;  Tet. 
tetracycline; Tob. tobramycin. Tmp. trimethomprim; Typ. typosin.  R. resistant
1.2.2.3.1.4  Transposons
Transposons are segments of DNA that are capable of excising and inserting into a 
new position  within the host chromosome or that of a recipient cell  (Twiss et al.. 
2005; Joan Curcio &  Derbyshire,  2003;  rev iewed in Rice.  1998a  1998b;  Burrus et 
al.,  2002).  They  harbour  a  range  of different  genes,  including  antibiotic  resistant 
genes (tables  1.6 and  1.7). however, they lack the genes for transfer and replication 
(reviewed in Burrus et al.,  2002).
671.2.2.3.1.5  Conjugative Transposons
Conjugative transposons are sequences of DNA that encode proteins for their own 
transfer. They are extremely common and have been found in virtually all bacteria 
in  which  they  have  been  looked  for  (reviewed  in  Mullany  et  al,  2002:  Salyers, 
1995:  Clewell  &  Flannagan,  1995).  They  are  not  able to  replicate autonomously, 
but  do  so  when  inserted  into  co-resident  plasmids  or  the  host  chromosome 
(reviewed  in  Burrus et al..  2002:  Scott et al..  1995).  Their mechanism  of transfer 
involves the excision of a double stranded  covalently closed circular intermediate 
from  the  donor  genome,  the  transfer  of a  single  strand  of the  DNA  through  the 
mating channel,  synthesis of a complementary  strand  in both donor and recipient, 
and the insertion of the transposon into the recipient genome either randomly or at 
specific  sites  depending  on  the  specificity  of the  CTn  (reviewed  in  Burrus  et al., 
2002:  Lu.  1994).  For example. Tn916 integrates into a large number of sites in E. 
faecalis (although preferably A+T rich), but in C.  difficile strain CD37 it integrates 
preferentially into only one site. att9I6 (H Wang et al.,  2002).
The nomenclature for transposons and conjugative transposons is confusing.  Some 
conjugative  transposons  have  a  Tn  designation  which  does  not  account  for  their 
ability to transfer, for example Tn916 (Senghas et al.,  1988). The addition of a  C' 
prefix  has been suggested to denote those which are conjugative but this system  is 
not  universally  followed  as  there  is  no  longer  a  central  database  issuing  Tn 
numbers  (Campbell  et  al.,  1979).  Furthermore,  the  numbering  of  transposons 
appears to be random with consecutive numbers being assigned whether or not the 
transposon  is conjugative:  for example.  Tn/575  is conjugative,  but Tn 1546  is  not
68(Clevvell  et  al.,  1995;  Arthur  et  al.,  1993).  To  overcome  this  problem,  a  new 
database was set up at the start of 2006 (http://www.ucl.ac.uk/eastman/tn/).
1.2.2.3.1.5.1  Tn9/6
Tn916  (Figure  1.9)  has  been  reported  to  transfer  between  a  broad  range  of both 
Gram positive and Gram  negative organisms (Bertram et al.,  1991;  Clewell  et al., 
1995;  Rice.  1998).  Excision  is  mediated  by  the  transposon-encoded  proteins  Int 
and Xis. The circularisation of Tn916 is required for the expression of the transfer 
genes via a system that is regulated by the presence of tetracycline (Celli & Trieu- 
Cout.  1998). The circular form of the transposon is nicked at oriT prior to transfer 
and  a  single  strand  is  transferred  (Hinerfeld  &  Churchward.  2001).  Once  in  the 
recipient  the  single  strand  acts  as  a  template  for  synthesis  of the  complementary 
strand  (Salyers et al.,  1995;  Abbani  et al.,  2005).  This repaired  covalently  closed 
molecule  contains  attTn.  the  attachment  site  at  which  intergration  occurs. 
Integration  is mediated by  Int (Storrs et al..  1991).  The presence of Tn9/6  in the 
recipient  cell's  genome  does  not  significantly  reduce  its  ability  to  acquire  further 
CTns of the same family (Norgren,  1991).
1.2.2.3.1.6  The Evolution of Mobile Elements
The  evolution  of mobile  elements  is  through  the  exchange of functional  modules 
(Frost  et al..  2005:  Osborn  &  Boltner.  2002;  reviewed  in  Bennett,  2004).  This  is 
certainly the case for Tn916 and  its relatives.  For example the Tn5397 and Tn916 
conjugation,  tetracycline  resistance  and  regulation  modules  exhibit  high 
homology.  However,  their  recombination  modules  are  unrelated  (Figure  1.9) 
(Roberts et al..  2001a).
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Figure  1.9:  Diagrammatic representation of CTns Tn9/6 and Tn5.?97, and Tn/549. Arrowed 
boxes  represent  ORFs  (the  direction  of the  arrow  indicates  the  direction  of transcription).  The 
percentage similarity is shown between different functional modules. (Burrus et al, 2002).
Such  exchanges  can  also  occur  between  different  types  of  mobile  elements 
(Osborn &  Boltner,  2002).  For example, the site-specific element  ICEStI  from S. 
thermophilus encodes a restriction modification system related to that encoded by 
the L.  lactis plasmid pKR233, and a putative conjugation module related to that of 
Tn916 (Burrus et al., 2000, 2001).
The  insertion of one element  into another,  followed by recombination events and 
deletions can  lead  to the  formation of novel  genes and genetic  elements (Rice & 
Carias et al.,  1998).
The erm{33) gene demonstrates the extent of genetic  rearrangements in elements. 
Its sequence suggests it is a product of a recombination event between an erm(C) 
and an erm(A) gene (Schwartz et al., 2002). The first 284 bp of erm{33) show 99.3
70%  identity  at  the  nucleotide  level  to  erm(C)  from  plasmid  pSES21,  whereas  the 
last 403  bp show  100 % identity to erm(A) from Tn557.  Between these sequences 
in  a  45  bp  region  at  which  the  recombination  occurred  (Schwartz  et  al.,  2002). 
This was the  first report of a  functional  erythromycin gene constructed by natural 
recombination.
Unfortunately, relatively  few CTns have been characterized.  However,  it has been 
predicted  that  if such  a  variety  of transfer  mechanisms  exist  for  closely  related 
transposons it is probable that a great many more exist (Wicker et al., 2003; Stokes 
et al.,  2001).  Furthermore,  the exchange of functional  modules suggests more are 
evolving all of the time (Pasquali et al.,  2005; reviewed in Rice. 2002).
1.2.3  Transfer of Antibiotic Resistance Genes
1.2.3.1  Transfer of Macrolide- and Tetracycline Resistance Determinants
Many  antibiotic  resistance  genes  are  contained  on  mobile  genetic  elements 
(MGEs)  (Cooper  et  al.,  1996).  Erythromycin  and  tetracycline  resistance 
determinants  have  been  found on a range of mobile elements  (tables  1.6  and  1.7) 
and  their  transfer  in  the  GI  tract  is  discussed  in  section  1.3.  However,  it  is 
important to  realise that  upon  integration  into a  new host a  gene  may  not express 
well  or  indeed  at  all  (Wenzel  &  Muller.  2005;  Gustafsson  et  al.,  2004).  For 
example,  the  so-called  'Gram  negative  tetracycline  resistance  genes'  which  have 
only  been  reported  in  Gram  negative  hosts do  not express  well  ir. Gram  positives 
(reviewed in Roberts, 2002).
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gene
Mobile
Element
Type of 
Element
Homology 
to /
functional 
modules 
shared with
Hosts Reference
erm( F) CTnDOT CTn CTnERL, 
Tn4351, 
Tn4551, 
Tn4399
Bacteroides Whittle et 
a l, 2001
pBF4 Plasmid Bacteroides Shoemaker,
1985
pBI 136 Plasmid Bacteroides Smith & 
Macrina, 
1984
PBFTM10 Plasmid. 
Composite 
element 
flanked by 
IS
IS4351 Bacteroides Tally et al 
1982
erm{ B) CTnBST CTn Clostridium
perfringens
Bacteroides Gupta et al., 
2003
Tn5398 Mobilisable
genetic
element
Tn 916 Clostridium 
difiicile 
(various 
strains), S. 
aureus,  B. 
subtilis
Adams et 
al, 2002. 
Farrow et 
al, 2001
Tn 917 Tn pAD2 E. faecalis Okitsu et al., 
2005
pRE25 Plasmid pIP501 E. faecalis Teuber et 
a l, 2003
pIP501 Plasmid pRE25 S. agalactiae Teuber et 
al, 2003
Tn3692 Transposon Lactobacillus
crispatus
Stroman et 
al, 2003
erm( B), 
tet( M)
Tn3872 CTn Tn 916 Abiotrophia
defectiva
Poyart et al, 
2000
erw(B). 
tet{ M), 
aphA-3
Tn1545 CTn pAM77 Broad host 
range
Okitsu et al, 
2005
Serai et al, 
2000
erm(C) CTn S. aureus Spiliopoulou 
et al,  2004
pSES22 Plasmid S.
saprophyticus
Hauschild et 
al, 2005
Table 1.6: Examples of Mobile Genetic Elements harbouring the most Common 
Ery thromycin Resistant Genes.
72tet Gene Mobile
Element
Type of 
Element
Homology
to
Hosts Reference
/e/(M) Tn 916- 
Tnl545 
family
CTn E. faecalis, 
S.
pneumonia
e.
Broad host 
range
Flannagan et 
al.,  1994. 
Lancaster et 
al, 2004. 
Poyart et al, 
2000.  1995b. 
Agerso et a l, 
2002.
Tn5397 CTn Tn916-
Tnl545
family
C. difficile 
E. faecium
H Wang et 
al, 2000 
Agerso et al, 
2006
CW459te/(M) CTn?
Tn?
C.
perfingens
A Roberts et 
al., 2001
/e/(B) Tn/0 Transposon E. coli Chalmers et 
al, 2000
pPAT2 Plasmid Tn/0 P.
aeruginosa
Hillen,  1994, 
Kehrenberg 
& Schwarz, 
2001
pHS-tet Plasmid pCCK3259 Haemophil
us
Guerra et al, 
2002;
Lancashire et 
al, 2005
Multi­
drug
PUO-stVR2 Plasmid S. enterica Guerra et al., 
2002
tet{ W) TnB/230 CTn B.
fibrisolven
s
Melville et 
a l, 2004
tet(A) Tn 1721 Transposon Class 1  
integrons
Broad host 
range
Agerso &
Sandvang.
2005
Ribera et al, 
2003
Table 1.7:  Examples of Mobile Genetic Elements Harbouring Tetracycline Resistance Genes.
In conclusion, bacteria containing antibiotic resistance genes are ubiquitous. They 
have  been  reported  in  clinical,  veterinary  and  environmental  isolates,  in  Gram 
positives  and  Gram  negatives,  in  commensals  (as  a  reservoir  of resistance)  and 
pathogenic bacteria.
731.2.4  The need for Further Investigation
As predicted  by  Wicker et a/.. (2003) many mobile elements exist that have yet to 
be  discovered.  In  addition,  the  transfer  of certain  antibiotic  resistance  genes  has 
been observed, but the elements which supports them have yet to be identified.
It  is  through  the  characterisation  and  understanding  of mobile  elements  and  their 
transfer mechanisms that we are able to predict host ranges and establish routes of 
transmission.  This  is  especially  important  if the  element  harbours  an  antibiotic 
resistance gene(s).  Studies have shown the importance of commensal organisms as 
a reservoir of resistance  genes  and  the  potential  for them  to  spread  to  pathogenic 
bacteria.  Furthermore,  following  characterisation  of  specific  elements,  genetic 
linkages  of  different  resistances  can  be  identified,  and  an  appropriate  clinical 
response to pathogens possessing such elements can be established.
741.3  The Microbiota of the Human Gastrointestinal Tract
1.3.1  The Oral Microbiota
The  normal  microbiota  of the  oral  cavity  consists  of a  wide  range  of organisms 
(Table  1.8).  A  recent estimate of its diversity by  William  Wade put the number of 
different  species  present  at  -800  (William  Wade  Personal  communication;  Wade 
et al.,  2002).  Approximately  50% of the oral  microbiota have  not  been  grown  on 
artificial culture media (Munson et al., 2004).
The  oral  cavity  provides  a  welcoming environment  for bacterial  colonisation due 
to its ambient temperature (36T). suitable pH (7.0-7.4). and the presence of water, 
nutrients and growth factors (Wilkins et al.,  2003). The microbiota is in a dynamic 
state  (Morhart  &  Fitzgerald.  1976).  Repeated  periodic  flushing  of bacteria  to  the 
stomach  (where  they  are  usually  destroyed  by  the  acidic  pH)  by  swallowing; 
brushing  and  flossing;  and  through  the  contact  it  has  with  other  individuals'  oral 
microbiota through kissing etc. constantly alters the composition of the microbiota 
(Marsh.  1999;  Paster  et  al.,  2001).  In  addition,  food-borne  bacteria  often  pass 
through the oral cavity increasing diversity and providing an input of novel genetic 
material  (Eaton  &  Gasson.  2001).  This  dynamic  state  of  the  microbiota  has  a 
knock-on  impact on the conditions, and thus a dynamic equilibrium  is established. 
Certain  species  are  exclusive  to  different  sites  (microenvironments)  within  the 
mouth,  for  example  approximately  one  third  of  bacterial  species  found  on  the 
tongue dorsum have not been found at other oral sites (Kazor et al.. 2003).
The  host  specific  and  site-specific  nature  of diversity  does  not  lend  itself well  to 
the development of diagnostic tests for oral diseases (Bowden,  1997), this coupled
75with  the  unknown  portion  of the  microbiota  makes the  treatment of such  disease 
difficult (Prescott Harley Klein, 2005).
1.3.1.1  Colonisation of, and Bacterial Diversity' in, the Oral Cavity’
As with the rest of the GI tract, colonisation of the oral cavity occurs within hours 
of  birth  with  bacteria  from  the  mother  (vaginal,  oral,  and  skin  microbiota) 
(Fehervary et al.,  2004) and  food-boume bacteria (Martin et al.,  2003) and  further 
develops  throughout  childhood.  Initially  aerobic  species  such  as  Streptococcus 
spp.,  Xeisseria  spp..  Actinomyces  spp.,  and  Lactobacillus  spp.  predominate 
(Prescott  Harley  Klein.  2005).  The  anaerobic  portion  of the  microbiota colonises 
on  the  eruption  of the  teeth  due  to  the  opportunity  for them  to  occupy  the  space 
between the teeth and gums (Marsh. 2003a.  1999).
In healthy adults, by far the most predominant species are the streptococci. At least 
18  different  species  have  been  isolated,  most  of which  are  from  the  mitis  group 
such  as  S.  salivarius,  S.  mutans.  S.  pneumoniae,  S.  oralis.  S.  mitis  and  the 
anginosus group;  with viridans group streptococci  predominating  in dental  plaque 
(Tanner. 2000; Bryskier. 2002).
Most  bacteria  in  the  oral  cavity  are  from  the  Proteobacteria.  the  Gram  positives, 
the  spirochaetes  or  the  flavobacter-bacteroides  group.  Isolates  from  the  other  six 
bacterial phyla have not been found in the oral cavity (Table  1.8).
76Genus Species
Eikenella E. corrodens
Kingella K. dentrificans
Neiserria N. sica
Actinobacillus A. actinomycetemcomitans
Haemophilus H. aphrophilus. H. paraphrophilus, H. segnis, H. influenzae, H. 
parainfluenzae, H. parahaemolyticus
Campylobacter C. rectus, C. concisus, C. curvus, C. sputorum, C. shoxvae, Bacteroides 
gracilis
Selenomas S. sputigena, S. flueggei, S. noxia, S. infelix, S. dianae. S. artemidis
Centipeda C. periodontii
Mitsuokella M. dentalis
Veillonella V. Parvula,  V. atypical,  V. dispar
Clostridium C. malenominatum, C. ramosum, C. sporogenes
Eubacterium E. branchy, E. nodatum. E. saburreum, E. timidum, E. saphenum, E. yurii
Peptostreptococcus P. micros, P. anaerobius
Bacillus B. cereus
Lactobacillus L. oris, L. pantarum, L. salivarius, L. acidophilus, L.grasseri, L.casei, L. 
fermentum
Atopobium Lactobacillus rimae, L. minutes
Staphylococcus S. epidermidis, S. aureus. S. capitis, S. haemolyticus, S. hominis., S. 
saprophyticus, S. simulans
Streptococcus S. oralis group/viridans group (including S. mitis), S. intermedius group, 
S. mutans group, S. salivarius group
Gemella G. haemolysins, G. morbillorum
Mycoplasma M. salivarium, M. orale, M. buccale
Rothia R. denticariosa
Bifidobacterium B. dentium
Propionibacterium P. acnes, P.avidum, P. granulosum, P. propionicus
Actinomyces A. georgiae, A. meyeri, A. odontolyticus, A. israelii, A. naeslundii
Micrococcus 16S matches to no known species
Stomatococcus S. mucilaginosus
Corvnebacterium C. matruchotii
Treponema T. denticola,  T. vincentii,  T. pectinovorum,  T. socranskii
Porphyromonas P. gingivalis, P. endodonlalis, P. asaccharolytica
Prevotella P. oralis, P. veroralis, P. buccalis, P. oulora, P. buccae. P. oris, P. 
intermedia
Bacteroides B. heparinolyticus, B. zoogleoformans
Capnocytophaga C. ochracea, C. sputigena, C. gingivalis
Table 1.8: Most commonly reported bacterial species from the human oral cavity. Species 
most associated with diseased states are in blue. (Tanner et al., 2000; Paster et al., 2001; Marsh. 
1999,2003a; Prescott Harley Klein, 2005)
771.3.1.2  Plaque
The  formation  of plaque  illustrates  how  the organisms of the oral  cavity exist  in 
various  microenvironments  and  niches  that  best  suit  their  needs.  Plaque  is  a 
biofilm, an organised microbial system consisting of bacterial cells associated with 
a surface and  fixed  in an extracellular matrix (Figure  1.10) (reviewed  in  Addy et 
al.,  1992; Guggenheim et al.,  2001), in which viable bacteria are mixed with dead 
cells  (Auschil,  2001;  Munson  et al.,  2004).  The  biofilms  that  form  on  teeth  are 
usually several cells thick compared to those formed on gingival tissues which are 
mostly  monolayers  due  to  the  constant  shedding  of cells  (Kolenbrander,  2000; 
Munson et al., 2004).
Figure 1.10: High definition Electron Scanning Micrograph of Human Dental Plaque
illustrating the co-aggregation of bacterial cells and extracellular matrix. Taken from 
www.medicdi rect.co. uk
It is estimated that -415 species are associated with subgingival plaque (Aas et al., 
2005; Addy et al.,  1992; Paster et al., 2001), of these -40% are thought to be novel 
phylotypes  (van  Wilkelhoff  &  Boutaga,  2005;  Paster  et  al.,  2001).  Known 
pathogens such as P. gingivalis,  Tan. forsythensis and  T.  denticola are reported in
78the majority of samples, but typically as only a minor component of plaque. In one 
molecular  study  using  16S  rDNA  libraries  to  detect  diversity  in  the  oral  cavity. 
215  unknown  phylotypes  were  identified;  33  were  found  to  be  cultivable  strains 
that had not yet been characterised and  182 were uncultivated (Perea et al.,  2004).
The advantages for the bacterial cells of biofilm  formation include protection from 
the  environment  (Mah  et  al.,  2001).  nutrient  availability  through  metabolic 
cooperation, and the acquisition of new genetic traits (in S.  mutans transformation 
within  an  active  biofilm  occurs  at  a  rate  of  10-  to  600-fold  higher  than  with 
planktonic  cells)  (Davey.  2000;  Molin  &  Tolker-Nielsen.  2003;  Roberts  et  al.. 
2001b; Luo et al.,  2005).
The  protection  offered  by  biofilms  includes  shelter  from  antibiotics  and 
antiseptics,  with  bacteria  less  susceptible  by  a  factor of up  to  1000  compared  to 
their  planktonic  counterparts  (Zheng  &  Stewart.  2002;  Marsh.  2003b).  This 
protection is thought to be afforded by the exopolymer matrix of plaque which has 
the  ability  to  exchange  ions  with  antibiotics  and  thus  prevent  their  diffusion 
through the biofilm (Costerton et al..  1994,  1999). Additionally, it has been shown 
in a constant depth film fermentor (CDFF) model using a human saliva innoculum, 
that the addition of tetracycline at concentrations which could be found in the oral 
cavity  alters  the  biofilm  composition  and  enriches  for  tetracycline  resistant 
bacteria (Ready et al.,  2002).
1.3.1.3  Antibiotic Resistance in the Oral Cavity
Antibiotic  resistant  bacteria  are  present  in  humans.  Both  infant  and  adult  oral 
samples  have  been  found  to  contain  bacteria  resistant  to  a  number  of antibiotics
79(reviewed  in  Roberts,  1998a,  1998b).  Even  children  who  had  not  received 
antibiotics  harboured  resistant  bacteria  (Millar  et  al.,  2001;  Ready  et  al.,  2003) 
with  up  to  100%  of  healthy  child  subjects  under  investigation  harbouring 
ampicillin  and  erythromycin  resistant  bacteria  in  their  oral  cavity  (penicillin  and 
tetracycline  resistant  bacteria were  present  in  97%  of the  children)  (Ready  et  al., 
2003).  A  further  study  put  the  prevalence  of tetracycline  resistant  bacteria  in  the 
oral  cavity  of healthy  children  at  98%  (Lancaster et  al..  2003,  2005).  In  the  first 
study,  28%  of isolates  recovered  exhibited  resistance  to  two  or  more  antibiotics 
illustrating  the  occurrence  of multidrug  resistant  strains  in  the  commensal  flora 
(Ready et al..  2003).
Tetracycline resistance is also common in the adult oral microbiota occurring in up 
to  11%  of  the  total  cultivable  microbiota  (Villedieu  et  al.,  2003).  tet{M)  is 
consistently identified as being the most common determinant (Lacroix &  Walker, 
1995;  Villdieu  et  al..  2003).  it  has  been  reported  in  Streptomyces,  Actinomyces, 
f eillonella.  Streptococcus.  Xeisseria.  Staphylococcus and  Prevotella oral  isolates 
(Roberts.  1996).  and  on  a  number  of different  Tn9/b-like  elements  in  the  oral 
cavity  (Bentorcha  et  al..  1992).  Additionally.  tet(W),  tet(O)  and  tet(Q)  are  also 
common (Olsvik et al..  1994.  1995; Okamoto et al.,  2001; Villedieu et al..  2003).
It  must  be  noted  that  resistances  to  antibiotics  (kanamycin.  ampicillin  and 
chloramphenicol)  existed  in  oral  bacteria  prior  to  the  clinical  use  of antibiotics, 
although  they  were  only  present  as  a  very  small  proportion  of  the  cultivable 
organisms  and  were  low-level  resistance  compared  to  contemporary  strains 
(Hughes &  Datta.  1983;  Houndt & Ochman. 2000).  This illustrates that antibiotic- 
resistant  bacteria  have  not  only  evolved  due  to  their  exposure  to  drugs,  but
80probably  due  to  incidental  transfer  from  antibiotic  producing  bacteria  which 
harbour  them  as  self-defence  mechanisms  (Edlund  &  Nord.  2000;  Fine  et  al.. 
1998).
1.3.1.4  Gene Transfer in the Oral Cavity’
I here is evidence that all three of the mechanisms of gene transfer described above 
occur in the commensal  bacteria of the human oral cavity.  Furthermore, it is likely 
that  resistance  genes  can  also  be  passed  from  the  transient  organisms  to  the 
resident microbiota and vice versa (Roberts et al..  1999b; Eaton & Gasson. 2001).
DNA  released  from  bacteria  (either  orally  derived  or  from  ingested  food), 
including  resistance-encoding  sequences  have  the  potential  to  transform  naturally 
competent oral bacteria.  Streptococci constitute  " 20% of the normal  flora and the 
genes  involved  in  natural  competence  have  been  found  in  many  of the  species of 
the  mitis  and  S.  angiosus  groups  (Kolenbrander.  2000).  Furthermore,  filter 
sterilised  saliva  has  been  found  to  induce  competence  in  the  early  coloniser  S. 
gonionii  DL1  (Mercer  et  al..  1999).  Both  broth  cultures  and  artificial  biofilms 
containing S.  gonionii  were  shown  to  transform  with  the erythromycin  resistance 
plasmid  pKMR4PE  (Wang  et  al..  2002)  In  addition,  some  Neisseria  spp.  and 
Actinomyces spp.  are  also  naturally  competent  (Sun et al..  2005;  Tompkins et al.. 
1997); and the biofilm mode of growth promotes increased rates of transformation 
as  there  is  increased  availability  of  DNA  from  dead  cells  held  within  the 
extracellular  matrix  in  plaque  which  contributes  to  increased  transformation  rates 
(Li et al.  2002).
81Many  organisms  such  as  the  black  pigmented  oral  Bacteroides  spp.  have  been 
shown  to  have  the  ability  to  transfer  conjugal  elements  encoding  tetracycline 
resistance  in  vitro  (Guiney  &  Hasegavva,  1992);  and  the  transfer of lr\5397 from 
B.  subtilis  to S.  acidominimus  has  been  illustrated  in  a CDFF  system  (Roberts  et 
al..  1999a).  Furthermore. Tn9/6-like elements are commonly found in oral isolates 
and have been shown to transfer tetracycline resistance determinants in model oral 
biofilms  (Roberts  et  al..  2001a).  Further  evidence  for  HGT  comes  from  the  high 
sequence  similarities of the  w e/gene  from  viridans  group  streptococci  which  has 
been transferred to  E.  faecium and  between Streptococcus  spp.  all  of which  share 
the  upper  respiratory  tract  as  a  habitat  (Luna  et  al.  1999).  It  is  likely  that 
conjugation  is  a  major  mechanism  of gene  transfer  among  bacteria  of the  oral 
cavity.
No  studies  of transduction  in  the  oral  cavity  have  been  performed.  However,  in 
vitro studies have demonstrated the ability of various streptococci to receive genes 
by  transduction  (Mercenier  et  al..  1988).  Additionally  bacteriophage  have  been 
isolated  from  the  oral  cavity  (Hitch  et  al..  2004)  and  many  of  the  recently 
sequenced  oral  bacterial  genomes  have  been  shown  to  contain  prophages, 
therefore,  it  is probable that  this mechanism of gene transfer may occur in  the GI 
tract.
821.3.2  The Gut/Faecal Microbiota
It  is  difficult  to  find  a  clear  distinction  between  the  gut  and  faecal  microbiota. 
Many  papers  refer  to  investigations  they  have  performed  as  looking  at  the  'gut 
microflora',  however,  the  materials  and  methods  of such  studies  would  suggest 
'faecal  microbiota'  would  have been a more correct description since the samples 
used  are  not  taken  directly  from  the  Cil  tract,  but  are  faecal  samples  (Shimizu  et 
al..  2006;  Tjellstrom  et  al..  2005;  Parracho  et  al.,  2005;  Park  et  al..  2005). 
However, the two are  undoubtedly  linked.  The  following description of the faecal 
microbiota includes any studies which use faecal samples but refer to their work as 
being on the gut or colon.
Bacteria represent a high  proportion of faecal  mass, accounting for approximately 
54.7%  of the  total  solids  (Stephen  &  Gumming,  1980).  The  bacterial  load  of the 
intestine of a healthy adult is thought to be  1-1.5 kg (Owehand. 2002).
At  present,  the  description  of the  human  gut/faecal  microbiota  is  limited  by  the 
inability  to  isolate  and  cultivate  these  organisms,  and  the  lack  of metagenomic 
studies on  this env ironment.  It  is thought  to consist of between  500-1000  species 
whose collective genomes are estimated to contain one hundred times the number 
of genes in the human genome (Backhed et al..  2004; Blaut et al.,  2002). hstimates 
based  on  difference  in  diversity  between  culture  studies  and  16S  rRNA  library 
studies  suggest  that  up  to  80%  of the  microbiota  is  uncultivable  (Duncan,  2003; 
Hayashi et al., 2002; Suau et al.,  1999).
831.3.2.1  Colonisation of and Bacterial Diversity in the Gut
In  humans,  the  gut  is  the  natural  habitat  for  a  large  and  dynamic  bacterial 
community (Table  1.9). As with the oral  microbiota, colonisation begins just after 
birth  with  organisms  from  the  environment  (Fanaro  et  al.,  2003),  the  maternal 
intestinal  flora (Fanaro et al.,  2003) and  food borne bacteria (Martin et al.,  2003; 
Edwards  &  Parrett.  2002)  and  the  development  of the  normal  commensal  flora 
proceeds  over time  (Kirjavainen  &  Gibson,  1999).  Its  composition  is  dependent 
upon a number of factors including the maternal microbiota, environmental (stress 
and dietary  changes) and host genetic factors (Kirjavainen & Gibson,  1999), and it 
is host-specific  (Dick  et al.,  2005;  Eckburg et al.,  2005).  Studies  with germ-free 
models  have  shown  that  the  inhibition  of the  systemic  response  to  commensal 
bacteria  rapidly  arises  after  initial  colonisation,  and  that  the  development  of 
important  gut  defenses  such  as  the  synthesis  and  secretion  of  polymeric 
immunoglobulin  A  and  the  generation  of a  balanced  T  helper  cell  response  are 
dependent  on  colonisation  with  a  diverse  microbiota  (Bourlioux  et  al.,  2003; 
Castagliuolo et al.  1999; Shi & Walker, 2004).
Part of GIT Common bacterial residents
Stomach Streptococcus spp.. Prevotella spp., Actinobacteria spp., Deinococcus spp.. 
Staphylococcus spp., Lactobacillus, Peptostreptococcus, H. pylori, 
Fusobacteria, Proteobacteria, Firmicutes, Fusobacteria and 
Deferribacteres.
Small intestine Lactobacillus spp., Bacteroides spp., Clostridium spp., Mycobacterium spp., 
Enterococci. bacteria of Enterobacteriaceae
Large intestine 
(colon)
Bacteroides spp., Fusobacterium spp., Clostridium spp., Peptostreptococcus 
spp., E. coli, Klebsiella spp., Proteus spp.,  Lactobacillus spp., Enterococci, 
Streptococcus spp., Pseudomonas spp.. Acinetobacter spp.. coagulase- 
negative Stapylococci. S. aureus, Mycobacterium spp., Actinomyces spp.. 
Bifidobacterium bifidum, Enterobacter spp., Peptococcus spp.,
Methanogens (Archaea), Salmonella spp., Ruminococcus spp., Eubacterium
SPP
Table 1.9: Common resident gut bacteria (taken from Upreti, 2004 with up-dates from Bik et al.,
2006).
84I he gut can be divided into three principle regions: the stomach, the intestines and 
the colon.
The stomach  has a  low microbial  count of approximately -100 CFU  per ml  since 
the environment has an  inhibitory  low pH  (Rastall.  2004).  Due to this only 29 out 
of  500  species  found  in  the oral  cavity  have  been  recovered  from  faecal  samples 
(Moore.  1994).  Facultative anaerobes predominant (Bik et al.,  2006).
The  small  intestine  also  harbours  a  high  degree  of  facultative  anaerobes.  In 
addition  to  lactobacilli  and  streptococci,  enterobacteria  are  present  in  large 
numbers,  although  the  anaerobes  Bifidobacterium,  Bacteroides  and  Clostridia are 
thought to predominate with CFUs o f-1 0 4 -  108 per ml (Rastall. 2004).
The colon is the most widely studied region of the GI tract and  is most associated 
with  the  ‘faecal  microbiota'.  It  is  the  most  heavily  colonised  region  with  a  total 
population of between  101 1   -   1012  CFU/ml.  based on  16S  rRNA  studies (Rastall. 
2004: Hckberg et al.,  2005).
The  predominant  genera  in  the  human  colonic  microbiota  are  Bacteroides  and 
Prevotella  (which  commonly  occur  at  numbers  in  excess  of log10  9.5  cfu/g  wet 
faeces).  Bifidobacterium,  Eubacterium,  Clostridium,  Peptoeoecus  and 
Peptostreptococcus  (Dick  et al.,  2005;  Rastall,  2004;  Blaut  et al.,  2002).  Aerobic 
species  (facultative  anaerobes)  are  also  present,  including  Escherichia, 
Enterobaeter.  Enteroeoccus,  Klebsiella,  Lactobacillus  and  Proteus  (Upreti.  2004; 
Dick  et  al.,  2005).  Studies  have  put  the  ratio  of obligate  anaerobes  to  facultative 
anaerobes  at  300:1  (Duncan  et  al.,  2003).  E.  coli.  the  most  common  facultative 
anaerobe  is  thought  to  account  for  only  0.1%  of the  total  bacteria  (Blaut  et  al.,
2002).  In addition to the bacteria. Candida and the protozoa Trichomonas hominis.
85Entamoeba hartmanni.  Endolimax nana and Iodamoeba butschlii are also common 
inhabitants of the large intestine (Duncan et al.,  2003).
It  is has been found that bacteriophage also  influence the diversity and population 
structure  of the  intestinal  microbiota  (Breitbart  et  al.,  2003).  Molecular  methods 
used  to  describe  the  microbiota  have  uncovered  phages  that  infect  E.  coli. 
Salmonella sp and B. frugal is at up to  10^ phages per g dry faeces (Breitbart et al.,
2003).  The  most  common  phage  in  a  faecal  sample  from  a  healthy  adult  were 
bacteriophage  Ah8  of  Listeria  monocytogenes,  bacteriophage  El 25  of 
Burkholderia  tluiilandensis  and  bacteriophage  bIL285  of L.  lactis.  Overall  it  is 
estimated  that  there  are  approximately  2-5  times  as  many  viral  genotypes  as  the 
number  of bacterial  species  in  the  human  intestine,  with  a  shot  gun  sequencing 
approach  on  a  faecal  viral  library  finding  that  -59%   of clones  harboured  inserts 
with no significant similarity to anything in the database (Breitbart et al.,  2003).
1.3.2.2  Antibiotic Resistance in the Gut
The GI tract provides huge potential  for genetic exchange due to its dense, diverse 
flora  and  the  input  of  transient  organisms  and  DNA  from  exogenous  sources 
(Upreti  et  al..  2004).  Only  recently  have  resistance  genes  and  their  associated 
mobile  elements  been  looked  for  in  the  human  Cil  tract.  Both  novel  genes  and 
C' I ns have been described (Scott.  2002; Calva et al.,  1996; Osterblad et al.,  2000; 
Rice et al.,  2004; Shoemaker et al.,  1992).
Studies by  Houndt and Ochman. (2000) have  shown that among strains of enteric 
bacteria  isolated  from  diverse  hosts  between  1885-1941  before  the  commercial
86application ot antibiotics began,  levels of resistance were low.  This is presumably 
due to the  lack  of a strong selective  pressure.  Strains  from  collections originating 
trom  1972-1982  showed  an  increase  in  high-level  resistance  in  20%  of isolates. 
However.  Corpet  (1992)  reviewed  short-term  studies  on  whether  antibiotic 
residues can modify the human gut flora and found that volunteers given low doses 
of ampicillin or oxytetracycline (1.5  mg/day and 2.0 mg/day respectively) showed 
no  significant  changes  in  the  numbers  of resistant  faecal  enterobacteria  (Corpet, 
1992): and De La Cochotiere et al.,  (2005) found that after a course of amoxicillin 
(1.5  g/day)  volunteers'  faecal  microbial  diversity  returned  to  pre-antibiotic  state 
after 60 days.
However, tetracycline resistance has been found in up to  12 % of infantile colonic 
E.  coli. with tet( A) and tet(B) occurring in 49 % and 51  % of tetracycline resistant 
isolates, respectively (Karami et al..  2006). Colonisation with tetracycline resistant 
strains  was  unrelated  to  treatment  with  antibiotics  indicating  there  is  limited 
pressure  against  the  carriage  of tet  genes  in  the  gut  microbiota  (Karami  et  al., 
2006).  In other studies tetracycline  resistance has  been  found  in  32.8  % of faecal 
bacteria  from  individuals  not  receiving antibiotic  therapy (Stark et al.,  1993);  and 
in  30 % o f Bifidobacterium  spp.  species  from the human GI  tract (Delgado et al.,
2005).  Additionally,  resistance  to  ampicillin,  cefoxitin  and  cefuroxime  has  been 
found  in  bacteria  from  70 % of faecal  samples  from  hospitalised  patients (mainly 
Bacteroides  thetaiotaomicron,  C  'lostridium  innocuum  and  Bacteroides  ovatus) 
(Stark et al.,  1993).
In addition, in the last ten years, the GI pathogens Salmonella spp.. Campylobacter 
spp.  and  H.  pylori  have  become  resistant  to  antibiotics  commonly  used  to  treat
87them  (Threlfall.  1999;  Giraud  et  al.,  2006;  Keller  &  Perreten,  2006). 
Fluoroquinolones and third generation cephalosporins are no longer useful against 
salmonellae.  fluorquinolones  and  macrolides  are  redundant  in  the  treatment  of 
Campylobacter  infections  and  metronidazole  and  clarithromycin  are  no  longer 
effective  against  //.  Pylori  (Kim.  2006).  Studies  have  suggested  that  the  use  of 
antibiotics  in  food  animals  selects  for  antibiotic  resistance  genes  which  are  then 
transferred to humans on consumption (Krause, 2002).
1.3.2.3  Gene Transfer in the Gut
Horizontal  gene  transfer  has  not  yet  been  studied  in  situ  in  the  colon,  however, 
v arious transfer experiments have been conducted that  implement colonic  species 
in such processes.  Transfer of van  A  has also been detected from a resistant animal 
derived E.  faecium to a sensitive human derived E.  faecium in human  faecal  flora- 
associated  mice  (Bourgeois-Nicolaos  et  al.,  2006);  tet(M)  has  been  shown  to 
transfer  from  Lactobacillus  spp.  to  E.  faecal  is  (Gevers  et  al., 2003);  the 
nonrecombinant  plasmid  pAMbetal  has  been  observed  to  transfer  from  L.  lactis 
strains  to  enterococci  in  a  faecal  flora-associated  mouse  model  system  (Tuohy  et 
al..  2002);  and  Tn916  (Bahl  et al.,  2004)  and  Tn 1549 (Launay  et al,  2006)  have 
been  shown  to  readily  transfer  between  E.  faecal is  strains  and  from  Clostridium 
symhiosum  to  Enterococcus  spp..  respectively  in  the  gut  of  gnotobiotic  mice. 
Futhermore,  the  carriage  of  fet(Q)  alleles  within  the  human  GI  bacteroides 
populations has  increased  from  -30%  to more than -80%  of isolates over the past 
thirty  years,  all  alleles except one  showed  between  96-100%  identity,  implicating 
1IGT (Shoemaker et al.. 2001).
88In  addition,  transfer  events  between  human  colonic  bacteria  and  human  oral 
anaerobes  (potentially  via  an  intermediate  host)  has  been  detected,  with 
tetracycline  resistance  determinants  of the  human  Bacteroides  uniformis  and  the 
oral Prevotella intermedia being  100 % identical at nucleotide level (Shoemaker et 
al.,  1991;  Nikolich  et  al.,  1994a).  Furthermore,  tet(Q)  of the  ruminal  Prevotella 
ruminocola  is  almost  identical  to  (>  97  %)  the  tet(Q)  of  human  Bacteroides 
strains,  implicating  HOT  between  these  species  and  possible  intermediate  hosts 
(Nikolich  et  al.,  1994b).  Similar  high  identities  have  been  observed  for  tet(W) 
genes  in  the  ruminal  bacteria  B.  fibrisolvens,  Selenomonas  runimantium  and 
Mitsuokella  multiacidus  (Barbosa  et  al,  1999);  sequences  flanking  the  /e/(W)  in 
Butyrivibrio fibrisolvens  isolates  and  other  gut  genera  were  found  to  be  between 
96  -   100  %  similar  in  all  strains  examined,  with  TnBJ230  implicated 
(Kazimierczak et al.  2006).
There is no evidence of transduction or transformation occurring in the gut. 
However, the recent investigation of the faecal viral metagenome (Breitbart et al., 
2002) has illustrated the huge number of phage present, and thus the potential for 
transduction to occur. This study found Siphophages to be the most common of the 
recognisable bacteriophages, these have previously been implicated in transduction 
(Seguritan et al.,  2003).  Furthermore, chloramphenicol resistance has been shown 
to transfer by phage among E.  coli strains in the house fly gut (Petridis et al.,
2006). tetracycline resistance transfer between S.  aureus strains has been shown to 
be phage mediated (Perira et al,  1997) and mef(A) in S. pyogenes have been 
shown to be prophage-associated (Giovanetti et al.,  2005).
89Due to the enormous amounts of bacteria (both live and dead) that pass through 
the GI tract and the lysis of these bacteria by stomach acid and intestinal enzymes 
(Drouault et al.,  1999), there is likely to be DNA available for uptake via 
transformation (although this has yet to be conclusively proven). Furthermore, the 
dense population of bacteria in the colon provides favourable conditions for DNA 
uptake (Salyers et al.,  2004).
901.4  Metagenomic Studies
1.4.1  The Concept of Metagenomics
Microorganisms account for a huge proportion of life on earth.
Bacteria  were  first  reported  in  1663  by  Antonie  van  Leeuwenhoek  (reviewed  in 
Tan.  2003).  Work  on  the  microbial  world  continued  through  culture  studies  thus 
unintentionally dividing it into the cultured and uncultured bacteria.  However, it is 
only relatively recently that the extent of the uncultured world has been recognised 
(Figure  1.11).  DNA-DNA  reassociation  studies  have  since  demonstrated  that  the 
diversity of bacteria in the soil was -100  fold greater than could be accounted  for 
by  culture  techniques  alone  (Torsvik  &  Ovreas.  2002;  Streit  &  Schmitz,  2004). 
This, and the realisation that much of the microbial  world is the foundation for the 
Earth's geochemical cycles (reviewed in Streit & Schmitz. 2004) demonstrated the 
need  to  explore  further  the  unknown.  Thus  ‘metagenomics'  was  bom. 
Metagenomics  is  defined  as  the  culture-independent  analysis  of  microbial 
communities  or  the  ‘compound  genome  of  the  environmental  microbiota' 
(reviewed in Schloss & Handelsman. 2003; Steele & Streit. 2005). it is also termed 
‘environmental  genomics'  or  ‘community  genomics'  (reviewed  in  Rodriguez- 
Valera. 2004; Tyson & Banfield. 2005; Handelsaman, 2004).
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Figure  1.11:  Relative  representation  in  selected  bacterial  divisions  of  16S  rRNA  sequences 
from  cultivated  and  uncultivated  organisms.  Compiled  from  5224  and  2918  sequences  from 
cultivated and  sequences  from uncultivated organismss.  respectively.  (Taken  from  Hugenholtz et 
al,  1998).  Red  sections  indicate  cultivable  portions  of  each  division,  blue  sections  indicate 
uncultivable portions
1.4.2  The Focus of Metagenomic Studies
There  has  been  a  dramatic  increase  in  the  application  of molecular  approaches 
applied to microbiota based on  16S rRNA gene sequence, however, sequence data 
does not provide any  information about the organisms phenotype (Steele & Streit, 
2005;  Hugenholtz  et  al.,  1998).  Instead  the  emphasis  has  begun  to  shift  into
92'functional  genomics'  which  is based on the comparison of nucleic acid sequence 
information  in  order  to  identify  and  assign  functional  roles  to  non-cultivable 
bacteria,  and  the  expansion  of databases  through  the  sequencing  of novel  genes 
(Steele & Streit, 2005; Venter et al.,  2004; Gill et al.,  2006).
Some of the common methods used in these studies are outlined below.
1.4.2.1  Sequence Based Studies
The  16S  rRNA  gene  (Figure  1.12)  is  often  used  to  describe  the  diversity  and 
population structure of a particular environment (Schloss & Handelsman. 2004).  It 
is a standard reference in the identification of bacteria and the databases have been 
expanded  to  include  over  90000  16S  rRNA  sequences,  including  those  from 
cultivated and uncultivated organisms (Clarridge. 2004). Such techniques have had 
a  major  impact  on  the  classification  of bacteria  which  were  previously  grouped 
according to phenotypic properties (Clarridge, 2004).
93Figure  1.12: Genetic organisation of the  16S rRNA gene. The rate of change in the gene is not 
known, but it has been determined to represent evolutionary distance and relatedness of organisms 
(Ochman  et  al.,  2000).  The  16S  rRNA  gene  sequence  is  -1550  bp  and  contains  both  variable 
(double  lines)  and  conserved  (thick  black  lines)  regions.  Universal  primers  used  to  amplify 
sequence for comparison are based either side of the variable regions VI  or V3  (image taken from 
Tortoli, 2003; Klijn et al.,  1991).
Since the use of the  16S rRNA gene as a phylogenetic tool, 50 bacterial phyla have 
been  identified.  Half of these  are  exclusively  composed  of uncultured  bacteria 
illustrating  the  extent  to  which  molecular  techniques  have  expanded  our 
knowledge (Schloss and  Handelsman, 2004).  However,  in 2004 there were still  a
7  o
predicted  10-10  different species of bacteria still to be discovered, a Figure based 
on bacterial  rarefaction curve analysis which is used to estimate the completeness 
of data sampling (Hugenholtz et al., 2002).
Importantly.  HGT  appears  to  affect  the  informational  genes  (those  involved  in 
transcription  and  translation)  far  less  than  it  does  the  operational  genes  (those
94involved  in  housekeeping),  allowing  us  to  disregard  it  as  a  method  of obscuring 
phylogeny  (Jain  et  al..  1999;  Schloss  &  Handelsman,  2004;  Hugenholtz  et  al.. 
2002).
1.4.2.2  Analyses of Microbiota
Techniques used  to  investigate environmental  samples  focus either on description 
and  quantification  of  species  present  (mainly  due  to  the  abundance  of  16S 
sequence  data  available)  or  the  in  situ  activities  of bacteria  (including  numerous 
as-yet-unknown biochemical and metabolic activities) (Table  1.12) (Spiegelman et 
al..  2005).  Some  of the  methods  used  in  these  studies,  and  their  limitations  are 
outlined in Table  1.10.
95Method Uses Limitations
Cultivation Isolation, ‘the ideal' Not representative, slow and 
laborious
16S rDNA Sequencing / 
16S rRNA clone 
libraries
Phylogenetic identification Laborious, subject to PCR  / 
cloning biases
DGGE/TGGE/TTGE Monitoring of community shifts; 
rapid comparative analysis
Subject to PCR biases and co­
migration of bands (disorting 
diversity); semi-quantitiative; 
identification requires clone 
library
T-RFLP Monitoring of community shifts; 
rapid comparative analysis; very 
sensitive; potential for high 
throughput
Subject to PCR biases; semi- 
quantitiative; identification 
requires clone library
SSCP Monitoring of community shifts; 
rapid comparative analysis
Subject to PCR biases; semi- 
quantitative; identification 
requires clone library
RT (real time)-PCR Quantification of bacteria in an 
environmental sample. Promising for 
species present at low concentrations
Requires sequence information
FISH Detection; enumeration; comparative 
analysis possible with automation. In 
combination with flow cytometry can 
sort uncultivable from cultivables to 
access to sequence information
Requires sequence 
information; laborious at 
species level; high detection 
levels; relies on cell 
permeability
Dot-blot Hybridisation Detection; estimates relative 
abundance
Requires sequence 
information; laborious at 
species level
Qualitative PCR Detection; estimates relative 
abundance
Laborious
Diversity Microarrays Detection; estimates relative 
abundance
In early stages of 
development; expensive
Shotgun libraries Access to sequence information of 
the whole metegenome
Subject to cloning biases; high 
detection level; generates 
sequences encoding unknown 
functions
Non-16S rRNA profiling Monitoring of community shifts; 
rapid comparative analysis
Identification requires 
additional  16S rRNA-based 
approaches
Table 1.10: A summary of current techniques used to study complex microbial ecosystems
(adapted from Zoetendal et al., 2004; additional information from Gafan et al., 2005).
1.4.2.3  Metagenomic Libraries
One  method  for  accessing  the  functional  information  of  a  microbiota  that 
eliminates  this  PCR-induced  bias  and  the  need  for  sequence  information  is  the 
construction  of metagenomic  libraries  constructed  from  the  total  DNA  extracted
96from  an  environmental  sample  (although  this  method  has  biases  of  its  own) 
(Rondon  et  al.,  2000;  Handelsman,  2004).  In  2000,  Rondon  et  al.,  published  a 
landmark paper describing the use of Bacterial Artificial Chromosomes (BACs) to 
clone  total  community  DNA  thus  accessing  the  entire  metagenome,  potentially 
allowing  the  unbiased  cloning  of intact  genes  with  all  the  long  range  controlling 
elements that drive expression and even entire biosynthetic/metabolic pathways.  It 
is  one  of  the  most  effective  techniques  for  identifying  functional  genes  from 
environmental samples (Entcheva et al.,  2001).
As  with  16S  libraries  a  number  of  vectors  can  be  used.  In  recent  years  the 
Bacterial  Artificial  Chromosome  (BAC)  has  been  a  popular  choice  (Beja  et  al., 
2000; MacNeil et al.,  2001; Gillespie et al.,  2002; Riesenfeld et al.,  2004).
1.4.2.3.1  Bacterial Artificial Chromosomes
BACs were developed by Shizuya and colleagues in  1992 as a bacterial cloning 
system for mapping and analysis of complex genomes as part of the effort to create 
a high-resolution map of the human genome. The BAC (Figure  1.13) is based 
around the mini-F plasmid pMB0131  which contains genes that regulate its own 
replication (OriS and repE) and control its copy number {par operon. which is 
involved in the exclusion of multiple f factors (Easter et al.,  1998) thus allowing 
the stable maintainence of inserted bacterial DNA. The addition of a 
chloramphenicol resistance gene as a selectable marker; a cloning segment 
composed of cosX sites from bacteriophage k and loxP sites from PI, and a 
multiple cloning site Hanked by promoters completed the vector (Figure  1.13) 
(Shizuya et al..  1992; 2001). The vector was used to clone inserts of more than 300 
kb (Shizuya et al.,  1992)
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Figure 1.13: pBeloBACll. derived from Shizuya’s original BAC vector. Orange arrows and 
purple box labelled parC indicate genes, purple box beneath lacZ represents the multiple cloning 
site (www.rzpd.de)
1.4.2.3.2  Current Applications of the BAC System
1.4.2.3.2.1  Single species studies
Perhaps  the  most  useful  study  based  around  a  single  species  library  is  that 
analysing the expression of B.  cereus genes cloned  into BAC  in an E.  coli host.  It 
high-lighted the need for continued development of molecular tools. Rondon et al., 
1999  screened  the  BAC  library  for  expression  of B.  cereus  activities  and  found 
that 60% were detectable in the Gram negative host (Table 1.11).
98Activity Tested Expression Detected
Starch hydrolysis
Casein hydrolysis
Haemolysis +
Esculin hydrolysis +
Orange pigment +
Ampicillin resistance +
Zwittermicin A resistance +
Lecithinase +
Chitinase
Lipase
Table 1.11:  Expression of B. cereus activities in E. coli (taken from M  Rondon et ai,  1999). 
1.4.2.3.2.2 Metagenomic studies
Metagenomic studies are capable of identifying novel bacterial properties. To date, 
most studies have concentrated on aquatic and soil environments using a variety of 
different vectors (Table 1.12).
99Vector Metagenome/
sample
Novel Genes/ 
Characterizations
Reference
BAC Marine Novel bacteriorhodopsin Beja et al., 
2000a, 2000b
BAC Soil Kanamycin resistance 
encoded by a novel 
aminoglycoside gene
Riesenfeld et al 
2004
Small insert 
(pJN 105 / 
pCF430)
Soil Eight novel aminoglycoside 
resistance genes and a novel 
tetracycline resistance gene
Riesenfeld et al., 
2004
BAC Soil Novel indirubis-like 
antimicrobial compound
MacNeil et al 
2001
BAC Soil Turbomycin A and B 
synthesis characterisation
Gillespie et al., 
2002
Fosmid Soil Novel copper-containing 
nitrate reductase
Treusch et al., 
2005
Cosmid Soil Novel Violacein-like 
antibacterial pigment
August et al 
2000
Cosmid Soil Putative stereoselective 
amidase,
13  cellulases, 
a-amylase,
1.4-a-glucan branching 
enzyme,
2 pectate lyases
Voget et al., 
2003
Cosmid Soil Long chain V-Acyltyrosine 
synthases
Brady et al., 
2004
pBluescriptSK+ Soil 4-hydroxybutyrate
utilisation
Henne et al., 
1999
Fosmid Marine Characterisation of 
uncultured prokaryotes
Vergin et al. 
,1998
Stein et a l , 
1996
Fosmid Soil Uncultured Crenarchaeote Quaiser et al., 
2002
Fosmid Thermal soil Thermostable esterase Rhee et al., 2005
Fosmid Marine Novel candidate phylum 
Poribacteria; novel 
molybdenum containg 
oxidoreductas
Fieseler et al., 
2006
Fosmid Marine Discovery of a novel lineage 
of Alvinella
Moussard et al., 
2006
TOPO-XL Human
saliva/plaque
Tetracvcline resistance 
(tet(37))
Diaz-Torres et 
al.,  2003
Table 1.12:  Metagenomic libraries and the novel characteristics and / or genes found during their 
screening.
1001.4.3 The Future of Metagenomics
In  light of the  findings  by  Rondon  et al,  (1999)  that only 60% of genes  from  a 
Gram positive organism are expressed in the Gram negative E.  coli host a number 
of new  vectors  have  been  developed  in  order  to  provide  a range of hosts  to  use 
when  performing  functional  screens  (Table  1.  13).  Through  construction  of 
libraries in these vectors and their screening in alternative hosts, differences in the 
expression of certain traits  have  been detected  (Alduina et al.,  2003;  Martinez et 
al, 2004; Wang et al,  2000).
Vector Hosts Important
Characteristics
Reference
BIBAC (binary 
bacterial artificial 
chromosome) & TAC 
(transformation- 
competent BAC)
E. coli and various 
plants
Transforms plants 
directly
Liu et al., 2002
ESAC (£. coli- 
Streptomyces 
Artificial 
Chromosome)
E. coli
Streptomyces
coelicolor
BAC-based shuttle 
vector.
Incorporates into 
Streptomyces host 
using d>C31  attP-int 
system
Sosio et al, 2000, 
2001
Alduina et al, 2003
pMBD7, -9,-12 E. coli 
Sm. lividans 
Pseudomonas puiida
BAC based shuttle 
vector
Courtois et al., 2003
pDL276, pDL278 E. coli 
B. subtilis 
E. faecalis 
Streptococci
Produces random, 
representative libraries 
with inserts of 10 Kb
Dunny et al.,  1991
Table 1. 13: Alternative vectors for metagenomic cloning with both Gram positive/eukaryotic 
and Gram negative hosts.
1.4.4  Analysis of Metagenomic  Data
Since the rise in the use of BACs and other HMW-insert vectors to create libraries, 
the  development  of  supporting  analytical  techniques  is  required  in  order  to
101optimise  the  benefits  of these  systems  (Chen  &  Pachter,  2005;  Ball  &  Trevors, 
2002).
Libraries have been screened for beneficial genes either by functional or sequence 
screens  (Handelsman.  2004).  Both  have  advantages.  Sequence-based  approaches 
allow the quick  identification of genes through comparisons to the databases,  and 
if a  16S  rRNA or other marker gene is  identified  in a clone then the phylogenetic 
identity of the insert can be determined (Handelsman. 2004; Francke et al,  2005). 
Functional  screens  are  laborious  and  time  consuming  (although  pooling  schemes 
have  been  described)  (Bruno  et  al.  1995)  but  offer  an  opportunity  to  discover 
functional, novel genes if appropriate assays exists (Yun et al,  2005).
The ultimate aim of sequenced-based approaches is to assemble whole genomes of 
uncultured  organisms  (Francke  et  al.  2005).  Liles  et  al,  (2003)  have  so  far 
assembled  Mb  of  Aeidobacterium  DNA  from  73  metagenomic  clones.  A 
similar project is also underway  for an uncultivated soil Crenarchaeote (Quaiser et 
al.  2002).  However, at present this approach is largely based around anchors such 
as  16S rRNA or recA  genes.
So  far,  fewer products have been  identified than expected (products found to date 
are  listed  in  Table  1.12).  One  explanation  is  that  the  synthesis  of some  products 
often  requires  large  fragments  of DNA  of up  to  100  genes  to  be  cloned  (Shleh- 
Lakha et al.- 2005). This is only likely to occur rarely in a library. One way around 
this  is the  development  of highly  sensitive  assays  which  are  capable  of detecting 
low  levels  of activity  (Williamson  et  al,  2005;  Schloss  and  Handelsman,  2004). 
such  as  Substrate-Induced  Gene-ELxpression  Screening  (SIGEX)  which  selects
102clones harbouring catabolic genes with fluorescence activated cell sorting by using 
tagged aromatic hydrocarbons (Yun & Ryu. 2005)
1.4.4.1  Combined Approaches
The  combined  use  of  library  construction  and  array  analysis  of environmental 
samples allows clones of interest to  be  identified  without  the need  for expression 
in a heterologous  host and  without  laborious screening of individual  clones (Ball,
2002).  Sebat  and  colleagues,  (2003)  developed  an array  consisting of DNA  from 
previous  isolates,  reference  strains  and  whole  community  DNA  for  screening  a 
ground water cosmid  library.  This produced a comparative genomic  hybridisation 
profile  for  each  cloned  insert.  Furthermore,  clones  which  failed  to  hybridise  to 
anything were easily  identified  for sequencing.  This approach identified functions 
with  potential  ecological  importance  including  those  involved  in  hydrogen 
oxidation,  nitrate  reduction  and  transposition.  The  study  recognized  the  potential 
use of such arrays for rapid screening of metagenomic libraries.
Call  et al.  (2003)  have  since  developed  a glass-based  microarray  for detection  of 
17  tetracycline  resistance  determinants  (tet(A)-(E),  tet{G),  /e/(H),  tet(L).  /e/(M), 
tet(O).  tet(S).  tet(W).  tet(Z).  /e/(30).  letA(P).  /e/B(P).  and  o/r(B)0.  bla\\:\m  and 
16S  rRNA  oligonucleotides)  which  could  be  exploited  for detection  of resistance 
genes in environmental  libraries.
1.4.5  Molecular Techniques Applied to the Cl Tract
Many  of  the  techniques  outlined  above  have  been  employed  to  further  our 
understanding of the oral and intestinal microbiota (Table  1.14). Currently most of
103the  work  focuses  on  descriptions  of  the  diversity  in  both  health  and  disease 
(O'Sullivan, 2000;  Gill  et al,  2006).  However,  more recent work has focused on 
functional  screens  and  COG  (Clusters  of Orthologous  Groups)  analysis  (which 
groups  functionally  related  genes  using  evolutionary  relationships  and  thus 
estimates  community  richness  of  metabolic  functional  groups  in  a  microbiota) 
(Tannock,  2001, 2002; Diaz-Torres et a l 2002), to gain a more meaningful insight 
into the microbiota.
Method  1   Sample Study Reference
FISH
TGGE
Faecal Identification of the predominant bacteria 
species, and investigation of changes in 
diversity over time
Zoetendal et al, 
2004
TGGE Faecal Demonstration that the intestinal flora is 
host specific, indicating the role of genetic 
factors in colonisation
McCartney, 2002
16S rDNA 
libraries/PC R
Various along 
the GI tract
Demonstration of the dominance of 6 
phyla: firmicutes, Proteobacteria, 
Bacteroides, Fusobacteria,
Verrucomicrobia, and the Actinobacteria. 
Demonstrated Clostridia and Streptococcus- 
like species predominate in the colon 
Demonstration that Firmicutes and 
Actinobacteria are the only divisions 
represented in the distal gut, and 
Methanobrevibacter smithii is the only 
archael phylotype
X Wang et al., 
2003
M Wang et al, 
2005
Vaahtovuo et al, 
2005
R V/ang et at., 
1996
Wilson &
Blitchington,
1996
Gill et al, 2006
16S rDNA +
RFLP
analysis
Jejunal and 
ileal mucosa
Measured diversity in elderly patients Hayashi et al, 
2002, 2003, 2005 
Jemberg et al, 
2005
SSCP
Fingerprinting
RT-PCR
Faecal Investigated diversity in the colonic 
microbiota of patients with inflammatory 
bowel disease (demonstrated a reduction in 
diversity of 50% for Crohn's patients and 
30% for UC patients)
Ott et al, 2003
16S rDNA 
libraries
Saliva/ plaque Measured diversity in healthy subjects, 
endodontic patients and those with 
aggressive periodontitis
Saito et al, 2006 
Sakamoto et al, 
2000, 2004
T-RFLP Saliva/
plaque
Assessment of oral microbial diversity Sakamoto et al, 
2003. 2005
DGGE Saliva/ plaque Investigation of diversity over time, 
between individuals and in dental plaque 
microcosms
Rasiah et al, 
2005
Y Li et al. 2005
FISH Saliva Indentification and quantification of 
bacteria in carious dentine
Bar.erjee et al, 
2002
TOPO-XL
metagenomic
libraries
Saliva/ plaque Screening of the oral microbiota for 
tetracycline resistance
Diaz-Torres et al, 
2003
104RT-PCR Plaque Quantification of periodontopathic bacteria Sakamoto et al., 
2004
RT-PCR Faeces Characterisation of faecal flora and 
investigation of the effects of antibiotic 
treatment
Bartosch et al., 
2004.
Whole-
genome
Shotgun
Sequencing
Faeces Investigation of the diversity of metabolic 
functions in the faecal microbiome - 
demonstration of enrichment in genes 
involved in metabolism of complex 
carbohydrates which the human genome 
lacks
Gill et al., 2006
Table  1.14:  Metagenomic studies of the Human GI Tract.
Despite  all  the  advances  in  this  field  outlined  above,  the  concept  of finding  a 
certain gene or pathway in an environmental sample using metagenomics depends 
on a number of factors.  The abundance of the gene in the environmental  sample; 
the length of the gene or operon; the size of insert and the presence of expression 
signals  that  are  functional  in  the  host  organism;  and  the  correct  folding  of the 
resulting  protein  in  a  heterologous host  by  trans  acting  host  factors (chaperones, 
cofactors,  protein-modifying  enzymes)  all  contribute  to  the  likelihood  of 
successful cloning (Gabor et al., 2004).
The  minimal  requirements  for  gene  expression  are  an  appropriately  spaced 
promoter  for  transcription,  a  ribosome  binding  site  (RBS)  and  a  start  codon  for 
initiation  of  translation,  both  of  which  need  to  be  compatible  with  host 
transcription factors (Gabor et al, 2004).
In metagenomic cloning, expression may be via
i)  independent gene expression (both the RBS and promoter are provided 
by the insert)
ii)  expression as a transcriptional  fusion with only the RBS located on the 
insertiii)  as  a  translational  fusion  (the  RBS  and  promoter  are  provided  by  the 
vector), although this is highly unlikely to occur.
Gabor  et  al.,  (2004)  have  taken  these  factors  into  account  and  designed  to 
statistical  models to determine what proportion of genes might be expressed  in an 
E.  coli host,  taking  into account  the  three  modes  of gene expression  listed  above. 
Their results how approximately 40% of enzyme activities from a metagenome can 
be expected to express in E.  coli and thus recovered by random cloning. Therefore, 
the  challenge  still  remains  to  access  all  the  genetic  information  from  a 
metagenome.
Perhaps  one  concern  of the  wide  use  of these  methods  to  define  environmental 
microbial diversity is the deposition of sequences in the database which provide no 
further information than the degree of relatedness o f ‘clones'  to cultivable species. 
While it allows us to numerically quantify diversity, these methods shed no further 
light on the role of these novel species in the microbiota. There is also concern that 
the relative ease of obtaining Mb of sequence data is eclipsing the need to continue 
culture  based  studies,  especially  in  light  of  the  fact  that  novel  cultivation 
stratergies  are  possible  and  have  recently  been  developed  for  butyrate-producing 
(Gourque-Jeannot et al., 2006) and cellobiose-degrading bacteria (Zoetendal  et al.
2003)  allowing access to  potentially  marketable  novel  biochemical  pathways,  and 
a greater understanding of its role within the environment.
1061.5  Rational for This Study
I he  human  commensal  microbiota  is  known  to  be  a  reservoir  of  antibiotic 
resistance genes (Lacroix &  Walker.  1995;  Millar et al.,  2001;  Ready et al.,  2003; 
Villedieu  et  al.  2003).  This  has  important  impact  on  antimicrobial  therapy 
(reviewed  in  Martinez &  Baquero.  2002;  Lipsitch  &  Samore.  2002).  However,  to 
date,  studies  have  concentrated  on  which  resistance  determinants  and  genetic 
supports are present  in the cultivable  flora (Lacroix &  W alker.  1995;  Millar et al., 
2001;  Ready  et  al..  2003;  Villedieu  et  al.  2003).  Since  -50  %  of  the  oral 
microbiota  (Wade  et  al..  2002);  and  -80  %  of the  faecal  microbiota  (Hayashi  et 
al..  2002;  Duncan  et  al..  2003)  is  yet  to  be  cultivated,  the  presence  of  some 
resistance  determinants  may  be  inaccurately  estimated.  Indeed  it  has  been  shown 
that  the  uncultured  portion  of  the  oral  microbiota  harbours  novel  tetracycline 
resistance  determinants  (Diaz-Torres  et  al..  2003).  Therefore,  in  order to  provide 
effective antibiotic  treatment  for infections of the GI  tract, an antibiotic  resistance 
profile for the complete microbiota is required.
The aims of the study are:
1).  To  determine  the  incidence  of resistance  to  the  antibiotics  erythromycin  and 
tetracycline  in  the  aerobic  cultivable  and  total  flora  of the  human  oral  and  faecal 
microbiota of samples from six  Luropean countries.
Only  (iram  positive  isolates  from  the  culture  study  will  be  investigated  further as 
they  represent  a  distinct  phylogenetic  group  which  can  be  investigated  in  detail, 
f urthermore,  as  this  project  was  part  of  a  larger  Luropean-vvide  study  on  the 
biologv  of Gram  positive  organisms,  can  be  compared  to  the  results  obtained  by
107our European partners  involved in the ARTRADI project (an EU project).  Enough 
tetracycline resistant  BAC clones will  be  identified so that a significant number of 
inserts  trom  Gram  positive  organisms  can  be  isolated  for  comparison  with  the 
Gram  positive  isolates  in  order  to  determine  if there  is  a  difference  between  the 
genetic  basis  of tetracycline  resistance  in  the  cultivable and  uncultivated  portions 
of the microbiota in that phylogenetic group.
2).  To  describe  the  genetic  basis  of tetracycline  resistance  in  the  Gram  positive 
cultivable portion of the  samples and  compare  it to the genetic  basis of resistance 
in the whole microbiota.
3).  To  construct  12  metagenomic  libraries,  one  from  each  of the  oral  and  faecal 
samples obtained from each partner country.
4). To screen the metagenomic libraries for tetracycline resistance and characterise 
any novel genes or mobile genetic elements.
108Clones of interest investigated 
further
Gram positive isolates identified to 
genus level
Isolates of interest investigated 
further
Cell suspensioned washed 
thoroughly. Metagenomic 
DNA extracted
BAC library constructed 
using DNA fron each sample 
type from each country
BAC libraries screened for 
tetracycline-resistant clones
Samples pooled and mixed 
according to country and sample 
type
Tetracycline- and erythromycin- 
resistance genes identified on the 
macroarray
Saliva and faecal samples obtained 
from 20 healthy volunteers for each 
of six countries
50 isolates of each resistant type 
from each country for each sample 
Gram stained; Gram positive 
isolates stocked
Samples suspended in PBS and  1ml 
removed dilution series used in an 
aerobic / facultative anaerobic 
culture study to identify 
tetracycline-, erythromycin- and 
vancomycin-resistant isolates
Figure  1.14:  Flow chart illustrating path of investigation in this study.
109CHAPTER TWO 
Materials and Methods
n o2.1  Bacterial Strains and Plasmids
Bacterial strains and plasmids used in this study are listed in Table 2.1.
Strains and plasmids Relevant characteristics/source Reference
Strains
S. aureus NCTC 6571 Antibiotic sensitive www.hpa.oru.uk
B. subtilis BS34A tet(M), Tn9l6 Roberts et al., 2001
E. c'o//::pGEM tet{0) Aminov et al.,2001
K10 tet( 32) Melville et al., 2001
E.faecium 664:IHI tet{ S) Roberts et al., 2006
E. coli EPI 300 BAC host Epicentre
E. coli DHlOb pUC19/pDL278 host Invitrogen
S.  mutans UA159 pDL278 host Dunny et al.,  1991
Plasmids
pUC19 Small insert cloning vector, ampicillin 
resistant
Invitrogen
pCClBAC
Large insert cloning vector, 
chloramphenicol resistant
Epicentre
pDL278
Small insert shuttle vector.
Dunny et al.,  1991
spectinomycin resistant
Table 2.1:  Bacterial Strains and Plasmids used in this study.
2.2 Chemicals and  Reagents
All  growth  media were obtained from Oxoid Ltd (Basingstoke,  UK); All antibiotics 
and other chemicals were obtained  from  Sigma Aldrich (Poole,  UK);  All  molecular 
biology enzymes were obtained from Promega (Southampton, UK); Competent cells
111were obtained  from  Epicentre (distributed  through  Cambio,  Cambridge,  UK) unless 
otherwise stated. Composition of buffers and solutions are listed in Appendix  1.
2.3  Sampling and Processing of Saliva and Faecal Samples
2.3.1  Subjects
20  healthy  adults  who  had  not  received  antibiotic  therapy  in  the  previous  three 
months  were  recruited  as  volunteers  from  each  of the  countries  under  investigation 
(England  (Eastman  Dental  Institute.  University  College  London),  France.  2  centres 
(Faculte de  Parmacie.  Universite  Paris  Sud and  INRA-UEPSD,  Domain de Vilvert), 
Finland  (VTT  Biotechnology).  Italy.  2  centres (Istituto  di  Microbiologia.  Universita 
di  Ancona  and  Istituto  Superiore  di  Sanita.  Roma),  Norway  (IMB  University  of 
Tromsd)  and  Scotland  (Rowett  Research  Institute).  No  set  of 20  were  exclusively 
male or female and represented a range of ages (Appendix 2)
2.3.2  Sample Collection
Instructions were  given to each  vounteer (Appendix  3).  Saliva samples (-5ml)  were 
acquired  using  lg sterile  low melting point  W4  physiowax  (Raymond  A  Lamb  Ltd. 
Eastbourne.  East  Sussex)  to  stimulate  saliva  and  dislodge  plaque.  Samples  were 
collected by expectoration into a sterile container (care was taken not to contaminate 
the  samples  with  bacteria  from  the  lips  and  chin).  An  equal  volume  of  Reduced 
Transport  Fluid  (RTF)  (Syed  et  al..  1972)  was  added  to  each  sample  in  a 
microbiology  safety  cabinet  (BioMAT-1  Class  1   microbiological  safety  cabinet)  to 
avoid contamination.  Faecal samples (>2.5g) were obtained from 20 individuals from 
the  same  centres.  Volunteers  defecated  into  a  disposable  paper container  (Sarstedt, 
Leicester.  UK).  They  then  used  a disposable  spatula to  transfer  faeces  into a  sterile
112plastic  collection  tube  (Sarstedt)  until  it  was  a quarter  full.  Cary-Blair medium  was 
then used to completely cover the sample in a safety cabinet so that the container was 
approximately half full.
Each  set  of samples  was  kept  separate  according  to  sample  type  (oral/faecal)  and 
country  of origin. They were processed with 48 h of their collection.
2.3.3  Processing of Saliva and Faecal Samples
2.3.3.1  Saliva Samples
The saliva was vortexed (Fischerbrand whirlimixer) for 30 s to resuspend any settled 
plaque  or  planktonic  cells.  All  samples  from  individual  countries  were  pooled  in  a 
sterile 200ml Duran (Fisher Scientific. Loughborough. UK).
2.3.3.2 Faecal Samples
2.5g of each of the 20  faecal  samples  from a country  were pooled,  mixed by manual 
kneading  in a sterile disposable plastic  bag (Steward  Scientific) and  divided  into 5g 
aliquots. The faeces were suspended in 50ml  PBS and centrifuged at 4000 rpm (2862 
x  g.  eppendorf  centrifuge  5804R)  for  2  mins  to  pellet  the  coarse  sediment.  The 
supernatant  was  removed  and  centrifuged  at  6000  x  rpm  (6800  x  g.  Eppendorf 
centrifuge  5804R)  for  10  mins  to  pellet  the  bacterial  load.  The  pellet  was  washed 
three times with 50ml  PBS. A  final suspension of the bacteria was made in 5ml  PBS.
lml total sample was removed for the culture study (Chapter three).
1132.3.4  Extraction of Genomic DNA
2.3.4.1  From Saliva samples
DNA  Irom  the  saliva/PBS  mixture  was  purified  from  samples  according  to  the 
'Gram-positive bacteria and yeasts'  protocol  from the  Puregene  Kit DNA extraction 
kit  (Centra,  distributed  by  Flowgen.  Nottingham,  UK).  Cells  were  pelleted  by 
centrifugation  at  13000  rpm  (15700  x  g.  Eppendorf centrifuge  5415D)  in  10  ml 
aliquots  in  50  ml  sterile  plastic  centrifuge  tubes  (Sarstedt).  Pellets  were  gently 
resuspended  in 5  ml of Cell  Suspension Solution provided with the kit.  5  pi of Lytic 
Enzyme Solution (4,000 U/ml) was added (alternatively  lysozyme at a concentration 
of 4mg/ml  could  be  added);  the  samples  were  inverted  25  times  and  incubated  at 
37°C  for 30 minutes (Grant incubator) to digest cell walls. After centrifugation of the 
samples  for  1   min  at  13.000  rpm  (15700  x  g.  Eppendorf 5415D)  in  a  bench-top 
centrifuge the supernatant was removed and the cells were suspended in 5 ml of Cell 
Lysis  Solution  (Puregene)  and  gently  pipetted  up  and  down  to  lyse  the  cells.  The 
samples  were  heated  at  80°C  for  5  minutes  to  complete  cell  lysis.  To  this  15  pi 
Proteinase  K  (lOpg/ml)  (New  England  Biolabs,  Hitchin,  Herts,  UK) was added  and 
the  sample  was  incubated  in  a  water  bath  at  55  C  for  1   h.  Five  pi  of RNAse  A 
Solution (4 mg/ml) (Puregene) was added to the cell  lysate,  the samples were mixed 
by  inverting the tubes 25  times and then  incubated at 37°C  for  1   hour to remove the 
RNA.  After cooling  the  samples  to  room  temperature.  2  ml  of Protein  Precipitation 
Solution (Puregene)  was added  to the cell  lysate and  it  was  mixed  and  incubated  on 
ice  for  30-60  mins.  The  samples  were  centrifuged  for  5  minutes  at  14.000  rpm 
(15700 x g,  Eppendorf 5415D) and  the supernatant containing the  DNA  was poured 
into  a clean  15  ml  sterile centrifuge  tube  containing  3  ml  100%  (CH.A2CHOH.  The 
samples  were  inverted  gently  50  times  and  centrifuged  for  3  mins  at  14,000  rpm
114(15700 x  g.  Eppendorf 5415D).  The  supernatant was removed  from the  DNA  pellet 
using  a  pipette.  The  pellet  was  then  washed  with  1   ml  70%  C2H5OH  (BDH 
Chemicals.  Poole.  UK)  and  centrifuged  for  1   minute  at  14.000  rpm  (15700  x  g, 
Eppendorf  5415D).  The  tubes  were  drained  on  3  mm  Whatman  paper  (Whatman. 
Brentford,  UK)  and  allowed  to  air  dry  for  30  minutes.  The  DNA  pellet  was 
redissolved overnight in 500 pi sterile distilled water.
2.3.4.2  From Faecal Samples
The above protocol  was used  for the  initial  stage of DNA extraction  from the faecal 
suspensions  outlined  in  the  sample  processing.  However,  samples  remained  visibly 
dirty and the following clean-up protocol was used:
500  pi  of original  DNA  extract  was  mixed  with  13.5  ml  DNA  extraction  buffer 
(Appendix  1)  and  100  pi  proteinase  K  (10  mg/ml)  (NEB)  in  a  15  ml  sterile  plastic 
centrifuge tube (Sarstedt).  This was incubated horizontally at 37°C with shaking (225 
rpm,  Sanyo  Orbital  Incubator)  for 30  min.  Following  this  1.5  ml  of 20%  SDS  was 
added  and  the  samples  were  incubated  in  a  65°C  water bath  for 2.5  h.  The  reaction 
was then transferred to a 50 ml sterile centrifuge tube (Sarstedt) and an equal volume 
(15.6  ml)  of chloroform-isoamyl  alcohol  (24:1  v/v)  was  added.  The  mixture  was 
vortexed gently and the aqueous phase was recovered by centrifugation for 20 min at 
4000  rpm  (2862  x  g.  eppendorf 5804R).  Once the contents of the tube had  settled  a 
wide-bore  pipette  tip  (Sarstedt.  cut  with  sterile  scissors)  was  used  to  removed  the 
upper DNA-containing phase.  To this 0.6 volume (9.4  ml) (OUECHOH  was added 
and the mixture was incubated  for  1   h at room temperature.  Finally the solution was 
centrifuged  for 20 min  at the highest rpm (-4000:  2862  x  g.  Eppendorf 5804R) and
115the  DNA  pellet  was  washed  with  70%  C2H5OH  (100%  AnalaR  BDH,  diluted  with 
sterile  distilled  water).  This  was  removed  with  a  pipette  and  the  DNA  pellet  was 
allowed  to  air-dry  before  being  resuspended  in  500  pi  sterile  distilled  water at  4 °C 
overnight.
2.4 MIC Determination
The  MIC  of isolates of interest  for tetracycline,  erythromycin,  and  vancomycin  was 
determined  by  plating  each  on  iso-sensitest  agar  plates  supplemented  with  5% 
defibrinated  horse  blood  containing  lpg/ml,  2pg/ml.  4pg/ml.  8pg/ml,  16pg/ml, 
32pg/ml. 64pg/ml and  128pg/ml of the antibiotic.  The inoculum was a single colony 
from  an  over-night  streak  plate  which  was  spread  on  plates  containing  the  above 
concentrations.  Plates  were  read  after 24  hr  incubation  at  37°C  aerobically  or 48  hr 
incubation  at  37°C  anaerobically  according  to  the  atmosphere  requirement  of  the 
isolate.  The  highest  dilution  of antibiotic  that  inhibited  visible  growth  was  taken  to 
be  the  MIC  (MacGowan  &  Wise  2001;  Andrews  2001).  E.  coli  DHB10  and 
NCTC657I  were  used  as  a  negative  controls  in  the  tetracycline  MIC  point 
determination,  and  B.  subdlis  BS34A  (containing  tet{M)  on  Tn9/6)  was  used  as  a 
positive control.
2.5 PCR of tet Determinants
PCR  reactions  used  plasmid  DNA  template  prepared  using  the  Qiagen  plasmid 
extraction  kit,  described  in  section  2.10.1.  The  PCR  reaction  mixture  (total  100  pi) 
included  5  pi  template DNA  in a  final  concentration of 0.1  to  1   pg,  10 pi  10 x  PCR 
buffer  (Invitrogen),  3  pi  MgCl:  buffer  (Invitrogen),  0.3  pi  DNA  Taq  polymerase
116(Invitrogen). 300 pM of each of the deoxynucleotides dATP. dCTP, dGTP and dTTP 
(Invitrogen) and dFUO.
Individual  PCR  reactions  were  performed  for  /e/(M),  tet{O).  te({W).  tet(S)  and 
tet(32).  Primers are  listed  in Appendix 4 (Aminov et al.,  2001).  PCR reactions were 
run  on  the  Biometra  T3000  Thermocycler  (Biometra,  Goettingen.  Germany)  using 
the  following  programme:  30 cycles of 1   min  at 90 C.  1   min at  54  °C. and  1   min  at 
72  C,  with a  final  extension  for  10  mins at  72  C.  The annealing step (54  °C  for  1  
min)  was  variable  and  altered  depending  on  the  melting  temperature  (Tm)  of the 
primers used, and calculated by the following equation:
Tm = 2 °C x (A+T) + 4  C x (G+C)
The annealing step for a particular reaction was deriv ed as 5  °C below the Tm of the 
primer with  the  lowest  Tm.  The times of the elongation step (72  °C  for  1   min)  were 
dependent  on  the  expected  length  of the  product  that  is  being amplified:  1   min  for 
each  1   Kb.
2.6  16S rRNA PCR
The  synthesis  of all  oligonucleotides  was  carried  out  by  Genosys  Biotechnologies 
(Hurope) Ltd. (Pampisford. UK).  Sequences of all primers used throughout this study 
are shown in Appendix 4.
Metagenomic genomic/plasmid  DNA  was  extracted  and  purified  as  described 
elsewhere in the materials and methods.  A  1465-bp subregion of the  16S rRNA gene 
was amplified using primers 27F and  1492R (Appendix 4)
In  a total  reaction  volume of 100  pi.  10  pi  of 10  x  buffer (Invitrogen,  Paisley.  UK) 
was mixed with 3  pi  of 50 mM  M gCf  (Invitrogen).  1   pi of 100 mM dNTPs mixture
117(Invitrogen).  1   pi of each primer (50 pmole), 2-5  pi of template (to a final amount of 
0.1  to  1   pg), X pi of sterile distilled water and 0.3 pi of Taq polymerase (Invitrogen). 
PCR  were  performed  for 30 cycles of 60  s  at  94°C,  60  s at  54°C,  and 90  s at  72°C. 
with a final extension at 72°C for 5 min (Biometra T3000).
2.7  Agarose Cel Electrophoresis
DNA  (metagenomic.  genomic,  plasmid.  PCR  products)  were  visualised  by  agarose 
(Amresco. Solo, Ohio. USA) gel electrophoresis (Sambrook et al.,,  1989).
Gels were made up with  1   x TAE (Appendix  1) according to the volume required.  A 
standard  concentration  of 1%  agarose  was  used.  The  mixture  was  heated  in  a glass 
conical  flask  in  a  microwave  (Sharp  Compact)  until  the  agarose  had  completed 
dissolved. The liquid was then cooled and 0.5 pg/ml of Ethidium Bromide was added 
while  the  mixture  was  still  liquid.  The  agarose  was  poured  into  the  appropriate  gel 
tray and allowed to cool to a gel.
DNA samples were mixed with 6 x  Blue/Orange Loading dye (Promega) and loaded 
into  the  gel  wells.  The appropriate  marker,  most  commonly  10  kb  bench  top  ladder 
(NEB) was loaded  in the  left hand  lane.  The gels were run at an appropriate voltage 
(70-100V)  for  an  appropriate  length  of time  depending  on  the  expected  size  of the 
DNA to be visualised.
The  gel  was exposed  to  UV  light  in  an  Alpha  Imager (Alpha  Innotech  Corporation, 
distributed  through  Flowgen)  to  visualise  the  DNA.  Where  appropriate  a 
photographic record was made of the results (Alpha Imager  1220 Documentation and 
Analysis System).
1182.8 Purification of PCR samples
Prior to  sequencing,  the  PCR  products  were  purified  from  the other components  in 
the  reaction  such  as excess  primers,  nucleotides,  DNA  polymerase,  and  salts,  using 
the GenFluteIN 1  PCR Clean-Up Kit (Sigma Aldrich).  Each sample (50 pi) was mixed 
with 5 volumes of Binding Solution (250 pi), transferred into a GenElute PCR Clean­
up miniprep column  (Qiagen) and  centrifuged  for  1   min at  14,000 rpm (15,800 x  g, 
Juoan  A14 centrifuge).  The  flow-through  was discarded and  500  pi  of diluted  Wash 
Solution (12  ml of Wash Solution diluted with 48  ml  of 100% C2H5OH) was added, 
the  sample  was  centrifuged  for  1   min  at  14.000  rpm  (15.800  x  g.  benchtop  Juoan 
A14  centrifuge).  The  flow-through  was  discarded  and  the  sample  was  centrifuged 
again  for  2  min.  The  column  was  transferred  to  a  fresh  eppendorf tube.  50  pi  of 
Elution  Buffer was applied to the centre of the column and each tube was  incubated 
at room temperature  for  1   min.  To elute the DNA. the column was centrifuged  for  1  
min.  The  sample  was  run  on  a  gel  to  confirm  the  presence  of  DNA  before 
sequencing.
2.9 DNA Sequencing
2.9.1  DNA sequencing PCR
The  sequencing  of PCR  products  was  carried  out  according  to  the  PE  Biosystems 
(Warrington.  UK)  protocol  with the  following modifications.  In  a total  volume of 7 
pi,  5  pmol  of primers  were  mixed  with  2  pi  of  1:4  ABI  BigDye  Terminator  Ready 
Reaction  Mix  diluted  with  sequence  buffer (400mM  Tris-HCL,  pH  9.0 and  10  mM 
MgCE).  and  1   to 4 pi  of DNA  sample.  The samples were then  run on the  following 
program;  rapid  thermal  ramp  to  95°C.  held  for  10  sec,  rapid  thermal  ramp  to  50°C. 
held  for  5  sec.  rapid  thermal  ramp  to  60°C,  held  for  4min.  These  four  steps  are
119repeated  tor 99 cycles  followed by  a rapid thermal  ramp to 4°C  until  removed  from 
the PCR machine.
2.9.2 Purification of Sequence Products
15  pi  of  FEO,  2  pi  of  3M  CHiCOONa  and  50  pi  -20°C  100%  C2H5OH  (100% 
AnalaR  BDH) was added to each  PCR tube.  They were incubated on ice for 20 min. 
I he samples were spun at  14000 rpm (15700 x g,  Eppendorf centrifuge 5402) for 25 
min  at  4"C.  Following  that,  the  supernatant  was  removed  using  a  pipette,  and  the 
pellet washed and centrifuged with 250 pi -20°C  70% C2H5OH by centrifugation for 
15  min  at  14000  rpm  (15700  x  g.  Eppendorf 5402).  The  supernatant  was  removed 
similarly and the sample was dried at 95°C  for a few seconds and resuspended in 20 
pi of template suppresser reaction buffer (Applied Biosystems. Warrington. UK).
2.9.3 Sequencing of Tetracycline Resistant BAC Clone Inserts
All  sequencing  was  performed  by  LARK  DNA  Sequence  Technology  Systems 
(Takeley. Essex).
2.10  Molecular Cloning
2.10.1  Plasmid Extraction
pUC19. BAC' and pDE278 plasmids were extracted in a similar manner, both from E. 
coli  hosts.  Prior  to  extraction  one  colony  containing  the  plasmid  from  a  fresh  over 
night  plate  culture  was  inoculated  in  10  ml  of broth.  LB  was  used  for  pUC19  and 
BAC  plasmids  and  BUI.  for  pDL278.  Cultures  containing  pUC19  contained  50 
pg/ml  of ampicillin.  strains  containing  BACs  were  supplemented  with  12.5  pg/ml
120chloramphenicol, and cultures containing pDL278 were supplemented with 50 pg/ml 
spectinomvcin.  Liquid cultures were incubated 37°C with shaking at 225 rpm (Stuart 
Scientific  Orbital  Shaker SOI) overnight.  Bacteria were recovered by centrifugation 
at  6000  rpm (6800  x  g.  Lppendorf 5804R)  for 5  min and the plasmid was extracted 
using  the  midiprep  kit  (Qiagen)  according  to  the  manufacturer's  instructions. 
Plasmids were then extracted using the Qiagen plasmid mini kit.
2.10.2 Plasmid Digestion and Dephosphory lation
Plasmid digests  were  carried out  in  a total  volume of 50  pi.  (5pl  restriction enzyme 
buffer.  2  pi  restriction  enzyme  (10  units/pl),  30  pi  plasmid  DNA  and  13  pi  sterile 
distilled water and incubated at 37°C for 90 min.
Dephosphorylation  was  carried  out  at  37°C  for  lh  by  adding  1   unit  (U)  of alkaline 
phosphatase at time 0 and 30 min. The mixture was inactivated with the addition of 2 
pi  of 0.5M  EDTA  (Appendix  1).  incubated  at  60°C  for  20  min.  The  sample  was 
purified  using  QIAquick  PCR  Purification  Kit  (Qiagen),  as  above,  and  resuspended 
in 30 pi of sterile distilled water.
2.10.3 Insert Preparation
For  the  construction  of both  metagenomic  and  single  species  libraries  in  BAC  and 
pDL278.  and  for  sub-cloning  in  plJC19.  the  sample  DNA  was  digested  in  a  final 
volume  of 40  pi  consisting  of 4  pi  10  x  restriction  enzyme  buffer.  1   pi  restriction 
enzyme  (Ilindill.  10  units/pl  for  metagenomic  libraries:  AV«R1,  10  units/pl  for 
pUC19)  diluted  1:5  with  sterile  distilled  water.  22  pi  DNA  (-50  pg/ml)  and  13  pi 
sterile distilled water.  Samples were incubated at 37°C. and depending on the vector.
121were  incubated  for  10  mins (pUC19).  for 5  mins (pDL27S),  or were split with  50% 
of  the  sample  incubated  for  1   min,  and  50%  of the  sample  incubated  for  2  mins 
(BAC).
Samples  were  cleaned-up  by  ethanol  precipitation.  4  pi  of 3M  CHiCOONa (Sigma 
Aldrich)  and  lOOpl  CMIsOH  (100%  AnalaR  BDH)  were  added  to  each  sample. 
Samples were incubated at -7 0 C  for a minimum of 1   h.  The DNA was recovered by 
centrifugation in a bench-top centrifuge at  14000 rpm (15700 x g. eppendorf 5415D) 
for  30  min.  Pellets  were  washed  with  70%  CNHsOH  (100%  AnalaR  BDH  diluted 
with  sterile dfTO)  and  centrifuged  at  14000  rpm  for  15  min as detailed above.  The 
ethanol  was  removed  with  a  pipette,  the  pellet  allowed  to  dry  and  the  DNA 
resuspended in 30 pi sterile dH :0.
2.10.4  Ligations
For BAC libraries the Epicentre CopyControl Ligation kit was used:
1   pi  pCClBAC  (25  ng/pl)  (Figure  2.1)  (diluted  1:5  with  sterile  distilled  water) 
(supplied  as  a  cloning-ready  vector  by  Epicentre),  and  86  pi  50  pg/ml  insert  DNA 
were  incubated  on  their  own  for an  initial  10  min  at  55  C  to  encourage  linkage  of 
cohesive ends.  To this  10 pi  10 x Fast-Link Ligation Buffer,  1   pi  lOmM ATP, and 2 
pi  Fast-Link  DNA  Ligase  were  added  and  incubated  at  16°C  over  night.  The  DNA 
Ligase was denatured by heating to 70°C  for  15 mins.
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Figure  2.1:  pCClBAC  vector  used  to  create  single  species  and  metagenomic  libraries  in  E.  coli. 
Primers  for sequencing are  indicated  with  small  black  arrows:  plB  FP-I  (forward  primer for  insert 
sequencing), plB RP-1  (reverse primer) (from the Epicentre CopyControl BAC Cloning kit manual).
For  pDL278  (Figure  2.2)  and  pUC19  cloning  and  sub-cloning,  the  insert  and  the 
vector (dephosphorylated) were mixed together in a total volume of 100 pi: including 
2pl  T4  DNA  ligase  (3  units/pl)  and  10  pi  of  10  x  T4  DNA  ligase  buffer.  The 
insert:vector  concentration  ratio  was  kept  at  approximately  3:1.  The  sample  was 
incubated overnight at  16°C and then at 60°C for 20 min to inactivate the reaction.
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Figure  2.2:  pDL278  vector  used  for  cloning  in  S.  mutans  (Dunny  et  al.,  1991).  Black  arrows 
indicate  genes  and  their direction  of transcription  (spec;  spectinomycin  resistance  gene);  thin  black 
lines indicate restriction sites.
2.10.5 Desalting
All ligation reactions, regardless of method used were desalted on agarose cones (0.9 
g glucose, 0.5 g agarose, 50 ml water heated to dissolve, dispensed into eppendorfs) 
for 1   h, on ice prior to transformation.
1242.11  Transformation
2.11.1  Electroporation of E. coli
2.11.1.1  pUC19 and pDL278 into E. co/i DH5a
5  pi  of the  ligation  mixture  was  mixed  with  50  pi  of chemically  competent  cells 
(DH5a  sub-cloning efficiency  cells  from  Invitrogen).  The  sample  was  incubated  on 
ice for 30 min. heated at 37°C for  1   min. and returned to ice for 2 min. To this 950 pi 
SOC  (Invitrogen)  was  added,  and  the  cell  suspension  was  incubated  at  37°C  for 90 
min  with  constant  shaking  at  225  rpm.  The  mixture  was  plated  onto  selective  LB 
plates  (Appendix  1)  containing  50  pg/ml  of ampicillin  for pUC19  and  50  pg/ml  of 
spectinomycin  for  pDL278  (with  10  pg/ml  tetracycline  if screening  for resistance), 
and they were incubated for  18 h at 37°C.
2.11.1.2 BAC into E. coli EPI300-T1R
Cells were transformed according to the BAC CopyControl kit (Epicentre) protocol:
5  pi  of desalted  ligation  product were mixed  in an eppendorf with 50  pi  just-thawed 
competent  EPI300  E.  coli.  The  mixture  was  transferred  to  a  pre-chilled 
electroporation  cuvette  0.1  cm  (Bio-Rad.  Hemel  Hempsted,  UK).  The  mixture  was 
immediately  electroporated  at  1.7  kV.  25uF,  200G  (BioRad  Gene  Pulser  II 
electroporater).  Following eletroporation.  950 ml  fresh  SOC  (Invitrogen) was added 
to the cells and they were allowed to recover for  1   h at 37°C with shaking at 225 rpm 
(Sanyo  Orbital  Shaker),  before  plating  on  selective  medium  (LB  +  12.5  pg/ml 
chloramphenicol. 40 pg/ml  X-Gal. 0.4 mM  IPTG).
1252.11.2 Transformation of S. mutans with Competence Stimulating Peptide (CSP)
An  overnight  culture  of a  single  fresh  S.  mutans  colony  was  grown  in  10  ml  BHI 
broth  containing  5%  heat  inactivated  horse  serum  without  antibiotics  in  5%  CO: 
(LEEC cabinet, with C02 from BOC gases, Guildford, UK).
The  culture  was  diluted  1:20  into  10  ml  of  fresh  pre-warmed  BHI  broth  and 
incubated  in  the  CO:  incubator  until  the  OD^oo  =  0.2.  Five  pg  Competence 
Stimulating  Peptide  (CSP).
MKKTLSLKNDFKHIKTDLEIIIGGASGSLSTFFRLFNRSFTQALGK  (Sigma 
Genosys) was added to the  10 ml culture, and  1   ml aliquots of culture were added to 
the  DNA to be transformed (5  pi  high-concentration vector).  Aliquots were returned 
to the CO: cabinet and incubation continued for 90 mins.
Cells were concentrated  5  times by  centrifugation (6000 rpm / 6800 x  g.  Eppendorf 
5804R).
2.12  Determining the Coverage of a BAC Library
The  following  equation  (taken  from  the  Epicentre  BAC  CopyControl  Cloning  Kit 
Manual) was used to establish the 'coverage' of each library i.e. the likelihood of any 
one sequence occurring in the library.
N = In(l-P) / ln(l-[l/GSj)
Where:
P  =  Desired probability (expressed as a fraction)
I  =  Average insert size of the library
126N  =  Number of clones required
GS =  Genome size (average microbial  genome size was taken to be 4.5  Mb (based 
on  sequences  in  the  database  at  the  time  of calculation)  multiplied  by  the 
estimated number of organisms in the microbiota
2.13 Induction of BAC Clones to High-Copy Number
1   ml aliquots of LB +  12.5 pg/ml chloramphenicol  were inoculated with single BAC 
colonies.  Cultures were incubated at 37aC overnight without shaking.  Following this 
incubation,  each  tube  was  vortexed  and  800  pi  was  removed  and discarded.  800  pi 
fresh  LB  +  12.5pg/ml  chloramphenicol  was  added  to  the  remaining culture  and  the 
tubes were incubated for 30 min at 37°C with shaking at 250 rpm. Following this  1   pi 
1000  x  CopyControl  Induction  Solution  (Epicentre)  was  added  to  each  tube.  The 
cultures  were  incubated  horizontally  (to ensure  maximum aeration)  for 2  h at 37  °C 
with shaking at 250 rpm.
2.14 Screening of Clones
2.14.1  Screening on Selective Media
BAC  and  pDL278  containing  clones  were  plated  directly  onto  selective  agar.  BAC 
clones  were  plated  onto  LB  agar containing  12.5  pg/ml  chloramphenicol,  10  pg/ml 
tetracycline.  pDL278  clones  (in  S.  mutans)  were  screened  on  800  pg/ml 
spectinomycin and 8 pg/ml tetracycline.
1272.14.2 Macroarray Analy sis of Clones
The Macroarray developed by Patterson et al.,  (ahead of publication) was used for all 
samples.  For the antibiotic resistant  isolates and clones of interest, the samples were 
spotted on the  membrane,  as detailed  below.  For the array analysis of genes present 
in  the  crude  DNA  from  each  environment  the  probes  were  spotted  on  the 
membranes, and the sample DNA  labelled and used as the  'probe'.  The arrangement 
of probes on the membrane is shown in Figure 2.3.
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Figure 2.3:  Layout of probes on the macroarray when probing with metagenomic DNA2.14.2.1  Printing the Array
400pl  ot each  isolate/clone glycerol  stock  was  spun down  in a bench-top centrifuge 
at  top  speed  for  2  min  (^14000  rpm.  15700  x  g.  Eppendorf 5402).  Samples  were 
resuspended  in  60pl  sterile  dlLO.  The  cell  suspensions  were  lysed  and  the  DNA 
denatured  by  boiling  in  a  water  bath  for  10  min.  Samples  were  placed  in  a  pre­
assigned grid in a round-bottomed microtitre plate.
Samples  were  printed  onto  Biodyne  B  pre-cut  modified,  0.45pm  nylon  membranes 
(Pierce.  Cheshire.  UK)  using the  Biorobotics  Microgrid  II  System.  They  were dried 
and cross-linked using the Bio-Rad GS Gene Linker (Bio-Rad) for 20 sec.
2.14.2  Labelling the Probe
PCR  products  of  genes  of  interest  were  used  as  probes.  500ng  of  probe  was 
suspended  in  11.5pl  of sterile distilled water.  Probes were boiled  in a water bath  for 
10  min  to  denature  the  DNA.  They  were  placed  on  ice  for  10  mins.  lpl  of each  of 
dATP.  dGTP.  and  d l TP;  2pl  of reaction  mix;  lpl  klenow  enzyme  and  2.5pl  32P 
dCTP were added to the probes.  The mixtures were incubated on a heat block for 30 
min at 37T\
In  a  separate  sterile  corex  tube  lOpl  herring  sperm,  970pl  dl 120.  and  20pl  32P  mix 
were  mixed and  placed  in a boiling  water bath  for  10 mins.  This was poured  on  the 
prehvbridised membrane.
1302.14.3 Prehybridisation and Hybridisation
lg dextran sulphate. 9ml dFFO and  1ml  10% SDS were mixed in a sterile corex tube 
and warmed to 65°C. 0.58g NaCl was added, and kept at 65°C.
The nylon membranes were dampened with water and placed in hybridisation tubes. 
The  above  mixture  was  added  to  these  tubes  and  they  were  placed  in  the 
hybridisation  oven  at  65°C  with  turning  for  30  mins  before  the  radioactive  probe 
mixture was added.
Upon addition of the probe, the membranes were returned to the oven and hybridised 
overnight.
2.14.4 Washes
The probe mixture was disposed of and the membranes washed twice with  100ml 2 x 
SSC  for 5 mins; twice with 200ml 2 x SSC +  1% SDS for 30 mins; twice with 200ml 
1   x SSC + 0.5% SDS for 30 mins; and finally twice with  100ml  1   x SSC for 5 mins. 
Membranes were then placed between Saran wrap and secured in place in a Fujifilm 
BAS 2340 cassette. A Fuji Imaging plate was placed on top of the membrane and the 
cassette  closed  while  the  film  developed.  All  washes  were  conducted  at  room 
temperature with gentle agitation.
1312.14.5 Signal Generation and Detection
I he  films were exposed  for 24h.  and  a second  film  was used for a second exposure 
from  24h  -   3  weeks.  The  films  were  removed  from  the  cassettes  and  immediately 
placed in a Fujifilm FLA-3000 scanner.
2.14.3  Colony Blotting -  ECL Direct Nucleic Acid Labelling and Detection 
System
2.14.3.1  Blotting Colonies onto the Membrane
The  BAC/pUCI9/pDL278  libraries  of isolates  of interest  were  screened  using  the 
colony  blot protocol of the Amersham Biosciences ECL direct nucleic acid labelling 
system (Amersham Biosciences. Buckinghamshire. UK). Libraries were plated out to 
give -200-300 colonies per plate on the appropriate medium.
The Hybond-N+ membrane (Pierce) was cut into discs and laid on the agar plates for 
30  s  until  the  disc  was completely  wet  (orientation  was  marked  with  a  pencil).  The 
discs were  placed,  colony  side  up  for 5  min on  two  sheets of Whatman  3mm  paper 
saturated with 0.5M NaOH to fix the DNA.
The discs were rinsed  twice by  gentle agitation  in a dish containing 400ml  5  x  SSC 
for  1   min.  They  were  then  allowed  to  dry  by  placing  them  DNA  side  up  on  3mm 
Whatmann paper.
2.14.3.2 Labelling of DNA Probes
The  DNA  to  be  labelled  was  diluted  to  a  concentration  of  10  ng/pl  using  sterile 
distilled  water.  10  pi  of each  probe  was  denatured  by  boiling  in  a  water  bath  for  5 
min followed immediately by 5 min incubation on ice. The contents of the tube were
132then  briefly  centrifuged  to  collect  them  in  the  bottom  of the  tube.  An  equivalent 
volume (10 pi) of DNA labeling reagent (Amersham) was added to the cooled DNA 
and mixed gently but thoroughly.  lOgl gluteraldehyde solution was added and mixed 
thoroughly. The contents of the tube were again spun. The tube was incubated for  10 
min at 37°C and, if not used immediately was held on ice for 10-15 min.
2.14.3.3 Hybridisation and Stringency Washes
The  hybridisation  buffer  was  prepared  as  follows:  solid  analytical  grade  NaCl  was 
added to the required  volume of hybridisation buffer (50 ml) to a final concentration 
of 0.5  M.  Blocking reagent was then added to a final concentration of 5% (w/v) and 
immediately  mixed  until  the  blocking  reagent  was  present  as  a  free  suspension. 
Mixing  continued  with  a  magnetic  stirrer  for  1   h  at  room  temperature  and  was 
followed  by  incubation  at  42  °C  for 0.5-1.0  h  with  occasional  mixing.  If the  buffer 
was not being used immediately it was stored at -20 °C for 3 months.
2.14.3.4 Prehybridisation and Hybridisation
The  blots  (damped  with  5  x  SSC  in  order  to  arranged  them  in  an  appropriate 
position) were placed in a hybridisation tube. The hybridisation buffer, at 42 °C, was 
added (0.0625 -  0.125  ml/cm2), and the blot was pre-hybridised for 2 h at 42 °C in a 
Biometra (Luton, UK) OV3 rotisserie oven.
The labelled probe was added to the buffer, taking care not to place it directly on the 
membrane.  In  some  cases,  a  small  volume  of  the  prehybridisation  buffer  was 
removed  for  mixing  with  the  probe  before  its  reintroduction.  Hybridisation  was 
carried out for 4 h in the rotisserie oven at 42 °C.
1332.14.3.5 Washes
The  appropriate  volume  of primary  wash  buffer  containing  urea (Appendix  1)  was 
warmed to 42  °C.  The hybridisation  buffer in the tube was discarded and  50-100 ml 
of 5  x SSC added.  The tube was replaced in the rotisserie oven and incubated for 20 
min at 42 °C. The primary wash was repeated. The blots were then removed from the 
hybridisation  tube  and  washed  twice  in  an  appropriate  container  in  an  excess  of 
secondary' wash buffer (2 x SSC). with gentle agitation on a rotary' shaker for 5 min.
2.14.3.6  Signal Generation and Detection
An equal volume of ECL reagent  1   and  ECL reagent 2 (Amersham) were mixed in a 
20  ml  universal  tube.  The  amount  mixed  was  sufficient  to  cover  the  blot  (0.125 
ml/cm2).  The  excess  secondary  wash  buffer was  drained  from the blot  and  the  blot 
was  placed  DNA  side  up onto  a clean  piece  of Saran  Wrap.  The detection  reagents 
were poured onto the blot immediately  and incubated at room temperature for  1   min 
with gentle agitation. The excess detection reagents were drained from the blot and it 
was wrapped  in Saran  Wrap.  Air pockets were smoothed out and the blot was placed 
in  a  film  cassette  DNA  side  up.  Autoradiography  film (Hyperfilm,  Amersham)  was 
placed  over  the  blot.  The  film  cassette  was  closed  and  the  film  exposed  for  1-3  h. 
The film was removed under safe light conditions and developed.
2.15  Bioinformatics
DNA sequences were edited using the Chromas  1.45  software, and analysed with the 
DNA-MAN  version 5.2.2 program (Lvnnon Biosoft).  Similarity analysis was carried 
out with the Advance Blast program of GenBank (National Centre for Biotechnology
134Information,  National  Institutes  of Health,  Washington,  DC),  open  reading  frames 
(orfs)  were  identified  with  ORF  finder  (www.bioinformatics.va/sms/orf  find.html), 
and  appropriate  ribosome  binding  sites  were  identified  by  eye.  Alignments  were 
performed  using the  CLUSTAL  W7   program  service at the  European  Bioinformatics 
Institutes  (http://www.ebi.ac.uk/).  G+C  content  was  analysed  using  the  GeeCee 
program of h11p:  w w w. hioi n formatics.net.
Macroarray  images  were  analysed  using  the  AIDA  Metrix  alignment  software,  and 
hybridisation  intensities  were  determined  to  be  a  percentage  of  the  hybridisation 
signal, detected using this software, of the  16S rRNA control.
2.16  Statistical Analysis
The  difference  between  average  plate  counts  on  each  antibiotic,  for  each  country 
were  analysed  using  the  student's  /-test  in  the  SPSS  statistical  package  (SPSS  Inc. 
(2000)  10.0 Syntax reference guide. Chicago, IL).
135CHAPTER THREE
Prevalence of tetracycline, erythromycin and vancomycin resistance 
determinants in the Gram positive aerobic and facultative anaerobic 
cultivable portion of the human oral and faecal microbiota from six
European countries.
1363.1  Introduction.
It  is  widely  documented  that  the  human  GI  tract  is  a  reservoir  of  resistance 
determinants  (Ready  et  a l 2003;  Roberts,  1998a,  1998b;  Millar  et  al.,  2001)  that 
have the ability to be transferred to and from transient organisms and subsequently to 
bacteria in  the environment  including soil  and  marine  bacteria due to contamination 
by  effluent  (Eaton  &  Gasson,  2001).  They  are  then  able  to  spread  throughout  a 
population  due  to  their  presence  on  mobile  genetic  elements  (Cooper  et  al..  1996; 
Shoemaker et al.,  1985;  Roberts,  1998a).  Additionally the presence in both oral  and 
intestinal  environments of naturally competent  bacteria (e.g.  Streptococcus spp.  and 
Xeisseria  spp.)  (Stone &  Kwaik.  1999;  Solomon  &  Grossmann,  1996)  will  have  an 
impact  on  the  dissemination  of resistance  genes  throughout  these  species  in  these 
environments (Wang et al..  2002).
Tetracycline  has  long  been  used  in  the  treatment  of  a  wide  range  of  human 
infections,  including  atypical  pneumonia,  cholera,  periodontal  infection,  acne  and 
many  other  genital,  local  and  systemic  infections  (Roberts.  1998)  It  is  also 
commonly  used  against  oral  infections  and  as  a  prophylactic  agent  in  dentistry 
(reviewed  in  Chopra  &  Roberts,  2001;  Fine  et  al..  1998).  Erythromycin  is  a 
macrolide antibiotic  used  in the treatment of infections of lungs and throat and some 
SU s (Sexually Transmitted Infections) (reviewed in Goldman and Scalglione. 2004). 
Vancomycin  is  a  bacteriocidal  antibiotic  used  clinically  in  the  treatment  of multi­
drug-resistant infections caused by  Gram positive bacteria (Boneca & Chiosis,  2003). 
All  can  be administered  orally,  thus exerting  a selective  pressure on  the  bacteria  of 
the GI tract (Edlund & Nord, 2000; Ready et al.,  2002).
137The purpose of this part of the study  was to determine the levels of resistance to the 
above  antibiotics,  and  establish  the  genetic  basis  of tetracycline  and  erythromycin 
resistance  in Gram positive isolates by  macroarray analysis.  The results obtained are 
important  for  establishing  any  differences  between  the  basis  for  resistance  in  the 
cultivable  portion of the  microbiota compared to  the entire microbiota.  Additionally 
the data may  indicate trends in the presence of different genes or levels of resistance 
found in different environments (i.e. oral and faecal).
1383.2  Materials and methods.
3.2.1  Culture of Aerobic and Facultative Anaerobic Bacteria from Samples
A  10-fold  serial  dilution  of  1ml  total  sample  was  prepared  in  Luria  Bertani  broth 
(Appendix  1)  and  spread  onto  both  antibiotic-containing  and  antibiotic-free 
Isosensitest (5 % agar to prevent swarming of Proteus spp. (Jeffries & Rogers  1968)) 
agar  plates  to  determine  the  total  number  of cultivable  bacteria  in  the  specimen  in 
duplicate  (petri  dishes  from  Sarstedt).  The  concentrations  of antibiotics  used  were 
2pg/ml  (tetracycline)  1  pg/ml  (erythromycin)  and  8pg/ml  (vancomycin)  (Appendix 
5).  Growth  above  these  points  is  defined  as  resistant  by  the  British  Society  for 
Antimicrobial  Chemotherapy  (BSAC)  (MacGowan  &  Wise  2001;  Andrews  2001). 
Iso-sensitest  agar  supplemented  with  5%  defibrinated  horse  blood  (E&O 
Laboratories,  Bonnybridge,  UK)  was  used  for microaerophilic  incubation  (air +  5% 
CCT):  Wilkins-Charlgren  agar supplemented  with  5% defibrinated  horse  blood  was 
used for facultative anaerobic incubation.
3.2.2 Enumeration and storage - Identification of Antibiotic Resistance Bacteria
Identification  of isolates  was  initially  done  by  Gram  staining  (Pro-lab  diagnostics 
reagents).  Gram  positive  isolates  were  identified  to  the  species  level,  using  partial 
16S ribosomal  RNA (rRNA) gene sequencing (Lane et al.,  1985) outlined in Chapter 
two.
Gram  positive  aerobic  isolates  were  cultured  in  10ml  iso-sensitest  broth  containing 
the  relevant  antibiotic  at  37T .  overnight  with  shaking at  250  rpm  (Stuart  Scientific 
Orbital  Shaker  SOI).  Gram  positive  facultative  anaerobic  isolates  were  cultured  in
139WC  broth  plus  the  relevant  antibiotic  at  37°C  for three  days.  900pl  of culture  was 
added to a  1.5ml cry ogenic tube (Nalgene). To each  lOOpl sterile glycerol was added. 
Tubes were vortexed for 30 secs and frozen immediately at -70°C.
1403.3  Results
3.3.1  Gram Positive Resistant Isolates.
Following  Gram  staining  to  select  for  Gram  positive  bacteria  123  isolates  were 
collected and identified to genus level (Appendix 6). Seventy nine were isolated from 
the  oral  samples.  44  from  the  faecal  samples.  O f  these  123  isolates,  107  were 
tetracycline  resistant.  Sixty  nine  of  the  107  (63.9%)  were  oral  isolates  and  39 
(36.1%) were faecal isolates).  In addition,  105 of the  123 Gram positive isolates were 
erythromycin  resistant,  and  included  70  (66.7%) oral  isolates and 35  (33.3%)  faecal 
isolates.  No  vancomycin  resistant  Gram  positives  were  isolated  from  the  samples. 
Eighty  four  isolates  (66.7  %  of the  total)  were  resistant  to  both  tetracycline  and 
erythromycin.
3.3.2 Oral Isolates
In  the  oral  samples,  the  most  commonly  isolated  aerobic  /  facultative  anaerobic 
genus  from  the  tetracycline  and/or erythromycin  resistant  portion  of the  micro flora 
was  the  streptococci  (74.6%  of  isolates),  followed  by  the  staphylococci  (7.6%). 
Bacillus  spp.  and  Actinomyces  spp.  which  both  accounted  for  5.1  %  of resistance 
isolates.  Other  species  accounted  for  7.6  %  of total  resistant  isolates  and  included 
Acidobacterium  sp.  (2  isolates).  Lactobacillus  sp.  (2  isolates),  Rothia sp.  (1  isolate) 
and Enterococcus sp. (1  isolate) ( fable 3.1).
1413.3.2.1  Tetracycline  resistance  in  the Aerobic / Facultative Anaerobic Cultivable 
Oral Flora
The total percentage of tetracycline resistance from each sample are shown in Figure 
3.1. In the oral cavity levels tetracycline resistance varies between countries from 8.55 
% of the  total  aerobic /  facultative  anaerobic  cultivables  in  the  Scottish  samples, to
30.6  % in the Finnish  samples.  However, using the student’s t-test (P = >0.01), there 
was no significant difference between the levels of resistance in different countries.
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Figure 3.1: Tetracycline resistance profiles of the cultivable aerobic / facultative 
anaerobic oral and faecal microflora of six European countries.
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1423.3.2.1.1  Genetic Basis of Tetracycline Resistance
Genomic  DNA  from each isolate was blotted onto the nylon membranes of the array 
and fixed as described in section 2.12.2.1. The membranes were then probed with the 
let gene-specific probes to determine the genetic basis of resistance in each isolate.
tet{M)  was  the  most  common  let  gene  found.  It  was  present  in  76.8%  of the  oral 
tetracycline  resistant  isolates  (Table  3.1).  Levels of the  gene  in  individual  countries 
ranged from 28.6% in the Norwegian sample to 82.4% in the Scottish sample (Table
3.2).
tet(O)  was  present  in  66.7%  of the  oral  isolates.  It  was  the  second  most  common 
tetracycline  resistance  gene  isolated  (Table  3.1).  It  occurred  in  between  41.7  % 
(Italian  sample)  -  100  %  (English  sample)  of tetracycline  resistant  isolates  and  was 
found in even  sample set from the oral cavity (Table 3.2).
tet( W) was the third most frequently  isolated tetracycline gene.  It occurred in  10.1% 
of oral  isolates (Table  3.1).  However,  it  was not present  in the  English,  Finnish and 
Scottish samples ( fable 3.2).
Probes for other RPP genes  (/e/B(P), tet(S), tet(T), /e/(W), lel(32) and tet(36) but not 
tet and otr(A)) genes which were not probed  for on the array) were combined in one 
hybridisation  and  were  found  to  be  present  in  34.7  %  of Gram  positive  aerobic  / 
facultative anaerobic isolates.  18.8 % harboured an efflux gene (/c?/(A), tet{B), tet(C), 
tet(D).  tet{E).  tet(G),  tet{H),  tet(J),  /e/A(P).  tet(Y),  tet{Z)  and  tet(30)  (combined  in
143one  hybridisation)  but  not  tet{K),  tet(L),  tet(V),  tet(31),  tet(33),  tet(35),  tet{38). 
/£?/(39),  r;//*(B) and o/r(C) which are not on the array).
144tet{  M) tet( 0) tet(Q) tet( W) tet( 32) RPP Tetracycline
Efflux
erm{ B) erm( E) erm( F) erm{V) Other
erm
genes
Streptococcus 
spp. (59)
44
(63.8%)
37
(53.6%)
1
(1.4%)
2
(2.9%)
16
(23.2%)
12
(17.4%)
43
(61.4%)
1
(1.4%)
4
(5.7%)
4
(5.7%)
Staphylococcus 
spp.(6)
1
(1.4%)
2
(2.9%)
1
(1.4%)
1
(1.4%)
2
(2.9%)
1
(1.4%)
1
(1.4%)
3
(4.3%)
Bacillus spp. 
(4)
3
(4.3%)
3
(4.3%)
1
(1.4%)
2
(2.9%)
1
(1.4%)
1
(1.4%)
Actinomyces 
spp. (4)
3
(4.3%)
3
(4.3%)
1
(1.4%)
2
(2.9%)
2
(2.9%)
1
(1.4%)
1
(1.4%)
1
(1.4%)
Others (6) 2
(2.9%)
1
(1.4%)
1
(1.4%)
3
(4.3%)
1
(1.4%)
2
(2.9%)
1
(1.4%)
2
(2.9%)
Total (79) 53
(76.8%)
46
(66.7%)
1
(1.4%)
7
(10.1%)
2
(2.
9%)
21
(30.4%)
13
(18.8%)
50
(71.4%)
4
(5.7%)
5
(7.1%)
1
(1.4%)
11
(15.7%)
Table 3.1: Tetracycline and erythromycin resistance determinants isolated from the human oral cavity.
Percentages given are the percentage of total tetracycline, or erythromycin resistant isolates represented by the particular determinant.
145England France Finland Italy Norway Scotland
71.4% 54.5 % 75.0 % 58.3 % 28.6 % 82.4 %
tet( 0) 100% 62.5 % 63.6 % 41.7% 57.1 % 75.0 %
tet( W) 0 % 6.3 % 0 % 33.4% 28.6 % 0 %
erm( B) 75.0 % 72.7 % 100% 42.9 % 100% 62.5 %
erm( F) 0 % 5.5 % 11.1 % 0 % 12.5% 0 %
erm{ E) 25.0 % 0 % 0 % 14.3% 0 % 6.3 %
Table 3.2: The proportion of tetracycline and erythromycin resistant isolates from the aerobic, Gram positive cultivable oral flora of six European 
countries harbouring specific determinants.
1463.3.2.1.2 Isolate FStetl2
One  streptococcus  isolate  (FStetl2)  from  the  Finish  oral  sample  hybridised  to  the 
/e/(32)  probe,  but  not  the  tet{O)  probe  in  addition  to  the  probe  for  ‘other  efflux' 
genes.  This  isolate  had  an  MIC  of  10  pg/ml  in  air.  A  BAC  library  was  made  from 
DNA  from this isolate (Table 3.5) in order to obtain the full gene, which would then 
be sequenced to determine whether or not it was a hybrid gene, and the nature of its 
genetic  support.  -36  Mb  of  insert  (average  insert  size  30  Kb)  was  screened  on 
selective agar (8 pg/ml tetracycline). No tetracycline resistant colonies were isolated. 
Four large agar plates with -400 clones on each were subject to colony hybridisation 
using  a  PCR derived  tet{32)  probe.  Therefore  -48  Mb  of insert  (equivalent to  23.6 
streptococcal  genomes,  based  on  the  genome  of 5.  mutans  UA159  (2.03  Mb))  was 
screened. No clones harbouring tet(32) were found.
A small  insert library was made in pDL278 with an average insert size of 8 Kb. This 
was transformed into S.  mutans and -32.5 Mb of insert (16.0 streptococcal genomes) 
was  screened  on  selective  agar  (4  pg/ml  tetracycline).  No  tetracycline  resistant 
colonies were isolated.
3.3.2.2  Erythromycin  resistance  in  the  Aerobic  /  Facultative  Anaerobic 
Cultivable Oral Flora
Total percentages of erythromycin resistance in the oral cavity varies from  14.4 % of 
the  total  cultivable  aerobic  /  facultative  anaerobic  bacteria  in  the  English  sample  to
32.1  %  in  the  Finnish  sample  (Figure  3.2).  However,  these  Figures  include  the 
intrinsically  resistant  Gram  negative  bacteria  as  no  attempt  was  made  to  exclude 
these from the viable counts on selective media.
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Figure 3.2: Erythromy cin resistance profiles of the aerobic / facultative 
anaerobic oral and faecal cultivable flora of six European countries.
50  isolates  from each  sample were Gram  stained and the percentage Gram  positives 
was used to calculate levels of resistance among the Gram positive population (Figure
3.3).
England  Franca  Finland  Italy  Norway  Scotland
Country
Total 
Gram positives
Figure 33: Ery thromycin resistance levels in the total cultivable aerobic / facultative 
anaerobic flora, and the relative contribution of Gram positives3.3.2.2.1  Genetic Basis of Erythromycin Resistance
Genomic  DNA from each  isolate was blotted onto the nylon membranes of the array 
and  fixed  as  described  previosuly.  The  membranes  were  then probed  with the  erm 
gene-specific probes to determine the genetic basis of resistance in each isolate.
crw(B)  was  the  most  common  erm  determinant.  It  occurred  in  71.4%  of  oral 
ery thromycin  resistant  isolates (Table 3.1).  It was present  in the samples from every 
country  (Table  3.2).  and  was  harboured  by  up  to  100  %  of Gram  positive  isolates 
(Finnish and Norwegian samples).
erm{¥)  was  the  second  most  frequently  found  erm  gene.  It  was  present  in  7.1%  of 
oral isolates (Table 3.1).  It was found in one isolate from each of the Finnish. French 
and Italian oral samples (Table 3.2).
erm(E)  was  found  in  5.7%  of the  oral  isolates  making  it  the  third  most  commonly 
isolated  erm  gene  (Table  3.1).  However,  it  was  absent  in  the  French,  Finnish  and 
Norwegian oral  isolates (Table 3.2).
Other  erm  probes  were  combined  in  one  hybridisation  (erm(A),  erm(C),  erm{D). 
erm(G).  erm(Q),  erm (V).  erm{X))  and  were  found  in  15.7  %  of the  Gram  positive 
oral  erythromycin  resistant  isolates.  12.9  %  of  oral  Gram  positive  erythromycin 
resistant isolates did not contain any of the erm genes listed above.
1493.3.3 Faecal Isolates
From  the  faecal  samples  the  most  commonly  isolated  resistant  aerobic  /  facultative 
anaerobic  genus  was  the  enterococci,  accounting  for  47.7  %  of the  faecal  isolates 
(Table 3.3) followed by the streptococci (27.3  % of faecal resistant isolates), and the 
Staphylococcus  spp.  (18.2  %).  Other  genera  made  up  the  remaining  15.9  %  and 
included Lactobacillus spp. (2  isolates), Eggerthella sp. (2  isolates), Pediococcus sp. 
(1  isolate), Citrobacter sp. (1  isolate), and Comonomas sp. (1  isolate).
150tet( M) tet(  0 ) tet(  Q) tet{ W) tet{ 32) RPP Efflux erm{ B) erm(E) erm{ F) erm{\) Other erm 
genes
Enterococcus 
spp.(21)
13
(33.3%)
12
(30.8%)
1
(2.6%)
8
(20.5%)
1
(2.6%)
14
(40.0%)
1
(2.6%)
Streptococcus 
spp. (12)
9
(23.1%)
9
(23.1%)
1
(2.6%)
2
(5.7%)
1
(2.6%)
1
(2.6%)
Staphylococcus 
spp. (8)
4
(10.3%)
3
(7.7%)
1
(2.6%)
3
(7.7%)
3
(8.6%)
4
(11.4%)
Lactobacillus 
spp. (2)
1
(2.6%)
Others (5) 1
(2.6%)
1
(2.6%)
1
(2.6%)
2
(5.7%)
1
(2.6%)
Total (44) 26
(66.7%)
25
(64.1%)
4
(10.3%)
1
(2.6%)
11
(28.2%)
2
(5.1%)
19
(54.3%)
2
(5.7%)
2
(5.7%)
1
(2.6%)
5
(14.3%)
Table 3.3: Tetracycline and erythromycin resistance determinants isolated from the human faecal flora.
Percentages given are the percentage each group contributes to total tetracycline/erythromycin resistance for this environment.
151England France Finland Italy Norway Scotland
tet( M) 66.7 % 100% 33.4 % 50.0 % 50.0 % 63.6%
tet{0) 63.6% 33.4 % 66.7 % 33.4 % 0 % 83.3 %
tet( W) 9.1 % 0 % 0 % 0 % 0 % 0 %
erm{ B) 85.7 % 0 % 33.3 % 14.3% 0 % 0 %
erm(  F) 0 % 0 % 0 % 12.5% 50.0 % 0 %
erm{ E) 0 % 0 % 0 % 25.0 % 0 % 0 %
Table 3.4: The proportion of tetracycline and erythromycin resistant isolates from the cultivable faecal flora of six European countries harbouring 
specific determinants.
1523.3.3.1  Tetracycline  Resistance  in  the  Aerobic  /  Facultative  Anaerobic 
Cultivable Faecal Flora
The  total  proportion  of  viable  tetracycline  resistant  bacteria  isolated  from  each 
sample  is  shown  in  Figure  3.1.  Levels  of resistance  varied,  ranging  from  8.24  % 
(Scotland) to 37.1  % (France).  However,  no significant difference between countries 
was found using the student's t-test (P = >0.01).
3.3.3.1.1  Genetic Basis of Tetracycline Resistance
Genomic  DNA from each isolate was blotted onto the nylon membranes of the array 
and  the  genetic  basis  of tetracycline  resistance  was  determined  as described  for the 
oral samples.
66.7%  of faecal  tetracycline  resistant  isolates  harboured  tet{M)  making  it  the  most 
common  tetracycline  resistance  gene  isolated  (Table  3.3).  It  was  found  in  the 
samples from all countries at levels ranging from 33.4 % (Finland) -  100 % (France) 
of Gram positive tetracycline resistant isolates (Table 3.4).
tet(Q)  was  the  second  most  common  faecal  let  gene,  present  in  64.1%  of faecal 
isolates (Table 3.3).  It was found in all samples except that from Norway (Table 3.4)
tet{Q)  was  the  third  most  commonly  isolated  tetracycline  resistance  determinant, 
occurring in  10.3 % of tetracycline resistant isolates (Table 3.3). 
tet(W) was absent in all  faecal samples except the set from f£ngland in which 9.1% of 
tetracycline resistant isolates harboured it (Table 3.4).
153Other  RPP  genes  (tetB(P),  tet(S).  tet(T),  tet{W),  tet(32)  and  tet{36)  but  not  /£»/  and 
o//*(A))  were  found  in  28.2  %  of tetracycline  resistance  faecal  isolates,  and  other 
efflux genes (tet(A), /e/(B), /e/(C), /c/(D), tet{E), /e/(G), /e/(H), re/(J), /e/A(P), tet{Y). 
rc/(Z)  and  ^ (3 0 )  but  not  tet{K).  /e/(L),  /c/(V),  /c?/(31),  tet(33),  tet{35),  /c?/(38). 
tet(39), /cr3, o/r(B) and o/r(C)) in 5.1  % of isolates (Table 3.3).
3.3.3.2  Erythromycin  Resistance  in  the  Aerobic  /  Facultative  Anerobic 
Cultivable Faecal Flora
Total  percentages  of erythromycin  resistance  in  the  cultivable  aerobic  /  facultative 
anaerobic faecal  flora varies from  15.2 % (Finland) to 33.1  % (France) (Figure 3.2). 
However,  these  Figures  include the  intrinsically  resistant Gram negative  bacteria as 
no attempt was made to exclude these from the viable counts on selective media.
50  isolates  from each  sample were Gram stained and the percentage Gram positives 
was  used  to  calculate  levels  of  resistance  among  the  Gram  positive  population 
(Figure 3.4).
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Figure 3.4: Erythromycin  resistance levels in the total cultivable aerobic / 
facultative anaerobic faecal flora, and the relative contribution of Gram positives.
3.3.3.2.I  Genetic Basis of Erythromycin Resistance
The  genetic  basis  of  erythromycin  resistance  was  determined  by  Macroarray 
hybridisations as described for the oral samples (section 3.3.2.2.1).
erm{B)  was  the  most  common  faecal  erm  gene.  It  occurred  in  54.3%  of the  total 
faecal  erythromycin  resistant  isolates  (Table  3.3).  It  was  not  found  at  all  in  the 
Scottish,  French  and Norwegian  faecal  samples,  but  was  present  in  the  other  faecal 
samples (Table 3.4).
erm(F)  was  the  second  most  frequently  found  erm  gene.  It  was  present  in  5.7%  of 
faecal isolates (Table 3.3). It was found in one isolate from the Italian and Norwegian 
faecal samples (Table 3.4).
155erm(E)  was  found in 5.7% of the faecal  isolates (Table 3.3).  It was absent in all the 
erythromycin  resistant  faecal  isolates  except  two  from  the  Italian  samples  (Table
3.4).
Hybridisation to other erm probes was observed  in  14.3% of the total  faecal  isolates 
(Table  3.3).  25.7%  of ery thromycin  resistant  faecal  isolates  did  not  contain  an  erm 
gene that was probed for.
3.3.4  Vancomycin  Resistance in  the Aerobic / Facultative Anaerobic Cultivable 
Oral and Faecal Flora
Levels  of  vancomycin  resistance  in  the  Gram  positive  aerobic  and  facultative 
anaerobic cultivable portions of the oral and faecal samples are shown in Figure 3.5. 
However,  as  with  the  erythromycin  plates  no  attempt  was  made  to  exclude  the 
intrinsically  resistant  Gram  negatives.  No  Gram  positive  vancomycin  resistant 
isolates were  found by Gram staining, thus the level of vancomycin resistance in the 
cultivable  portions  of the oral  and  faecal  microbiota is considered to  be zero  in this 
study.
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Figure 3.5: Vancomycin  resistance profile of the oral and faecal 
aerobic / facultative anaerobic cultivable flora of six European 
countries.
3.3.5 Co-resistance
80.2% of tetracycline resistant  isolates contained  more than one tet gene. tet{M) and 
tet{0) occurred together in 59 isolates (55.1  % of total tetracycline resistant isolates). 
tet{M) occurred without tet{O) in  18/79 (22.8%) isolates and tet{O) occurred without 
in  11/71 (15.5%) isolates. 
tet{M)  and  the  integrase,  ini,  of Tn9/i5  occur together  in  71  isolates (66.4  % of the 
total  tetracycline  resistant  isolates),  with  tet(M) occurring  in  the absence  of int  in  8 
isolates, and Tn9/6 int occurring without tet(M) in  1   isolate (Figure 3.6). 
tet{M) was found with erm(B) in 55 isolates (44.7 % of total isolates). tet{M) occurred 
without  erm(B)  in  24/79  (30.4  %)  isolates  harbouring  this  determinant,  erm(B) 
occurred without tet{M) in  12/69 (17.4 %) isolates.
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Figure 3.6:  Macroarray  results for the hy bridisation of oral isolates with A), the tet(M) probe and 
B). the TnP/6 integrase probe. The isolates have been blotted and fixed to the nylon  membrane, and 
the tet{M) and int probes hybridised.  Illustrates the apparent linkage between the two genes  in some 
cases.
1583.3.6 Rare or Unknown Resistance Determinants
Of the Gram  positive tetracycline resistant  isolates  identified,  3  did not hybridise to 
any of the probes used in the array.  Of these, one was a Pediococcus from the Italian 
faecal sample.  Most Pediococcus spp. are resistant to tetracycline, but do not harbour 
the  genes  usually  found  in  Gram  positive  cocci  (Tankovic  et  al.,  1993).  No  further 
work was done on this isolate as it is considered intrinsically resistant.
The  other  two  isolates  were  streptococci,  one  from  the  Scottish  oral  sample 
(designated SStetl5), one from the French oral  sample (designated FRStetl2) which 
also harboured an erm{B) gene.
The MIC to tetracycline of the isolates that did not hybridise to anything on the array 
(SStet 15  and  FRStetl2)  was determined  by  the agar dilution  method  (Chapter 2)  to 
be 32 pg/ml in air.
The  PCR  of the  SStet 15  and  FRStetl2  isolates  using  universal  RPP  primers  was 
negative suggesting that no known RPP genes were present.
BAC  and  pDL278  libraries  of DNA  from  these  isolates  in  E.  coli  and  S.  mutans. 
respectively  were  constructed  as  detailed  in  Chapter  2.  The  properties  of  these 
libraries are shown in Table 3.5.
159FStetl2 (tet(32)) SStet 15 FRStetl2
pCClBAC pDL278 pCClBAC pDL278 pCClBAC pDL278
Average 
insert 
size (Kb)
30 8 26 8 22 7
Size of 
library' 
(Mb)
42.5 32.5 27.4 22.4 26.6 22.5
Coverage
(%) 99 99 99 99 99 99
Table  3.5:  Insert  size  and  coverage  (based  on  the  calculation  detailed  in  Chapter  2)  of  the 
libraries  in  E.  co/i  and  S.  mutans  of  the  isolates  harbouring  rare  or  unknown  tetracycline 
resistance determinants.
Approximately  27  Mb  of each  isolate  BAC  library,  and  -22.5  Mb  of each  isolate 
pDL278  library  were  screened  on  selective  medium  containing  tetracycline  at  10 
pg/ml. No clones expressing tetracycline resistance were found.
1603.4 Discussion:
The  total  cultivable  flora  of the  oral  and  faecal  microbiota has  been  investigated  in 
previous  studies (Kleessen,  2000;  Sutter.  1984;  Moore &  Holdeman,  1974; Justesen 
et al.,  1984).  The species present have been described in detail (Marsh, 2003;  Paster 
et  al.,  2001).  In  this  study  we  have  concentrated  on  the  aerobic  and  facultative 
anaerobic  cultivable  flora  due  to  restrictions  in  culture  techniques  available  in  the 
laboratory'  and  as a  result of the distance  some of the samples  have to travel  before 
processing can occur.  It is further refined to Gram positive bacteria.
3.4.1  Tetracycline  and  Erythromycin  Resistance  in  the  Aerobic  /  Facultative 
Anaerobic Oral Cultivable Flora
3.4.1.1  Levels of Resistance
Tetracycline and erythromycin resistance levels in the total cultivable flora from each 
European  country  were  not  found  to  be  statistically  different  by  the  use  of  the 
students  t-test.  This  suggests  that  resistance  persists  in  the  oral  cultivable  flora  of 
healthy adults and does not vary according to geographic location. However, a range 
of levels of resistance was found.
In  the  English  sample  resistance  levels  are  similar  to  the  average  levels  found  by 
Villedieu  et  al.,  (2003)  i.e.  that  11  %  of the  oral  cultivable  flora  were  tetracycline 
resistant  (cf 23.6 %  for the  English  sample  in this  study).  The  differences  are  most 
likely  due  to  the  absence  of  obligate  anaerobes  in  this  study,  however,  normal 
population  flux  within  the  oral  cavity,  or  sampling  differences  between  the  two 
studies may also contribute (Kolenbrander. 2000).
Other  studies  have  been  conducted  on  the  prevalence  of  individual  tetracycline 
resistance determinants in the oral cavity, however, these have been on  isolates from
161patients  with  endodontic  problems  (Rossi-Fedele  et  al.,  2006)  and  periodontitis 
(Lacroix  &  Walker,  1995,  1996),  and  so  direct  comparisons  between  the  current 
study  and  these  previous  studies  is  not  possible  due  to  the  changes  in  population 
composition  brought  about  by  the  diseased  state  (Marsh,  1999,  2001)  and  the 
selective  effect  that  any  antimicrobial  therapy  may  have  had  on  the  incidence  and 
persistence  of tetracycline-  and  erythromycin-resistant  bacteria (Ready  et  al.,  2002; 
Edlund & Nord, 2000).
3.4.1.2 Composition of the Resistant Flora
In  the  oral  cavity,  in  healthy  adults,  by  far  the  most  predominant  species  are  the 
streptococci  which  constitute  ~  20%  of the  normal  flora,  at  up  to  106  cfu  per  ml 
saliva (Kohler.  1992).  This  is  reflected  in the  results of the species  identification  of 
the resistant  isolates taken  from the oral  samples  in which streptococci  predominate 
(74.7  %  of oral  isolates).  This  allows  increased  opportunities  for  these  species  to 
obtain  resistance  genes,  furthermore,  this  genus  contains  naturally  competent 
organisms (Stone & Kwaik.  1999; Solomon & Grossmann,  1996). Oral staphylococci 
and  lactobacilli  commonly  have  a  high  level  of  tetracycline  and  erythromycin 
resistance (Villedieu et al.,  2003, 2004) in agreement with this study.  Other resistant 
genera  isolated  from  the  oral  samples  (Section  3.3.2)  have  all  previously  been 
reported in the oral cavity (M Roberts,  1999. 2002, 2004).
3.4.1.3 Genetic Basis of Tetracycline Resistance
3.4.1.3.1  tet(M)
In this study the most common tetracycline resistance determinant in the oral  cavity 
was  tet{M).  This  agrees  with  previous  studies  on  both  the  cultivable  and  total  oral
162flora (Lancaster et al.,  2005;  Villedieu et al., 2003; Diaz-Torres et al,  2006).  It was 
found  to  occur  in  76.8  %  of  the  total  tetracycline  resistant  oral  isolates.  It  has 
previously  been  found  to account  for tetracycline resistance  in  56  % of tetracycline 
resistant isolates from the oral cavity of healthy children (Lancaster et al.,  2003); and 
79 % of resistant isolates from healthy adults (Villedieu et al., 2003) illustrating that 
levels of /e/(M)  are  relatively  stable  in  the oral  cavity of healthy adults.  The  wide­
spread  distribution  of  fet(M)  is  explained  in  part  by  its  presence  on  Tn9/6-like 
elements,  the  integrase  of  which  was  commonly  found  in  89.9  %  of  isolates 
harbouring  the  gene.  Tn9/6-like  elements  have  been  found  in  many  oral  species 
(Bentorcha et al.,  1992; McKay et al.,  1995; Mercer et al., 2001) and Tn916 has been 
shown  to  readily  transfer  among  oral  streptococci  (Mercer  et  al.,  2001)  and 
enterococci (Bentorcha et al.,  1992), and in microcosm dental plaques (Roberts et al., 
2001a).  This is likely to account for the observed linkage (i.e. they are present in the 
same  cell)  of tet(M)  and  int  in  the  macroarray  results  for the  isolates.  In  addition, 
tet(M)  is  found  on  a  range  of other  mobile  elements  (Table  1.7)  which  is  likely  to 
account  for  the  occurrence  of tet(M)  without  int  in  8  isolates.  Furthermore,  Tn916 
has been found to harbour tet(S) in place of tet{M) (Tn9/6S) (Lancaster et al.,  2004); 
the ability of this  family of elements to aquire different tetracycline resistance genes 
provides  a  plausible  explanation  for  the  occurrence  of  int  without  /e/(M),  an 
alternative is that it is harboured by a phenotpyicaly negative element.
/c/(M) was harboured  in the same  isolate as erm(B) in 55  isolates. These genes have 
been reported together in a number of studies (Nielsen et al.,  2004; De Leener et al., 
2004;  Betriu  et  al.,  2002),  and  have  been  shown  to  be  linked  on  Tn/575-like 
elements  and  on  the  conjugative  transposon  Tn3872.  This  point  is  also  relevant  for 
the faecal  isolates, and may explain why tet(M) and erm(B) are so common and why
163they are often found in the same cell.  Further work should include a the probing of a 
southern  blot  with  a  probe  for  /e/(M),  erm{B),  the  Tn916/1545  integrase  and  the 
kanamycin  resistance  gene  to  establish  whether  the  genes  are  linked  on  the  same 
fragment of DNA.  if they are they would likely be present on a Tn/5-/5-like element 
as previously described (Villedieu et til., 2004).
3.4.1.3.2  tet(O)
Villedieu et al..  2003  found tet(O) to be common in the resistant flora, harboured by
10.4  % (mean) of tetracycline resistant isolates (the third most common determinant 
after  tet{M)  and  tet(W)  in  their  study).  In  this  study.  tet{O)  is  the  second  most 
commonly  detected  tet  gene  in  the  oral  samples,  found  in  66.7  %  of tetracycline 
resistant  isolates.  One  possible  explanation  for  this  difference  is  the  differences  in 
breakpoints  used.  Villedieu  et  al..  (2003)  used  8  pg/ml  tetracycline  based  on  the 
recommendations  of  the  NCCLS  (National  Committee  for  Clinical  Laboratory 
Standards.  1993).  whereas  in  this  study  a  lower  breakpoint  of 2  pg/ml  tetracycline 
has  been  used  as  recommended  by  the  BSAC  (British  Society  for  Antimicrobial 
Chemotherapy)  (MacGowan  &  Wise,  2001;  Andrews.  2001).  Thus  it  is  likely  that 
this study would recover higher numbers of isolates. Furthermore, this study does not 
include strict anaerobes or Gram negatives therefore the results of the two studies are 
difficult  to  compare  since  the  incidence  some  tet  genes  is  different  in  aerobic  and 
anaerobic organisms (reviewed in Levy et al..  1989; Roberts,  1996).
The  high  incidence  of  tet(O)  is  probably  due  to  its  presence  on  mobile  genetic 
elements, although only two have been characterised {Campylobacter jejuni plasmids 
pCC31  and pTet), however, these elements have not been shown to move outside the 
genus  (Giovanetti  et  al..  2003).  In  this  study  80.4  % of tet(0)  genes  were  found  in
164streptococci,  which  may  play  a  large  part  in  explaining  its wide  spread distribution 
due  to  the  natural  competence  of some  members  of this  genera  (Stone  &  Kwaik, 
1999; Soloman & Grossmann.1996).
In  the  current  study  tet{O)  was  found  in  Actinomyces  spp.  for  the  first  time. 
Actinomycetes  are  implicated  in  infections  of  the  tissue  adjacent  to  dental 
implantation  elements  and  tooth extraction  wounds  (Schaal  et al.,  1992; Jeansonne, 
2005),  and  tetracycline  is  one  antibiotic  used  in  the  treatment  of such  infections 
(Bubbico  et  al..  2004).  This  finding  has  important  implications  for  therapeutic 
choices  since  tetracycline  therapy  may  select  for  resistant  Acitnomyces  spp. 
harbouring this gene and cause the treatment to fail.
3.4.1.3.3  te/(W)
tet(W) was the third most commonly identified tetracycline resistance determinant in 
the oral  flora in this study  was identified  in  10.1  % of the total tetracycline resistant 
bacteria  compared  to  21  %  of  isolates  in  the  Villedieu  study  (2003).  Again, 
differences may be due to the absence of obligate anaerobes in this study. tet( W) was 
first  found  in  Butyrivibrio  fibrisolvens,  an  anaerobe  isolated  from  the  rumen 
(Melville et al..  2004).  It has subsequently been found in Bifidobacterium sp. (Masco 
et al.,  2006). Lactobacillus sp.  (Kastner et al.,  2006), and Megasphaera sp.  (Stanton 
et al..  2004) suggesting it is predominant among strict anaerobes (which are absent in 
this  study).  Furthermore,  it  has  also  been  found  in  Veillonella  spp.,  and  Neisseria 
spp.  (Villedieu et al..  2003) however. Gram negative bacteria are excluded from this 
study.  The  Villedieu  (2003)  study  also  found  tet(W)  in  Bacillus  spp.  and 
Actinomyces sp. which is mirrored in this study.
1653.4.1.3.4 tet{2>2)
In  other  studies  using  the  macroarray  tet(32)  has  always  hybridised  with  tet(O) 
(Andrea  Patterson,  personal  communication,  2004),  suggesting  the  presence  of 
mosaic-type genes (Scott et al,  2005).  Such hybrid genes are composed of different 
sections of tet(O) and tet(32).  In this study one of the streptococci  isolated  from the 
oral  cavity  was  found  to  hybridise  to  the  tet(32)  probe,  but  not  the  tet{O).  It  is 
possible that this gene is the first example of a complete tet(32) isolated from the oral 
cavity.
The  DNA  from  this  isolate  was  cloned  into  both  a  Gram  negative  (E.  coli  in  the 
pCClBAC  vector)  and  a  Gram  positive  (S.  mutans  in  pDL278)  and  screened  for 
expression.  -36  Mb  of the  BAC  library  and  32.5  Mb  of the  pDL278  library  was 
screened, which is equivalent of 17.7 streptococcal genomes (based on the S.  mutans 
UA159  genome  accession  number  NC  004350  (2.03  Mb))  for  BAC  and  15.9 
streptococcal  genomes  for  pDL278.  No  tetracycline  resistant  clones  were  found. 
There  are  various  reasons  why  a  gene  might  not  express  in  a  heterologous  host 
(Gabor  et  al,  2004).  Bias  in  the  cloning  of  the  tet(32)  encoding  fragment  may 
prevent  successful  cloning.  The  restriction  sites  used may  be too  far away  from  the 
gene and  the  large  DNA  fragment produced  would clone or express less efficiently. 
However,  if successfully  cloned;  the  size  of insert  and  the  presence  of expression 
signals  that  are  functional  in  the  host  organism;  and  the  correct  folding  of  the 
resulting  protein  in  a  heterologous  host  by  transacting  host  factors  (chaperones, 
cofactors,  protein-modifying  enzymes)  all  contribute  to the  likelihood  of successful 
expression  (Gabor et al,  2004).  Chapter five details the successful  cloning of tet(S) 
from Enterococcus faecalis and its failure to express in the EPI3000 E.  coli host.
166No  clones  containing  tet{32)  were  found  by  probing the  BAC  library with a tet(2>2) 
derived PCR probe.  -48  Mb was screened this way (equivalent of 23.5 streptococcal 
genomes).  This  suggests  the  problem  is  due  to  an  inability  to  clone  the  tet(32) 
sequence.
3.4.1.4  Genetic Basis of Ery thromycin Resistance
3.4.1.4.1  erm(B)
In this study erm(B) was the most common erm (methylase) gene in the oral aerobic / 
facultative  anaerobic  cultivable  flora.  Most  other  studies  that  have  investigated 
erythromycin  resistance  have  found  mef{A)  to  be  the  predominant  erythromycin 
resistance  gene  in the  cultivable oral  flora (Villedieu et al,  2004;  Ojo et al.,  2004). 
However,  these  studies  identify  erm(B)  as  the  most  common  erm  gene.  In the  oral 
cavity  it  has  previously  been  reported  to  be  harboured  by  33  %  of erythromycin 
resistant cultivable isolates (Villedieu et al., 2004) cf.  71.4 % in this study, however, 
as with the tetracycline breakpoint, the ery thromycin breakpoint used in the study by 
Villedieu  et  al..  (2004)  was  higher:  4  pg/ml  compared  to  1   pg/ml  in  this  study  as 
advised by  BSAC (MacGowan & Wise. 2001; Andrews, 2001).
In  this  study,  the  oral  streptococci  accounted  for  86.0  %  of  erw(B)-harbouring 
isolates,  compared  to  93.9  %  in  the  Villedieu  et  al.,  study  (2004),  illustrating  the 
relatively  stable  nature  of  erm(B)  within  streptococci,  and  high-lighting  their 
importance  as  a  reservoir  of  erythromycin  resistance  as  has  previously  been 
described (Bry skier,  2002).  The natural  competence of this genus partly explains the 
high  incidence of resistance genes it contains (Stone  &  Kwaik,  1999).  Furthermore, 
as  with  the  tetracycline  resistance  determinants,  the  erythromycin  resistant
167determinants are commonly found on mobile genetic elements (Table  1.6), including 
Tn/5-/>like  transposons  (Serai  et  al.,  2000),  which  goes  some  way  to  explaining 
their commonality in the oral cavity.
In  this  study  erm{B)  was  found  in  Rothia  sp.  for  the  first  time.  Rothia  spp.  are 
common  inhabitants of the human oral  cavity and causative agents of serious dental 
infections  including  caries  and  infectious  endocarditis  (Boudewijns  et  al.,  2003). 
Although  erythromycin  is  not  used  in  the  treatment  of Rothia  spp.  infections,  the 
presence of erm(B)  on  mobile elements  may  link  it to other resistance determinants 
with potential detrimental effects on antibiotic therapy.
3.4.1.4.2 Other erm genes
This study  identified erm(F) (a methylase gene)  in  7.1  % of resistant isolates.  Other 
studies  have  identified  methylases  as  being  common  in  the  oral  cavity  of healthy 
humans  (Ojo  et  al.,  2004;  Villedieu  et  al.,  2004).  but  so  far  erm(F)  has  only  been 
quantified  in studies on  samples of pathogens (Chung et al.,  2002).  As with erm(B), 
erm(F)  has  been  found  on  a number of mobile  elements  including CTnDOT.  pBF4 
and others (Table  1.6) (Whittle et al.,  2001;  Shoemaker et al.,  1985) which is one of 
the causes of it being so widespread.
3.4.2  Tetracycline  and  Erythromycin  Resistance  in  the  Aerobic  /  Facultative 
Anaerobic Faecal Cultivable Flora
3.4.2.1  Composition of the Resistant Flora
The  resistant  faecal  flora  isolated  in  this  study  has  a  predominance  of enterococci. 
This  is  probably  due  to  the  fact  that  the  culture  techniques  used  here  were  not
168suitable for strict anaerobes, which out number aerobic bacteria by  100-1000:1  in the 
intestinal  tract (Guamer &  Malagelada  2003).  However, enterococci are commonly 
reported  in  the  faecal  flora  in  culture  studies  (Blaut  et  al.,  2002,  Hayashi  et  al., 
2005),  as  are  streptococci  which  were  the  second  most  common  isolate  from  the 
faecal samples in this study and previous work (Blaut et al,  2002).
3.4.2.2  Levels of Resistance
Many genera found in the gut harbour antibiotic resistance genes (Krause, 2002). and 
the  gut  has  been  the  place  where  many  novel  genes  have  been  found  (Scott,  2002; 
Calva  et  al.,  1996;  Osterblad  et  al.,  2000;  Rice  et  al.,  2004).  Unfortunately,  it  is 
difficult  to  compare  the  results  of  this  study  to  previous  studies  on  antibiotic 
resistance in the human  gut as this study concentrates on the aerobic and  facultative 
anaerobic  species  (due  to  sample  collection  and  processing),  whereas  other  studies 
include  the  obligate  anaerobes  including  the  Bacteroides  /  Prevotella  group  which 
constitute the majority of the cultivable human faecal flora (Upreti et al.,  2004; Blaut 
et al.,  2002).
Levels  of  tetracycline  and  erythromycin  resistant  bacteria  show  no  significant 
difference,  as  determined  by  the  student's  t-test,  between  countries  suggesting 
resistance among the Gram positive aerobic and facultative anaerobic cultivable flora 
of  different  countries  is  similar  despite  different  levels  of  usage  of  antibiotics 
(Turnidge. 2001; Goossens et al.,  2005; Patrick et al,  2004).
1693.4.2.3 Genetic Basis of Tetracycline Resistance
3.4.2.3.1 tet{  M)
tet(M) is the most common tet gene in the cultivable aerobic / facultative anaerobic 
isolates.  As  with  isolates  from  the  oral  cavity,  tet(M)  was  commonly  found  in  the 
same  bacterium  as  the  Tn916  integrase.  This  may  be  responsible  for  its  transfer 
throughout the community,  since  it has  been shown to transfer readily  in the gut of 
gnotobiotic mice (Alpert et al,  2003; Bahl et al,  2004)
3.4.2.3.2 tet{O)
tet{0)  is the  second  most common tet  gene  isolated.  As with the oral  tet(O)  genes, 
their wide distribution in the faecal flora is likely to be due to the presence on mobile 
elements,  including the  C. jejuni plasmids  pTet and pCC31,  which  are  likely  to  be 
responsible  for the  previously  observed  transfer of tet(O)  (Giovanetti  et al.,  2003). 
tet(0)  is common  in the streptococcal  isolates (their natural  competence contributes 
to the high levels), and the enterococci.  Enterococci have been found to exhibit high 
levels  of tetracycline  resistance  (Hummel  et al,  2006;  Bentorcha et al,  1992)  and 
have been shown to be viable recipients of numerous mobile elements (Klare et al, 
2001;  Simjee  &  Gill,  1997).  This  may  explain  the  high  levels  of  resistance  in 
enterococci in this study.
3.4.2.3.3 tet{Q)
tet(Q) is the third most isolated tet gene in this study.  It was found in Enterococcus 
spp., Lactobacillus spp., and a Streptococcus spp.  It has been previously found to be 
harboured  by  80  %  of Bacteroides  strains  found  in  the  colon  (Shoemaker  et  al,
1702001) in a study  that  implicated the conjugative transposon CTnDOT which has the 
ability  to  transfer  to  other  genera  (Shoemaker  et  al.,  2001)  and  may  explain  its 
predominance in the  isolates of this study.  As with tet(O), tet(Q) is common among 
enterococcal  isolates, therefore the high  levels of genetic exchange exhibited by this 
genus (Simjee & Gill,  1907) may explain why  tet(Q) is so wide-spread.
3.4.2.4  Genetic Basis of Erythromycin  Resistance
The most commonly isolated erm gene from the human faecal  samples in this study 
was  erm(B).  As  is  the  case  with  it’s  predominance  in  the  oral  samples,  this  is 
probably  due  to  its  presence  on  Tn/545-like  transposons  (Serai  et  al.,  2000). 
Furthermore,  it has previously been  found to be present in  100 % of human-derived 
enterococci (DeLeener, 2004), the most common genus isolated in this study.  In this 
study it was harboured by 93.4 % of the tetracycline resistant enterococci.
3.4.3  V ancomycin Resistance
No  vancomycin  resistant  Gram  positive  isolates  were  recovered  during  this  study. 
Vancomycin  resistance  has  been  reported  in  various  oral  and  faecal  species,  both 
Gram  negative  and  Gram  positive  (Domingo  et al..  2005),  however,  they  have  not 
been  isolated  in  studies similar to this (Bueris et al.,  2005;  Ready et al.,  2003).  It  is 
possible  that  the  normal  microbiota  of  humans  has  not  yet  aquired  vancomycin 
resistance in any great amount and as yet remains relative free from mobile elements 
carry ing this resistance determinant.
1713.4.4 SStet 15 and FRStetl2
Two oral  streptococcal  isolates  did  not hybridise to any of the probes on the array. 
These  isolates  harbour either rare tetracycline resistance determinants or previously 
unreported determinants. A PCR reaction using universal RPP primers was negative 
(Appendix  4).  indicating  that  the  tetracycline  resistance  genes  in  these  isolates  are 
not  known  RRP  genes.  The  following  efflux  and  enzymatic  genes  are  not  on  the 
array:  tet{K),  tet{L), tet(V),  tet{31),  tet{33),  tet(35), tet(38),  tet(39), /cr3, o/r(B) and 
otr(C)  so  may  possibly  be  responsible  for resistance  in these  strains.  However,  the 
MIC  of both  isolates  was between  32  pg/ml -  64  pg/ml.  Tetracycline efflux genes 
confer  a  low  MIC  (Webber  &  Piddock,  2003)  therefore  the  probability  of these 
streptococci harbouring efflux genes is relatively small.
It  is possible that these  isolates  harboured  one  of the  enzymatic  inactivation  genes 
(tet(X) or tet(37)); or tet(U) which confer resistance through an unknown mechanism 
(Roberts 2005). This would need to be verified by PCR using the appropriate control 
strains.  In  this  study,  the  control  strains  were  not  available  and  single  species 
libraries  were  made  of  SStetl5  and  FRStetl2.  These  libraries  were  screened  on 
selective agar. No resistant clones were detected when using an E.  coli host (-27 Mb 
of  each  library  was  screened,  corresponding  to  -13.3  genomes  of  S.  mutans), 
suggesting that there is a problem with expression of the gene in this host, however, 
when cloned into a streptococcal host this also yielded no resistant clones (-22.5 Mb 
of each  library  was  screened  (-11.1  streptococcal  genomes)).  As  outlined  above, 
there are numerous reasons why this may have occurred (Gabor et al.,  2004).  It was 
not possible to probe the  libraries as this requires knowledge of the gene sequence. 
Thus  it  is  not  possible  to  determine  which  resistance  gene  is  responsible  for 
tetracycline resistance in these isolates without sequencing the whole genome of the
172original isolate or by using transposon mutagenesis to provide a tetracycline sensitive 
mutant  and  a  platform  from  which  to  sequence  out  into  the  genome  of the  mutant 
strain.  These  strains  have  therefore  been  stored  as  glycerol  stocks  for  future 
investigations.
1733.4.5 Conclusions
There  is  no  significant  difference  between  the  incidence  of  tetracycline  and 
erythromycin resistance  in the Gram  positive aerobic / facultative anaerobic portion 
of the cultivable microbiota of six European countries.
The  most  common  tetracycline  resistance  determinants  in  the  oral  isolates  were 
/e/(M),  tet{O)  and  tet(W)  (in decreasing order).  In the  faecal  isolates tet(M),  tet(O), 
and tet(Q) (in decreasing order) were the most common tet genes.
The  most  common  erythromycin  resistance  determinants  probed  for  were  erm(B), 
erm{F) and erm(E) (in decreasing order) for both the oral and faecal isolates.
One  isolate,  FStetl2.  hybridised  to  the  tet(32)  probe,  but  not  the  tet(O)  probe, 
suggesting  it  is  a  complete  tet(32)  gene  or  novel  mosaic  gene,  BAC  and  pDL278 
libraries were prepared, but no expression of tetracycline resistance was detected.
Two tetracycline resistance isolates did not hybridise to any of the probes on the 
array, therefore they contain either a rare tet gene or a novel resistance gene.
Libraries were made from DNA from the isolates but no tetracycline resistant clones 
were recovered. These strains are awaiting further investigation.
174CHAPTER FOUR
Analysis of Metagenomic Libraries from Human Oral and Faecal
Environments.
1754.1 Introduction:
In  the  relatively  well-studied  microbiota  of  the  human  oral  cavity,  where  it  is 
estimated that there are more than  800  species of bacteria (William  Wade,  personal 
communication  2006),  at  least  half of these  are  considered  to  be  not yet  cultivable 
(Kazor et  al.,  2003;  Pastor et al.,  2001).  Likewise  in  the  human gut  approximately 
20-40% (Blaut et al.,  2002;  Gill  et al.,  2006) of the estimated >1000 species are not 
yet able to be cultivated (reviewed in Kaper & Sperandio, 2005). One of the ways to 
obtain information about all of the organisms present in these complex communities 
is  through  the  use  of metagenomic  approaches  such  as  the  construction  of  BAC 
libraries  (Handelsman,  2004;  Streit  &  Schmitz,  2004).  Metagenomic  studies  have 
previously been used to investigate the healthy human faecal microbiota: Manichanh 
et  al.  (2006)  compared  the  healthy  microbiota  to  that  of  Crohn’s  patients.  The 
predominant  phyla  in  the  healthy  library  were  the  Bacteroides  and  Firmicutes  (of 
which Clostridium  spp.  predominated).  All  species  identified were from these phyla 
or  the  Actinobacteria  or  Proteobacteria.  The  study  also  found  34  %  of sequences 
were  novel.  Gill  et  al.  (2006)  employed  a  whole-genome  shotgun  sequencing 
approach  to  investigate  diversity  (identifying  16S  rRNA  sequences  from  random 
shotgun assemblies and supplementing the data with  16S rDNA libraries).  The study 
also  identified  the  Firmicutes  division  as  predominant,  and  identified  the 
Actinobacteria as the only other bacterial division present.  The same study also used 
COG  analysis  (which  groups  functionally  related  genes  using  evolutionary 
relationships)  to  identify  the  functional  diversity  of the  faecal  microbiota.  It  found 
the  microbiota  enriched  for  genes  involved  in  the  metabolism  of  glycans,  amino 
acids,  and  xenobiotics;  methanogenesis;  and  2-methyl-D-erythritol  4-phosphate
176pathway-mediated  biosynthesis  of  vitamins  and  isoprenoids  (i.e.  pathways  not 
encoded by the human genome).
The healthy oral microbiota has yet to be characterised using metagenomic libraries, 
however,  a  16S  rRNA  sequence  approach  has  been  used  which  found  the 
predominant  phyla  to  be  the  Proteobacteria,  the  Gram  positives,  the  spirochetes  or 
the  flavobacter-bacteroides  group  (M  Wang  et al.,  2005).  The tetracycline  resistant 
portion of the oral  microbial  metagenome has been investigated using metagenomic 
libraries  by  Diaz-Torres  et  al.,  (2006)  and  was  found  to  be  predominated  by 
enterococci, Prevotella spp., Campylobacter spp., and staphylococci.
This part of study  reports the  methods  used  for construction of BAC  libraries  from 
the human  oral  plaque  and  saliva and  human  faecal  metagenomes.  To  determine  if 
the libraries contained DNA derived from aerobes and anaerobes, and cultivables and 
not-yet-cultivables  a  random  collection  of cloned  inserts  were  analysed.  Using  an 
end-sequencing approach and Blastn analysis on over 600 randomly selected clones, 
the  current  study  demonstrates  that  the  BAC  libraries  contain  what  would  be 
expected  of  these  two  environments.  In  addition  sequences  were  analysed  using 
Blastx  to  investigate  the  range  of putative  proteins  that  could  be  encoded  by  the 
cloned DNA.
1774.2  Materials and Methods
4.2.1  Fragmentation of DNA from Human Samples.
4.2.1.1  Mechanical Shearing
1   ml  genomic  DNA  (between  60-100  pg/ml  depending  on  country  of origin)  was 
sheared  in  a  Hydroshear  device  (Genemachines,  USA)  which  uses  hydrodynamic 
shearing  forces  to  fragment  DNA.  A  shearing  setting  of 40  (arbitrary  units  of the 
machine) was used.  50 % of the sample under went  1   cycle of shearing, the other 50 
% under went 5 cycles.
4.2.1.2 Fragmentation by Restriction Digest
50 pi  aliquots of genomic  DNA (diluted to ~50  pg/ml) were partially digested  with 
SauSW   (multicore  buffer;  2  units  /  100  ng  DNA)  or  HindlW  (3.2  units  /  100  ng 
DNA). In all cases digests were performed at 37 °C with 50 % of the sample digested 
for 1   min and 50 % for 3 mins. The reactions were subject to an ethanol precipitation 
and resuspended in  100 pi sterile dH20 at 4 °C overnight.
All fragmented DNAs were run out on agarose gels (2 %) overnight at 30 V in a cold 
room  (4  °C).  Low  Melting  Point  (LMP)  agarose  was  used  if  DNA  was  to  be 
extracted by agarase digestion
4.2.2 Extraction of DNA from Agarose Gels
4.2.2.1  Agarase Digestion
178Gel slices containing HMW DNA were cut from the gels (above 40 Kb according to 
a  lambda  mono-cut  molecular  weight  standard).  They  were  melted  at  65  °C  and 
digested with agarase (lunit / 200 mg gel; 42 °C) until the gel had liquefied.
4.2.2.2 Gel Extraction using the Qiagen Gel Extraction Kit
Gel slices containing HMW DNA were cut from the gels and were subjected to DNA 
extraction using the Qiagen Gel Extraction Kit.
4.2.2.3 Electroelution
Gel  slices  containing  HMW  DNA  were  cut  from  the  gels.  They  were  placed  in 
dialysis tubing prepared as described by the manufacturer. 250 pi sterile d H2O  were 
added to the gel  slice  in the tubing.  The ends of the tubing were sealed with  sterile 
metal clamps, and the tubing placed in a Bio-Rad gel tank in a cold room (4  °C).  25 
V  was applied  for  1   hour.  The tubing was removed and the DNA solution removed 
with a wide-bore pipette.
1794.3  Results:
4.3.1  Fragmentation and  Isolation of HMW DNA
The  fragmentation  of  metagenomic  DNA  using  the  hydroshear  machine  was 
compared to the use of partial digests using a 4 bp cutter (Sau3A\) and a 6 bp cutter 
(Hindlll) (Figure 4.1). The hydroshear was only capable of producing DNAs of up to 
-40  Kb  (Figure  4.2)  compared  with  up  to  -100  Kb  (clone  IStetC2)  using  the 
restriction  digests  (based  on  insert  sizes  determined  by  EcoK\  digestion  of 20  or 
more clones). HindlU was found to be preferable to Sau3A\  since it produced larger 
DNA fragments under the conditions tested.
Figure  4.1:  Genomic  DNA  (lane  2)  digested  with Sau3\l  (lanes3-7)  and  Hindill  (lanes  8-12).
Digests for each enzyme had  incubation times of 1, 2, 3, 4 and  5  mins  left-right.  Lane  1   is a  10  Kb 
marker.
180Ml  2 3 4 5 6 7 8 9  1 0  1 1
10 K b  »
8 Kb    +
4 Kb  _____|
1.5 Kb    J
Figure 4.2:  Digested  BAC clones made using DNA fragmented using the hydroshear machine.
Lane M:  10 Kb marker. Lanes  1 -1 1   digested BAC clones. The average size of clone constructed using 
this DNA was  13 Kb. DNA was digested with EcoK\.
4.3.2  Isolation of HMW DNA from Agarose Gels
The relative yields of DNA recovery using electroelution, agarase and the Qiagen kit 
are compared  in  Figure 4.3.  All  methods resulted in a loss of DNA  of >=70 %.  In 
addition, the Qiagen kit was found to shear the DNA to -10-20 Kb, and in all cases 
LMW DNA remained  in the  sample.  Therefore,  no size selection was made on the 
fragmented genomic DNA.
1 8 1A B
Figure  4.3:  A.  DNA  recovered  after  size  selection  using  electroelution  and  agarose  digestion.
Lane  1;  10  Kb  marker.  Lane  2;  DNA  recovered  after  electroelution.  Lane  3;  undigested  genomic 
DNA. Lane 4; DNA recovered after agarase digestion.
B.  DNA  recovered  using  the  Gel  Extraction  Qiagen  kit  (lanes  2-6).  10  Kb  marker  lane  1. 
Recovered DNA lanes 2-6 (performed 5 times on the same sample).
4.3.3  Library Construction
BAC  libraries  from  each of the  European  Institutes  were  constructed,  however  for 
the purposes of this Chapter only the English libraries, one oral and one faecal, were 
analysed by end sequencing.
The  average  insert  size  for the  English  saliva  library  is  30  Kb,  that  for the  faecal 
library is 24  Kb (Table 4.1), as determined by the restriction digest of 10 randomly
1 8 2selected clones from each  library (Figure 4.4).  The range of insert size in these 20 
clones was 8 -  70kb.
Sample Average insert 
size (Kb)
Number of 
Clones
Size of Library' 
(Gb)
Estimated 
Coverage of 
Microbiota3
English saliva 30 1.49 x 106 44.8 85%
English faecal 24 1.99 x  106 47.7 91%
Table 4.1:  Large insert  BAC libraries. The estimated coverage of the microbiota is the probability 
that any one sequence has been cloned into the library and is based on the equation detailed in Chapter 
two.  “This  Figure  takes  into  account  the  percentage  of inserts  shown  to  contain  human  DNA  (see 
below).
183Figure 4.4: Sizing the inserts of the BAC libraries A). Hind\\\ digested English saliva clones (lanes 
1-10). Lanes M:  10 kb marker, Hindll digested lambda. B). £coRI digested Norwegian faecal clones 
(lanes  1  -  10). First lane M:  10 kb marker, second lane M: Hindlll digested lambda.
4.3.4  Analysis of BAC Library Inserts
Randomly  selected  BAC  clones  from  each  of  the  libraries  were  subject  to  end 
sequencing (carried out at the Sanger Institute), and blastn and blastx searches were 
performed  on  the  data  obtained.  A  total  of 621  sequences  produced  327.6  kb  of 
sequence  information:  195.5  kb  (336  sequences)  from the  saliva library  (Appendix 
7),  132.1  kb (285  sequences) from the  faecal  library (Appendix 8) (Table 4.2).  The 
average length of read  for the saliva end-sequences is 585.0 bp,  for the  faecal  end- 
sequences it is 463.4 bp.
184Library English
Saliva
% English
Faecal
% Total
No. clones end-sequenced 336 285 621
Total amount of DNA sequenced (Kb) 195.5 132.1 327.6
Sequences with BLASTX similarities 
<lel5
140 62.8 112 39.3
Human DNA 80 44.9 0 0
Non-human sequences with BLASTX 
similarities <1 e 15:
60 17.9 112 39.3
Bacterial DNA 58/60 96.7 111/112 99.1
Eukaryotic (non-human) DNA 1/60 1.7 1/112 0.9
Viral DNA 1/60 1.7 0/112 0
BLASTX no homology (below <1 e l5) 196 58.3 173 60.7
Of which show homology to human 
DNA at the nucleotide level 
(BLASTN <lel5)
Of which show homology to other 
eukaryotic / prokaryotic / viral 
sequences (BLASTN <1 e l5)
Of which show no homology to 
sequences in the database (BLASTN
<1 el 5)
63.8
125/196  (37.2  0  0 
% of 
total)
2.9
0  0  5/173  (1.8%
all  of 
bacterial  total)
71  21.1  168  58.9
Total number of human sequences in the 
library
205 61 0 0
Table 4.2: Analysis of End-Sequences of BAC Inserts.
A  large  amount  of human  DNA  is  contained  in  the  saliva  library  but  none  was 
detected  in  the  faecal  library.  The  saliva  library  contains  61.0  %  human  DNA. 
Taking  this  into  account,  the  coverage  of the  microbiota  by  each  library  has  been 
calculated (Table 4.1).
1 8 54.3.5 G+C Analysis
As a further indicator of the diversity of cloned sequences the G+C content of the end- 
sequences of each  library  were  calculated (Figure  4.5).  The  saliva  library contained 
sequences with an average G+C content of 41.5% (26-65%), with its most common 
range being that between 35-39 %. In contrast, the faecal library has an average G+C 
content of 50.1% (29-71%).  The  most common  faecal  G+C  range was  between 45- 
49%.
Saliva library 
Faecal library
20-24  25-29  30-34  35-39  40-4  4S49  50-54  55-59  60-64  65-69  70-74
G+C Content
Figure 4.5: G+C Content of the Oral and Faecal BAC Library Inserts.
4.3.6  Translated  End-Sequence Analysis
Blastx  searches  demonstrated  that  the  cloned  DNA  had  the  potential  to  encode 
proteins  predicted  to  be  involved  in  a  wide  range  of  functions  including  central 
metabolism,  response  regulators,  intercellular  signalling,  virulence,  antibiotic
186resistance and gene transfer (Table 3.3  and 3.4). The cut off value for acceptance of 
likely  homologues  was  <1 e l5.  This  Figure  was  chosen  because  it  is  the  more 
accurate  of  cut-off  levels  used  in  previous  studies  using  blastx  as  a  measure  of 
diversity  (Treusch et al, 2004; Abascal & Valencia, 2002; Wintero et al.,  1996).
Genus to which the 
closest matching 
protein  belongs
No.
matching
end-
sequences
Functions
Bacteria
Bacteroides 15 Pyruvate formate-lyase activating 
enzyme (e-37)
Hypothetical protein (e-35), (e-54), (e- 
18), (e-22)
Carboxy-terminal processing protease 
precursor (e-73)
Conserved hypothetical protein (e-45) 
Biosynthetic arginine decarboxylase (e- 
104)
Alanine racemase (e-80) 
Beta-glucosidase (e-43)
Putative arginine decarboxylase (e-106) 
DNA-directed RNA polymerase beta 
chain (e-58)
Elongation factor TS (e-36)
30S ribosomal protein slO (e-33) 
dGTP triphosphohydrolase (e-49)
-
Haemophilus 7 Large exoprotein involved in haem 
utilisation (e-92)
Serine/threonine kinase (e-64) 
Prephenate dehydrogenase (e-110) 
Uncharacterised protein involved in 
chromosome partitioning (e-118) 
Hypothetical protein (e-42) 
Dexgoctulsonic acid synthetase (e-45) 
Molybdopterin converting factor 
subunit (e-78)
187Streptococcus 6 Hypothetical protein (e-19)
Sortase (e-27)
Site-specific recombinase (e-80) 
Formate acetyltransferase (e-103), (e- 
130)
Putative histidine kinase of ComD (e- 
23)
Clostridium 3 Pyridoxal kinase (e-22) 
Transketolase N-terminal (e-60) 
FAD synthase (e-26)
Porphyromonas 3 Hydrolase (e-48)
Hypothetical protein (e-19)
Reverse transcriptase homolog (e-64)
• Treponema 3 Phosphoglycerate mutase (e-33) 
Ankyrin repeat protein (e-54)
ABC transporter, ATP binding protein 
troB (e-20)
Bacillus 2 Endo-beta-N-acetylglucosaminidase (e- 
16)
Type-I restriction modification system 
restriction subunit (e-70)
Desulfitobacteria 2 Preprotein translocase (e-37) 
ABC-type transport system ATPase 
component (e-71)
Kineococcus 2 Translation elongation factor (e-32) 
Predicted membrane protein (e-16)
Moorella 2 Guanosine polyphosphate 
pyrophosphohydrolase (e-28) 
Leucyl-tRNA synthetase (e-84)
Pasteurella 2 Unknown hypothetical protein (e-20) 
PyrD dihydrorotate dehydrogenase (e-
51)
•
Actinobacteria 1 Geramylgeranyl phosphate synthase (e- 
72)
Azotobacter 1 ATPase (e-52)
Corynebacteria 1 Conserved hypothetical protein (e-68)
Fusobacteria 1 Hypothetical exported protein (e-36)
Mycobacterium 1 Phosphotransacetylase (e-35)
Mycoplasma 1 Conserved hypothetical transmembrane 
protein (e-15)
Phytoplasma 1 Nef attachable protein (e-15)
Streptomyces 1 Conserved hypothetical protein (-69)
Sulfurospirillium 1 Formate dehydrogenase subunit (e-60)
Thermosynechococcus 1 Heat shock protein HSP33 (e-34)
Xanthomonas 1 Branched chain amino acid 
aminotransferase (e-54)
188Eukaryotes Dictyostelium 1 Hypothetical protein (e-30)
Viral
MS-associated
retrovirus
1 Hypothetical protein (e-40)
No
Significant
Homology
71
Table 4.3: Translated End-Sequence Analysis of Oral BAC Clones. Only values of <1 e 15 were 
accepted.
189Genus to which 
the closest 
matching 
protein  belongs
No.
matching
end-
sequences
Function
Bacteria
Clostridium 36 Serine threonine phosphatase (e-21) 
Pyruvate phosphatase dikinase (e-18) (e- 
15)
Gy rase B (e-15)
RNA polymerase beta-subunit (e-92) 
DNA-directed RNA polymerase (e-99) 
SecA protein (e-42), (e-30)
L-lactate dehydrogenase (e-59) 
ABC-type multidrug/protein/lipid 
transport protein (e-30)
Hypothetical protein (e-49), (e-48), (e- 
30), (e-46)
Glycosyl hyrolase (e-17)
R-phenyllactate dehydratase (e-29) 
Ferrous ion transport protein (e-64) 
Helix-turn-helix AraC type protein (e-
21)
Multidrug resistance protein (e-18), (e- 
26)
Poly(A) polymerase (e-45)
DNA topoisomerase (e-32)
Glycogen synthase (e-73)
Tyrosyl-tRNA synthetase (e-59) 
NAD/FAD binding protein (e-18), (e- 
15)
50S ribosomal protein (e-28). (e-27) 
ATPase central region (e-63), (e-68) 
Methyltransferase (e-58), (e-48), (e-58), 
(e-48)
Anaerobic dicarboxylate transport 
protein (e-35)
Carbamoyl-phosphate synthase (e-77)
190*
Bacteroides 15 Preprotein translocase (e-41), (e-101) 
Probable cation efflux pump (e-48) 
Putative sulfatase (e-44)
Conserved hypothetical protein (e-31), 
(e-71)
ATP synthase beta-subunit (e-47) 
Phosphoribosylformylglucinamidine (e- 
126), (e-127)
Outer membrane efflux protein (e-19), 
(e-31)
Transcriptional regulator (e-18)
Electron transport complex protein (e- 
33)
Cu2+ homeostasis protein (e-47) 
Histidinol-phosphate aminotransferase 
(e-64)
Campylobacter 7 Mob/transferase protein (e-99)
TnpV (e-21), (e-29), (e-24), (e-27), (e- 
32), (e-32)
Arthrobacter 6 Hypothetical protein (e-23), (e-23), (e- 
23), (e-23), (e-23), (e-23)
Treponema 5 ORFA (e-77), (e-75), (e-76) 
Replication protein (e-21), (e-20)
Enterococcus 4 Hypothetical protein (e-27), (e-26), (e- 
21)
Prolipoprotein diacylgylceryl transferase 
(e-29), (e-27)
Bacillus 3 Alkaline phosphatase synthesis response 
regulator (e-49)
ATP-dependent RNA helicase (e-16) 
Alkaline phosphatase 2-component 
response regulator (e-25)
Exiguobacterium 3 Peptide chain release factor (e-38), (e- 
34), (e-41)
Lactobacillus 3 Putative carbohydrate kinase (e-48) 
Carbamoyl-phosphate (e-66) 
ABC-type antimicrobial peptide 
transferase (e-34)
Caldicellulosirup
tor
2 Metal dependent phosphohydrolase (e- 
15)
Acetolactate synthase (e-24)
Desulfitobacteriu
m
2 Drug antiporter (e-56) 
ATP-binidng region (e-18)
Mesorhizobium 2 Virulence factor SrfC homologue (e- 
45), (e-52)
• Staphylococcus 2 Replication protein (e-53), (e-56)
Streptococcus 2 30S ribosomal protein SI (e-19) 
Site-specific recombinase (e-70)
191Symbiobacteri  urn 2 Conserved hypothetical protein (e-24) 
Haloacid dehydrogenase (e-18)
Syntrophomonas 2 LuxR regulatory protein (e-20) 
Pro-6-E processing factor (e-20)
Actinobacillus 1 Beta-galactosidase (e-49)
Agrobacterium 1 50S ribosomal protein (e-21)
Alkaliphilus 1 Nitric oxide reductase (e-27)
Bifidobacterium 1 Beta-galactosidase (e-19)
Butyrivibrio 1 Hypothetical protein (e-90)
Crocosphaera
(Synechocystis)
1 Cysteine desulphurase (e-34)
Geobacillus 1 Trigger factor (e-23)
Moorella 1 Sodium/sulphate symporter (e-58)
Natronomonas 1 Molybdenum cofactor biosynthesis 
protein (e-28)
Prevotella 1 Mobilisation protein (e-62)
Porphyromonas 1 Hypothetical protein (e-15)
Rhodoferax 1 Ferrireducans (e-24)
Salmonella 1 LacZ fusion protein (e-30)
Thermoanaeroba
cterium
1 Sodium/alanine symporter (e-48)
Xanthomonas 1 Hypothetical protein (e-56)
Eukaryotes
Arabidopsis 1 Amino acid binding protein (e-30)
No
Significant
Homology
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Table 4.4: Translated End-Sequence Analysis of Faecal BAC Clones. Only values of <1 e 15 were 
accepted.
4.3.7  Analysis of TnpV Encoding End-Sequences
The  spread  of antibiotic  resistance  is  mediated  by  the  transfer  of mobile  genetic 
elements which harbour these genes (Cooper et al.,  1996;  Salyers et al.,  2004).  The 
end-sequence analysis of the  English  libraries revealed the relatively high  incidence 
of the  tnpV gene  which  is  harboured  by  the  mobilisable  transposon  lr\4451  which 
also harbours the catP gene for chloramphenicol resistance (Lyras et al.,  2004). tnpV 
has also  been  found  downstream  of tet(O)  in  a  B. fibrisolvens  isolate (Scott  2002). 
The TnpV sequences were analysed further to determine if they were likely to have
192the same phylogenetic origin which would be indicative of horizontal spread, and as 
a potential  indicator of the spread of antibiotic resistance due to its association with 
resistance genes.
Six  end-sequences  in  the  faecal  library  showed  homology  to  TnpV.  These  were 
aligned  with  known  sequences of the  protein,  and  a cladogram  constructed  (Figure 
4.6).
The  Cladogram  shows  that  BACTnpVl,  BACTnpV3  and  BACTnpV6  are  closely 
related, and BACTnpV2, BACTnpV4 and BACTnpV5 are also closely related.
They  are  all  distantly  related  to  the  protein  products  of  the  tnpV  genes  in  the 
database.  In  fact,  they  form  a  specific  group,  which  suggests  that  they  share  a 
common ancestor (indicated by the arrow on Figure 4.6) that had diverged from the 
common ancestor of all the previously reported TnpV proteins.
TnpV1: 0.01238 
TnpV3: -0.01238 
TnpV6:0.02667 
TnpV2: 0.04587 
TnpV4:0.03066 
TnpV5:0.02036 
TnpVCdifTicileTn4453:0.0 
TnpVTn4451: 0.00000 
TnpVSpyogenes: 0.30173 
TnpVCcoli: 0.30980
Figure  4.6:  Cladogram  showing  the  phylogenetic  relationship  between  translated  tnpV' genes. 
Number  of common  ancestors  can  be  determined  by  the  number  of  nodes  that  separate  genes, 
distances are listed beside the protein. The arrow represents the theoretical common ancestor of all the 
BAC derived TnpV sequences.
1934.4  Discussion
4.4.1  Construction of HMW Libraries
To realise the full potential of the BAC system it is imperative to isolate high quality 
HMW  DNA  from  bacterial  cultures  or  environmental  samples  (Berry  et  al.  2003; 
Strong et al,  1997).  The process of obtaining the  DNA can be complicated  if using 
environmental  samples.  Extraction  of  DNA  from  soils  and  faecal  samples  is 
especially  problematic  due  to  the  potential  contamination  by  organic  compounds 
such as humic acids, which inhibit downstream molecular processes such as PCR and 
cloning  (Tebbe  &  Vahjen.  1993;  Trevors.  1996),  and  the  difficulty  in  obtaining 
sufficient  yield  due  to  the  adsorption  of  DNA  to  particulate  surfaces  (Krsek  & 
Wellington,  1999).
A number of methods have been optimised for the removal of DNA from human and 
environmental  samples  for  use  in  PCR.  However,  these  often  shear  the  DNA  to 
lengths of -10 kb which is insufficient for BAC libraries (McOrist et al,  2002).
There  are  a number of processes that can  be  used  to  lyze the cells within a sample. 
Freeze-thawing,  bead  mill  homogenisation,  ultrasonication.  liquid  nitrogen, 
lysozyme and  SDS  in conjunction with chelating agents (EDTA) to inhibit nucleases 
(Miller.  1999;  Krsek  &  Wellington.  1999),  however,  these  too  inflict  mechanical 
shearing. As a result specialist methods have been developed. Zhou et al  (1996) first 
developed  a  method  to  extract  DNAs  of >23  kb  by  lysis  with  a high-salt extraction 
buffer,  extended  heating  in  the  presence  of  SDS.  hexadccyltrimethylammonium 
bromide  and  proteinase  K  to  lyse  the  cell.  However,  Berry  et  al,  2003  has  since 
optimised  extraction  of HMW  DNA  using  a  combination  of methods  including  the 
lysis of cells within biomass immobilised in agarose plugs,  followed by  pulsed-field
194gel  electrophoresis  to  isolate  DNAs  of the  required  size.  The  BAC  libraries  in  the 
current study were constructed using HMW DNA extracted from the oral and faecal 
samples  using  a commercial  kit.  This  produced  DNAs of up to ~100Kb which  was 
deemed sufficient for this project.
The use of partial digestion to fragment the DNA allows the possible inclusion of all 
sequences in the library.  Although digestion introduces a bias in to the DNA cloned, 
compared  to  the  use  of mechanical  shearing,  it  was  the  method  of choice  in  the 
current  study  since  it  produced  higher  molecular  weight  DNA  fragments. 
Furthermore,  the cloning of sticky-ended  DNA  molecules  is more efficient than  the 
cloning  of  blunt-end  fragments  (which  would  be  produced  following  mechanical 
shearing) (Maniatis.  1989).
Pulsed  field  gel  electrophoresis  (PFGE)  is  commonly  used  to  isolate  large  DNA 
fragments  for  use  in  cloning  thus  maximising  the  efficiency  of the  BAC  system 
(Strong  et  al.,  1997).  The  DNA  is  subsequently  removed  from  the  gel  through  the 
digestion of the agarose matrix by  DNase-free agarase. or by electroelution whereby 
the  DNA-containing  gel  slice  is  placed  in  dialysis  tubing  and  a  current  applied  to 
cause  the  DNA  to  migrate  into  solution  (Osoegawa  et  al..  1998).  Both  methods 
prevent unnecessary shearing of the  DNA. although electroelution is markedly  more 
efficient than agarose digestion (Strong et al.,  1997). No size selection of inserts was 
performed  in  this  study  due  to  the  low  efficiency  of gel  extraction  and  the  finite 
amount  of DNA  available.  It  also  prevents  the  introduction  of another bias  into  the 
cloning  process,  therefore  the  insert  sizes  reported  here  are  not  the  maximum 
permitted  in  BAC  vectors  (Shizuya  et  al.,  1992).  This  study  is  concerned  with 
screening the  library  for functional  antibiotic  resistance  genes,  therefore,  although a
195greater  number  of clones  would  need  to  be  screened  in  order  to  represent  a  good 
coverage of the microbiota, plating is not especially time consuming.
4.4.2 Blast Analysis
For the Blast analysis of the BAC end-sequences the cut-off of <1 e 15 was used. This 
figure was chosen as it is the most accurate cut off value used in previous studies of 
this  kind  (Treusch  et  al.,  2004).  Blast  analysis  revealed  that  the  libraries  obtained 
from the oral sample contain a considerable amount of human DNA (61.0 %). This is 
not  surprising  as  no  effort  was  made  to  remove  eukaryotic  cells.  The  presence  of 
human DNA further increases the number of clones that need to be screened to give 
an adequate coverage of the microbial  metagenome.  However, as discussed above  if 
using  a  functional  screen  it  is  not a problem  since only  those  clones containing the 
viable  pathway  or  conferring  the  desired  phenotype,  such  as  antibiotic  resistance 
would  survive  on  selective  media.  Clones  should,  however,  be  analysed  further  to 
ensure  the  insert  is  of bacterial  origin  since  Diaz-Torres  et  al.,  (2006)  found  that 
some  human  DNA  sequences  can  confer resistance  to  tetracycline  via an  unknown 
mechanism(s).
4.4.3 Putative Origins of Bacterial Inserts in the BAC Libraries.
The  Blastx  analysis  of the  BAC  end-sequences  gives  an  indication  of the  closest 
matches to the sequences obtained (Altschul  et al.,  1990).  Of the proteins  identified 
few  are  phylogenetic  markers,  and  previous  studies  have  shown  that  protein 
encoding  sequences  are  as  predictive  of genera  as  rRNA  sequences  in  57-96%  of 
genes (Nesbo et al.,  2005). Therefore the results are more indicative than definitive.
1964.4.3.1  Oral Library
The  BAC  clones  containing  bacterial  inserts  sequenced  from  the  oral  library  show 
that  the  three  most  commonly  matched  genera,  in  homology  searches,  was 
Bacteroides  followed  by  Haemophilus  and  Streptococcus  (Table  4.3).  This  is  in 
agreement  with  previous  studies  which  have  demonstrated  the  presence  of  these 
genera  in  the  healthy  oral  cavity  (Marsh,  1999,  2003;  Tanner et al.,  2000;  Paster et 
al.,  2001).  In comparison,  streptococci  predominated  in the culture study due to the 
fact that  Bacteroides  spp.  are  anaerobic.  Furthermore,  DNA  from  anaerobes  makes 
up 72.2 % (74.8 % of faecal; 67.2 % of oral) of the DNA sequenced, thus indicating 
the  libraries  are  representative  of  the  organisms  missed  since  the  current  culture 
study did not include obligate anaerobes.
This study has also found clones that can encode proteins homologous to those from 
bacteria  not  usually  found  in  the  oral  cavity  such  as  Moorella  (at  up  to  e-84), 
Sulfurospirillium  (e-60),  and  Thermosynechococcus  (e-34).  Moorella  species  are 
anaerobes  most  commonly  isolated  from  soil  samples  (Drake  &  Daniel,  2004). 
Sulfurospirillium  are  anaerobic,  halorespiring  bacteria  associated  with  hot  springs 
(Kamekura  et  al.,  1998),  and  Thermosynechococci  are  unicellular  cyanobacteria 
which  have  been  found  in  soils  and  lake  sediments  (Kucho  et  al.,  2004).  Their 
presence  here  as  sequences  with  a  high  similarity  to  those  in  the  databases  (hits  of 
< 1  e 15),  prove  that  it  is  possible  to  clone  DNA  originating  from  species  which  are 
likely to be transient in the oral  cavity.  It also suggests that there is a possibility that 
the DNA  from these transient organisms is capable of persisting in this environment 
for  a  period  sufficient  for  transforming  competent  oral  bacteria  such  as  the
197streptococci and Neisseria (Stone & Kwaik,  1999; Soloman & Grosmann,  1996).  An 
alternative explanation for the isolation of DNA showing homology to these bacteria 
is that there are members of this genus present in the oral cavity which are yet to be 
identified and characterised.
Other  interesting  matches  from  the  oral  BAC  clones  include Phytoplasma which  is 
the  etiological  agent  of a  number  of plant  diseases  (Christensen  et  al.,  2005).  It 
resides on the phloem sieve plates of plants, thus if a diseased plant was ingested the 
mechanical  grinding of the stems by teeth would release the bacterium into the oral 
cavity.  DNA related to that from Mycoplasma spp. was also found in the oral library. 
These  are  ubiquitous  in  nature  and  could  similarly  be  ingested  on  plant  matter 
(Rottem, 2003).
4.4.3.2  Faecal Library
DNA  with  homology  to  organisms  previously  reported  in  the  human  faecal 
microbiota  are  most  commonly  observed  (Table  4.4),  with  mostly  bacterial  DNA 
being  cloned.  Clostridium  spp.,  Bacteroides  spp..  and  Campylobacter  spp..  These 
have been reported to constitute up to 95% of the cultivable flora using a  16S rRNA 
gene  amplification  study  (Blaut  et  al.,  2002;  Gill  et  al.,  2006)  and  here  represent 
46.5% of sequences  with  homology  to  bacteria,  with respective matches  for each of 
up  to e-99.  e-127.  and  e-99.  In  contrast  to  this  study,  Campylobacter spp.  were  not 
found  in  the  metagenomic  library  representing  the  healthy  gut  in  the  Manichanh 
study (2006), but the other two genera were predominant.
198In contrast to the current culture  study on the same samples (Chapter 3), the  inserts 
were  predominated  by  sequences  with  homology  to  obligately  anaerobic  genera 
{Clostridium  spp.,  Bacteroides  spp.  Treponema  spp..  Bifidobacterium  spp.,  and 
Butyrivibrio  spp.  amongst  others),  demonstrating  the  ability  of the  metagenomic 
approach to investigate a representative spectrum of the microbiota.  Previous studies 
have  reported  these  genera to  be  normal  constituents  of the  microbiota  (Gill  et  al.. 
2006;  Blaut  et  al.,  2002),  however,  Manichanh  et al.,  (2006)  did  not  report  these 
other  genera  in  the  metagenomic  library  constructed  from  faecal  samples  from  a 
healthy volunteer.
In  addition  to  the  above  genera,  the  current  study  also  identified  Lactobacillus  and 
Bifidobacterium,  which  are  considered  commensal  and  are  also  taken  as  probiotics 
(Fooks  &  Gibson,  2002),  and  Enterococcus,  Bacillus,  Staphylococcus,  and 
Salmonella,  all  of which are represented above the  lei 5  cut-off level.  They have all 
been previously reported in the faecal microbiota (Blaut et al.,  2002).
In this study only Lactobacillus spp. and Staphylococcus spp. were cultured from the 
same sample.
As  with  the  oral  library  some  matches  were  unexpected.  Genera  more  commonly 
associated  with  the  oral  cavity  were  reported  {Treponema,  Actinobacillus)  (Marsh, 
1999. 2003).  Only 29/500 oral species have been reported in faecal  samples (Moore. 
1994),  however,  it  is possible that  DNA may persist through the GI  tract which may 
then  have  the  potential  to  be  cloned.  Furthermore,  some  genera  were  found  which 
have not previously  been reported  in the  faecal  microbiota.  Geobacillus,  an aerobic, 
motile  Gram  positive  rod  (Nazina  et  al.,  2001),  Caldicellulosiruptor  (Huang  et  al., 
1998),  an  anaerobic  Gram  negative  rod,  and  Alkaliphilus  are  all  more  commonly
199associated  with  soils  and  sediments  (Takai  et  al..  2005).  Xanthomonas,  known  to 
cause Black rot in plants (Qian et al..  2005) may be part of the transient microflora.  It 
is  possible  that  these  organisms  have  entered  the  GI  tract  via  the  consumption  of 
plant matter .(which may harbour residual soil particles).  However, it is also possible 
that these species are residents of the faecal microbiota and have yet to be cultivated.
4.4.3.3  Sequences With No Homology to Sequences in the Databases
Of  the  non-human  sequences  identified,  in  the  oral  cavity  56.8%  of clones,  and 
60.7%  of  faecal  sequences  showed  no  significant  similarity  to  anything  in  the 
databases.  These  Figures  roughly  reflect  the  predicted  proportions  of  uncultured 
organisms  present  in  each  environment  (Kazor et al.,  2003;  Suau et  al.,  1999).  and 
further  serves  to  indicate  the  libraries  to  be  representative  of  the  predicted 
communities.  In  comparison,  the  diversity  study  by  Gill  et  al.,  (2006)  using  16S 
rDNA  libraries and  shotgun sequence assemblies containing  16S rRNA genes found 
only 23 % of sequences were novel.  However, this discrepancy may be due to biases 
they  identified  in  faecal  lysis and  DNA extraction methods they used,  in addition to 
primer  biases  (Gill  et  al.,  2006).  It  is  likely  that,  as  more  completed  bacterial 
genomes  and  environmental  metagenomes  are  submitted  to  the  databases,  the 
proportion of data show ing no homology will reduce.
4.4.4  Protein Homologies
The  potential  functions  encoded  by  the  end-sequences  were  determined  by  Blastx 
analysis  (Altschul  et  al.,  1990).  Within  each  library  genes  encoding  functions  of
200information  storage  and  processing;  cellular  processes  and  signalling;  metabolism; 
and gene transfer were found.
Of particular  interest  to  this  study  is  the  homology  of six  clones  to  TnpV  from  C. 
coli.  Further sequencing would determine  if the tnpV gene  is contained on a mobile 
element  and  if this  element  has  spread  to  other  species  in  the  faecal  metagenome. 
The  tnpV  gene  resides  on  the  integrative  mobile  elements  Tn445I/Tn4453  which 
harbour the catP gene for chloramphenicol resistance (Lyras et al.,  2004), it has also 
been  associated  with  tet(O)  (Scott,  2002)  thus  by  sequencing  out  into  the  flanking 
DNA it can be determined which species in the faecal microbiota potentially harbour 
these resistance determinants.
The  end-sequencing  approach  has  not  yielded  complete  genes,  therefore  the 
relationships  illustrated  in  the  cladogram  may  not  be  representative  of the  entire 
protein.  All  of  the  BAC  TnpV  sequences  are  distantly  related  to  those  in  the 
databases  suggesting  that,  if originally  transferred  as  a  functional  module  from  a 
mobile  element,  this  happened  many  years  ago  and  the  sequences  have  since 
diverged.  Further  work  on  these  clones  should  include  further  sequencing  into  the 
insert  to  determine  the  full  sequence  of each  tnpV.  The  phylogenetic  relationship 
between the  published tnpV sequences and  the  BAC  tnpV sequences should then  be 
repeated.  Sequencing of the  insert  would  also  establish  if these  genes are  contained 
on  a  mobile  element  and  also  if  they  are  linked  to  an  antibiotic  resistance 
determinant.
One limitation of analysis of sequences from a metagenome is the large number that 
show  homology  to  ‘hypothetical'  proteins.  Without  further  investigation,  no
201supplementary  information  can  be  gained  on  the  function  of  these  sequences; 
however, they are  useful  in this study as they offer an idea of diversity.  The number 
of such  sequences  is  likely  to  decrease  in  the  future  due  to  expanding  databases. 
Furthermore,  functional  screens of libraries, such as that performed in Chapter 5, are 
likely to contribute to this reduction by assigning functions to hypothetical genes.
4.4.5  Limitations
This  study  uses  closest  matches  to  determine  if  the  libraries  represent  the  total 
microbiota.  If a  description  of species  present  is  all  that  is  required  there  are  more 
efficient  and  accurate  methods  (Table  1.11)  such as the  use  of 16S  rRNA  libraries. 
Metagenomic  libraries  have  been  used  in  this  study  because  further analysis  of the 
antibiotic resistance gene of each microbiota is desired (Chapters 5 and 6).
2024.5 Conclusion
The current study has optimised the methods used to construct metagenomic libraries 
from  oral  and  faecal  samples;  it  has  demonstrated  that  it  is  possible  to  construct 
metagenomic  libraries  of  samples  from  these  two  environments  containing  DNA 
from  representatives  of  all  the  genera  commonly  found  in  the  microbiota.  These 
libraries  can  then  be  exploited  to  gain  information  on  both  the  phylogeny  of the 
microbiota and also through  functional  screening to uncover rare or novel metabolic 
and biochemical processes such as antibiotic resistance.
203CHAPTER FIVE
Investigating the Tetracycline and Erythromycin Resistance 
Determinants in the Oral and Faecal Microbiota of Six European
Countries.
2045.1  Introduction:
Culture  independent  techniques  have  allowed  the  presence  of antibiotic  resistance 
genes in different environments to be monitored using arrays (Frye et al.,  2006) and 
functional  screens  followed  by  the  PCR  of  resistant  clones  to  identify  resistance 
determinants  (Handelsman,  2004).  Diaz-Torres et al.,  (2006)  recently  described  the 
oral  tetracycline  ‘resistome'  using  the  latter  method,  and  found  a  predominance  of 
/e/(M), tet(O) and tet(Q)  in healthy adults.  The use of libraries also allows access to 
previously  unsequenced  DNA.  and  provides  evidence  of  the  in  situ  activities  of 
bacteria  within  the  microbiota  (Handelsman,  2004;  Riesenfeld  et al.,  2004;  Beja  et 
al.,  2000a).
In the current study  a macroarray  of known tetracycline and erythromycin resistance 
determinants  and  the  integrase  genes of some mobile elements  is used to determine 
the  relative  abundance  of each  in  the  total  DNA  extracted  from  the  faecal  and  oral 
microbiota of six European countries. The results are then compared to the incidence 
of  the  same  genes  in  the  cultivable  portion  of  each  microbiota,  and  the  genes 
recovered  by  the  cloning  and  screening  of BAC  metagenomic  libraries  constructed 
from  the  total  DNA  from  each  environment.  This  allows  the  identification  of any 
discrepancies  each  method  introduces  in  the  recorded  levels  of each  determinant 
compared  to the results gained  from  the array  of total  DNA  extracted.  Furthermore, 
the screening of the  BAC  libraries allows the potential discovery of novel  resistance 
genes.  This  strategy  is  gaining  popularity  as  a  method  for  uncovering  novel 
biochemical  pathways  (and  antibiotic  resistance  determinants)  from  microbial 
metagenomes (Riesenfeld et al., 2004; Diaz-Torres et al., 2004)
205This part of the study also investigates the cloning and expression of tet{S) in E.  coli, 
to determine if it is expressed in the BAC host.
2065.2 Materials and Methods
All methods used in this part of the study are outlined in Chapter two.
2075.3  Results:
5.3.1  Macroarray of Total DNA Extracted from Each Sample
The total DNA extracted from each sample set from each country was analysed using 
the  macroarray  to  determine  which  genes  were  present  and  which  were  the  most 
common  tet  and  erm  genes  in  the  microbiota  of each  environment  (tables  5.1  and 
5.2).
Spot  intensity  for  all  of the  saliva  samples  was  low  relative  to  those  of the  faecal 
samples (Figure 5.1).  Faecal tet genes accounted for up to 6.9 % of the hybridisation 
intensity of the  16S rDNA control compared to oral tet genes in which the maximum 
intensity is 0.9 % of the control (for calculation see Chapter 2).
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Figure  5.1:  Comparison  of  the  spot  intensities  for  English  faecal  (A)  and 
Scottish  oral  (b)  total  DNA  hybridisations.  Illustrating the different concentration 
so  f bacterial  DNA  in  each  sample.  N.B  the  English  oral  array  is  not  shown  since 
only tet{M) was detectable and comparisons between the different intensities is better 
illustrated with more genes. The macroarray layout is shown in Figure 2.3.
209Hybridisation 
Intensityab teKQ) tetip) tet( B) /c7((i) tet( 30) M W   ... JVC
England 0.13+0.06 JV NDd ND ND ND ND ND
Scotland 0.48+0.06 JV ND ND 0.2+0.04 0.1+0.04 0.15+0.03 W
Italy JV 0.35+0.06 ND ND ND ND ND W
Norway 0.38+0.05 JV 0.1+0.0 0.15+0.03 ND 0.1+0.04 ND W
France 0.43+0.03 ND ND ND ND ND ND W
Finland 0.93+0.1 0.38+0.09 JV ND ND JV ND W. D, Z, 32
A
Hybridisation 
intensity “•b erm(B) erm(F) erm(V) erm(E) erm(C) erm(G) erm(X) Tn9I6 int
England ND ND ND ND ND ND ND 1.05+0.34
Scotland 0.45+0.09 ND 0.5+0.04 0.23+0.06 0.33+0.06 0.23+0.03 ND 0.63+0.05
Italy 0.43+0.05 1.63+0.28 0.53+0.08 0.48+0.14 ND ND 0.7+0.06 0.33+0.06
Norway 0.38+0.05 JV 0.33+0.03 0.43+0.06 0.35+0.03 JV ND 0.83+0.03
France 0.28+0.05 JV 0.25+0.03 JV JV ND JV 0.83+0.05
Finland 0.58+0.08 0.65+0.03 0.4+0.06 0.18+0.05 JV ND JV 0.83+0.05
B
Table 5.1. Abundances of: a) tet; and b) erm genes detected by the macroarray in human saliva.
“Abundance is expressed as a percentage of the hybridisation intensity of the 16S rDNA control as determined by the AIDA Metrix alignment software, 
intensities for each gene were are average of quadruplicate spots from which the standard error of the mean has been calculated. 
cGenes that were k Just Visible' (JV) were clearly visible by eye but intensities could not be calculated due to a high background. 
d  Genes that were not detected are labelled ND.
210Hybridisation 
Intensity *'b teti W) tet{0) tetiQ) tet( 32) te m teti B) tet(X) tet(  A) teKT) tet(30)
England 3.13+0.06 1.73±0.03 0.5+0.0 0.38+0.03 0.2+0.0 NDd ND 0.13±0.03 0.15±0.05 JVC
Scotland 2.08±0.03 2.0+0.04 0.53+0.03 0.2+0.04 0.1 ±0.0 ND ND ND ND ND
Italy 6.9±0.85 2.93±0.39 1.93+0.4 JV ND ND 1.4±0.7 ND ND ND
Norway 2.08+0.3 1.93+0.06 0.35+0.03 0.28±0.03 ND ND ND ND JV ND
France 3.05+0.06 2.25±0.06 1.28+0.03 0.58±0.03 0.1±0.0 0.2±0.0 2.13±0.05 JV ND ND
Finland 3.2±0.04 3.3+0.07 0.6±0.0 0.53+0.03 ND ND ND ND ND ND
A
Hybridisation
Intensity8’1 5 erm( B) erm( F) erm(G) erm(V) erm(E) erm(X)
Recomb inase 
ofTn4451
Integrase of 
Tn 1549
England 0.4±0.0 0.35±0.03 ND 0.58±0.08 0.43±0.05 ND 0.83+0.03 0.2+0.0
Scotland 0.25±0.03 0.3±0.03 0.5±0.0 0.1±0.0 JV ND 0.3+0.0 JV
Italy 2.93±0.72 JV ND JV JV ND JV ND
Norway 0.65±0.05 0.1±0.0 0.3±0.04 0.1±0.0 JV ND 0.2+0.0 JV
France 2.9±0.05 1.55±0.09 0.38±0.03 0.28±0.03 0.28±0.03 0.1+0.0 0.35+0.03 0.08+0.03
Finland 0.63±0.03 0.55±0.03 ND 0.15±0.03 0.1±0.04 ND 0.18+0.03 0.28+0.03
B
Table 5.2. Abundances of: a) tet; and b) erm genes detected by the macroarray in human faeces.
aAbundance is expressed as a percentage of the hybridisation intensity of the  16S rDNA control as determined by the AIDA Metrix alignment software. 
bRelative intensities for each gene were are average of quadruplicate spots from which the standard error of the mean has been calculated. 
cGenes that were ‘Just Visible’ (JV) were clearly visible by eye but intensities could not be calculated due to a high background 
d  Genes that were not detected are labeled ND
2115.3.1.1 Total Oral DNA Hybridisation
5.3.1.1.1  Tetracycline Resistance
tet(M) was the most commonly isolated tetracycline resistance determinant in all oral 
samples  except  that  from  Italy.  Spot  intensity  as  a  percentage  of  the  16S 
hybridisation  ranged  from  0.13  %  in  the  English  sample  to  0.93  %  in  the  Finnish 
sample.
tet(Q)  was  the  most  commonly  identified  tetracycline  resistance  gene  in  the  Italian 
sample (occurring at 0.35 % of the  16S spot intensity, compared to tet(M) which was 
just visible).  It  was  present  in  all  other samples  except that  from  France,  however, 
spot intensities were low relative to tet(M), in most cases they were just visible.
All samples except the English harboured tet(W). Other tetracycline resistance genes 
present  in  more  than  one  sample  were  tet(30)  (Scottish,  Norwegian  and  Finnish 
samples); and tet(0) (Norwegian and Finnish samples).
5.3.1.1.2 Erythromycin Resistance
erm  genes  were  detected  in  all  samples  except  that  from  England.  erm(B),  erm(E) 
and erm(V) were present in all other samples.
erm(W)  was the most common gene  in the  Scottish and  Italian samples occurring at 
0.5 % and 0.53 % of the relevant  16S spot intensities respectively.
erm(B)  was  the  predominant  erm  gene  in  the  French  sample  (0.28  %  of the  16S 
hybridisation);  erm(E)  was  the  most  common  erm  gene  in  the  Norwegian  sample
212(0.43  %  of the  16S  hybridisation),  and  erm(F)  the  most  common  in  the  Finnish 
sample at 0.65 % of the  16S spot intensity for that sample.
5.3.1.1.3  Integrase Genes
All oral samples contained the integrase gene, int, from Tn916.  It was most abundant 
in the English sample (1.05 % of the  16S intensity), and least abundant in the Italian 
sample (0.33 %).
5.3.1.2  Total Faecal DNA hybridisation
5.3.1.2.1  Tetracycline Resistance
tet(W) was the most abundant gene in all samples except the Finnish in which in was 
tet(O), at 3.3 % of spot intensity of the  16S control, compared to 3.2 % for the tet(W) 
probe.
The Italian sample has the greatest percentage hybridisation to the tetracycline  gene 
(te/(W)) compared to the  16S rRNA control (spot intensity at 6.9 % of its  16S).
tet{O) featured in all  sample sets as the second most common tetracycline resistance 
determinant  (except  for  Finland,  see  above).  Percentages  of  16S  hybridisation 
intensity ranged from  1.73 % (England) - 2.93 % (Italy).
tet(Q) was the third  most common  gene  in all  faecal  samples (with the exception  of 
the  French  sample  in which tet(X)  is the third  most common at  2.13  % of 16S  spot 
intensity).
213tet{32)  occurred  in  all  samples.  However,  it  should  be  noted  that the  tet{32)  probe 
does  not  distinguish  between  complete  tet{32)  genes  and  tet(0)/tet(32)/tet(0) 
hybrids.
No  tet(M)  was  found  in  the  faecal  DNA.  problems  with  the  array  were  ruled  out 
since the arrays are printed  in sets of 16 by the Biorobotics Microgrid II  System and 
the same array set was used for the saliva and faecal DNA hybridisations.
5.3.1.2.2 Erythromycin Resistance
The  most common  erm  gene  differed  from  sample to  sample.  erm{B)  was the most 
common  in  the  French  (2.9  %  of the  16S  hybridisation),  Finnish  (0.63  %),  Italian 
(2.93 %) and Norwegian (0.65 %) samples.
erm(W)  was  the  most  common  erm  gene  in  the  English  sample  occurring  at  a  spot 
intensity of 0.58 % of the  16S hybridisation.
erm(G)  was  the  most  common  erm  gene  in  the  Scottish  sample  (0.5  %  of the  16S 
intensity), but only occurred in two other samples (French and Norwegian).
5.3.1.2.3 Integrase / Recombinase Genes
Of the transposons probed  for the recombinase of Jn4451  was detected  in all  faecal 
samples,  and  the  integrase of Jnl549 was detected  in all  of the samples except that 
from Italy.
The DNA did not hybridise to the probe for int from Tn916.
2145.3.2 Metagenomic BAC Libraries
Twelve metagenomic  BAC  libraries have been constructed (Table 5.3).  Each has an 
average  insert  size  in  the  range of 21  -  35  Kb.  and  each  represents over 44 Gb of 
DNA  from  its  corresponding  microbiota.  The  English  oral  and  faecal  libraries  are 
those previously reported in Chapter 4.
Sample
Origin
Library Mean 
Insert 
Size (Kb)
No. of 
Clones
Equivalent
no.
bacterial
genomes
Total Gb
England
Saliva 30 1.50 x  106 9967.1 44.85
Faecal 24 1.99 x  10” 10 592.4 47.67
Finland
Saliva 21 2.34 x  106 10 941.5 49.24
Faecal 32 1.51 x lO6 10 708.8 48.19
France
Saliva 30 1.54 x 10” 10 243.0 46.09
Faecal 30 2.10x  I06 13 967.2 62.85
Italy
Saliva 27 1.82 x  10” 10 914.0 49.11
Faecal 30 1.73 x  106 11  514.0 51.82
Norway
Saliva 28 1.65 x  10” 10 272.0 46.22
Faecal 28 1.62 x  106 10  100.0 45.45
Scotland
Saliva 35 1.35 x  10” 10 476.0 47.14
Faecal 25 1.78x  10° 9885.0 44.48
Table  5.3:  Metagenomic  BAC  libraries.  Equivalent  number  of bacterial  genomes  is  based  on  an 
average genome size of 4.5 Mb (the average genome size in the databases at the time of calculations).
2155.3.2.1  Screening of the BAC Libraries
The  libraries  were  screened  for  inserts  conferring  tetracycline  resistance.  1100  Mb 
(hnglish).  822  Mb  (Finnish).  113  Mb  (French),  65  Mb  (Norwegian),  and  1320  Mb 
(Scottish) of the oral  libraries were plated onto selective media.
102 Mb (English),  124 Mb (Finnish), 754 Mb (Italian),  1260 Mb (Norwegian) and 53 
Mb (Scottish) of the faecal  libraries were also screened in a similar way.
32 tetracycline  resistant  clones  were  found  when  using a concentration of 10  pg/ml 
tetracycline in the selective media. Twenty three were from oral libraries (7 from the 
English  library;  6  from the  Finnish  library;  2  from  from  French  library;  and  8  from 
the Scottish library);  9 were from faecal  libraries (1  from the English library; 4 from 
the  Italian  library;  3  from  the  Norwegian  library;  and  1   from  the  Scottish  library). 
However,  when  re-grown  from  glycerol  stocks,  only  four  were  found  to  grow  on 
tetracycline.
5.3.2.2 Analysis of Tetracycline Resistant Clones
Tetracycline  resistant  clones  were  analysed  on  the  array.  They  were  probed  with 
/cf(M).  tet(O).  fet(W).  tet(Q).  tet(32)  and  probes  corresponding  to  the  efflux  and 
enzymatic tet genes  in one hybridisation  (tet(A).  tet(B),  tet(C), tet(D), tet(E).  /c7(G). 
/t'/(II).  tet(J).  /c/A(P),  tet(Y),  /e/(Z),  tet(X)  and  tet(30)  but  not /c/(K),  tet{L).  tet(V). 
/c/(31),  tet(33),  tet(35).  /c/(38).  tet(39),  /cr3,  otr{B)  and  otr(C)  which  were  not 
included  in  the  probes),  and  in  a  further  hybridisation  the  remaining  RPP  tet  genes 
(/e/B(P). tet(S). tet(T). tet{W), tet(32) and tet(36) but not tet and otr{A)).
216One  clone  from  the  Scottish  faecal  library,  assigned  SFtetCIO  hybridised  to  the 
tet(M) probe, but not the Tn916 integrase probe.
One  clone,  NFtetCl,  from  the  Norwegian  faecal  library  hybridised  to  the  tet(O) 
probe.
The two other clones, IStetC2 (from the Italian oral library) and FRStetCl 1   (from the 
French oral library) failed to hybridise to any probes on the array.
5.3.2.2.1  SFtetCIO (tet(M) Clone)
A  PCR  reaction  targeting  the  sequence  immediately  flanking  the  tet{M)  gene  in 
Tn916 was performed on the tet{M) containing clone,  SFtetCIO using primers  RT1 
and  RT2  and  RT3  and  RT4  (Figure  5.2).  Both  were  positive  (data  not  shown).  A 
PCR reaction targeting the integrase,  int, gene Tn916 on the SFtetCIO clone gave a 
negative  result.  End-sequencing  (see  Figure  2.1)  determined  the  insert  showed  no 
significant homology to anything in the databases (Appendix 9).
RTl  RT2
dcopaao
242322  21  20  19  18 17  16  15  14  13  6  910  78  xis  int
► 4  ►
RT3  4  Int/xisF  Int/xisR
I  I   I   I   I   |____ |____ |____ |____ |____ |____ |____ |____ |____ I____ |____ I____ |____ |_____
0.0  2.0  4.0  6.0  8.0  10.0  12.0  14.0  16.0  18.0
Figure 5.2:  Schematic of Tn9/6 and  location  of the primers  used  inPCR  reactions.  Small  black 
arrows indicate the primers used to check the flanking sequence of the tet(M) gene (Tn916 schematic 
taken from Flannagan & Clewell, 2004).
2175.3.2.2.2 NFtetCl  (tet(O) Clone)
The tet{O) gene of the NFtetCl  clone was sequenced (Appendix 10) and found to be 
closely  related  to  the  tet(0)  from  Streptococcus  pneumoniae.  Its  support  is 
characterised in Chapter six.
5.3.2.2.3 IStetC2 and  FR StetC ll  (Unknown Determinants)
The tetracycline resistant clones, IStetC2 (which contained an insert of 90.2 Kb) and 
FRStetC 11  containing unknown tetracycline resistance determinants were subcloned 
into pUC19 as described in section 2.10 (Table 5.4).
FRStetCll IStetC2
Average Insert Size 6.8 7.4
Mb Screened 22.37 17.91
Table 5.4: pUC19 subclone libraries of the tetracycline resistant BAC clones FRStetCl 1   and 
IStetC2
These  libraries  were  screened  on  selective agar (8  pg/ml  tetracycline).  No  resistant 
clones  were  identified  from  the  FRStetCll  library.  14  resistant  clones  were 
identified  from  the  IStetC2  library.  One  sub-clone  with  an  insert  of 8.5  Kb  was 
identified  for end-sequencing.  1494 bp sequence was gained  from sequencing using 
the M13F primer and subsequent sequencing reactions (Appendix  11). This sequence 
had  99  %  homology  at  the  DNA  sequence  level  to  the  pRSB107  plasmid  from  an 
uncultured  bacterium,  (accession  number  AJ851089)  bp  55597-57091  encoding 
TnpA,  YbjA  (hypothetical  protein)  and  CatA  (Figure  5.3).  It  also  showed  99  %
218homology  to  pRIOO  from  E.  coli  (Accession  number  AP000342.1)  and  44  other 
sequences  from  Gram  negative  organisms,  including a multidrug resistance locus  in 
Acinetohacter bcmmannii (accession number CT025832.1), a pathogenicity island  in 
Shigella  flexneri  (accession  number  AF326777.3),  and  plasmids  from  Klebsiella 
pneumoniae  (pRMH760,  accession  number  AY123253.3),  Serratia  marcescens 
(pR478.  accession  number  BX664015.1),  and  E.  coli  (pNRI,  accession  number 
DQ364638.1).
The M13R primer and subsequent sequencing reactions into the insert produced 2582 
bp sequence (Appendix  11) which had 98 % homology at the nucleotide level to the 
plasmids R64  from S.  typhimurium (Accession number AP005147).  BlastX searches 
identified  the  region  of R64  cloned  (bp  35612-38194)  as encoding the  hypothetical 
protein  YdfB  and  Mck  which  itself shows  homology  to  VagD  from  the  S.  dublin 
virulence plasmid (Figure 5.3).
All  the  above  plasmids  contain  the  tetracycline  resistance  determinants  tet(A).  In 
addition, pRSB107 and pRIOO also harbour tet(C), tet{D) and /e/(R).
The sub-clone was not fully sequenced due to financial and time constraints.
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pUC19
ybj'A  tnpA -4.4 Kb mck
■G
M13R
pUC19
0 Kb 1  Kb 6 Kb 7 Kb 8 Kb 8.5 Kb
J
99 % homologous at the nucleotide level to: 
pRSB 107 from an uncultured bacterium 
(accession number  AJ851089) 
pRIOO from E.  coli (AP000342.1) 
multidrug resistance locus from Acinetobacter 
sp. (CT025832.1)
Shigella flexneri pathogenicity island 
(AF326777.3)
98 % homologous at the nucleotide level to:
pR64 from Salmonella typhimurium (accession
number AP005147)
p300 from E. coli (AY205565.1)
pAPEC-01  -ColBM from E. coli (DQ381420.1)
Figure 5.3: Schematic of the Blastn and Blastx homology searches for end-sequences of the sub-clone of IStetC2.
Open arrows indicate genes from the first listed blastn match. Small black arrows indicate primers used. Insert produced using Hindll digestion5.3.3 Metagenomic pDL278 Libraries
Since it is known that only -60 % of genes from Gram positive organisms express in 
a  E.  coli  (Rondon  et  al.,  1999),  the  vector  pDL278  (Figure  2.2)  was  employed  to 
construct small insert metagenomic libraries. This vector has been proven to generate 
random,  representative  single  species  gene  banks,  and  is  capable  of  stable 
maintenance in E.  coli,  E. faecalis and various species of streptococci (Dunny et al., 
2001). The vector has a polylinker containing 19 restriction enzyme recognition sites, 
a spectinomycin resistance marker gene and  fragments of DNA up to  10 Kb can be 
cloned (figure 2.2) (Dunny et al.,  1991).
Metagenomic  libraries  of the  English  oral  and  faecal  samples  were  constructed  in 
pDL278.  The  inserts  were  sized  in  E.  coli  hosts,  the  average  insert  size  for  both 
libraries  was -8  Kb.  The oral  library contained 48.4  Mb of insert DNA;  the  faecal 
library  42.3  Mb.  The  vector-insert  ligation  product  was  also  transformed  in  to  S. 
mutans,  the  inserts  sizes were also  -8  Kb,  and -25  Mb of each was screened on  8 
pg/ml tetracycline. No tetracycline resistant clones were found.
5.3.4 Expression of tef(S)
As discussed  above,  not  all  genes express  in  a heterologous host.  Indeed,  Gabor et 
al,  (2004)  estimate  that  only  -40  %  of genes  recovered  by  random  cloning  of a 
microbiota can  be expected to express in E.  coli.  In order to  investigate if tet genes 
expressed  when  cloned  in  E.  coli  a  single  species  BAC  library  was  made  using 
genomic DNA extracted from E. faecium 664:1 HI  known to contain the let(S) gene.
221The  average  insert  size  of the  library  was  29.8  Kb,  38.6  Mb were  screened  on  10 
pg/ml tetracycline, no tetracycline resistant clones were found.
The  library  was  plated  out  (74.4  Mb)  and  colony  blotting  experiments  were 
performed  using a  probe  derived  from  a  PCR  reaction of the  internal  region  of the 
tet(S) gene.  One colony that hybridised strongly to this probe was shown to contain 
the tet{S) gene. The gene was sequenced and found to be identical to the tet{S) from 
Listeria monocytogenes (accession number L09756.1));  99 % similar to tet{S) from 
L.  lactis plasmid pK214 (accession number X92946); and 98 % similar to tet(S) from 
Tn9/6S  (accession  number  AY534326).  However  it  did  not  confer  tetracycline 
resistance in E.  coli (A Roberts et al.,, 2006).
2225.4  Discussion:
5.4.1  Resistance in the Oral Microbial Metagenome
5.4.1.1 Tetracycline resistance
5.4.1.1.1 tet{ M)
The results oi  the macroarray hybridisation of the total metagenomic DNA illustrate 
that tet(M) is the most common tetracycline resistance determinant in the oral cavity. 
This agrees  with  the  study  on  the cultivable  flora (Chapter 3),  and previous  studies 
on  the  distribution  of tet  genes  in  the  oral  cultivable  flora  (Villedieu  et  al.,  2003, 
Lancaster  et  al,  2003:  Lacroix  &  Walker,  1995;  Olsvik  et al,  1994),  and  the  oral 
microbial  metagenome  (Diaz-Torres  et  al,  2006).  tet(M)  is  usually  found  on  the 
Tn916  family  of  conjugative  transposons  (Roberts  et  al.,  2001a,b).  The  Jn916 
integrase  was  found  in  all  the  oral  metagenomes,  suggesting  that  this  is  one  of the 
vehicles of tet(M) dissemination in the oral cavity. Furthermore, Tn916 is commonly 
found in oral bacteria (Mercer et al.. 2001; Bentorcha et al,  1992).
5.4.1.1.2 tet(Q)
tet(Q) was the  second most commonly  detected let gene  in contrast to the results of 
the  culture-based  study  which  identified  tet(O)  as  the  second.  Furthermore,  the 
metagenomic  study  performed  by  Diaz-Torres et al  (2006) also  identified  tet{O)  as 
the  second  most  common  resistance  determinant,  although  tet(Q)  the  third  most 
common.  tet(Q)  has  been  previously  reported  in  various  oral  genera  including 
Bacteroides spp., Porphyromonas spp. and Prevotella spp. (Chung et al,  2002; Sanai 
et  al,  2002),  which  are  anaerobic,  this  could  go  some  way  to  explaining  the 
discrepancy  between the  incidence of tet(Q)  in the total  DNA  and that  found  in  the 
cultivable flora.  The difference between this study and the Diaz-Torres study can be
223explained by sampling and random variation since the number of tet(O) genes found 
in their study was only one more than the tet(Q) genes found.
5.4.1.1.3  tet(0)
tet(O)  was  only  present  in  the  Norwegian  and  Finnish  metagenomes  at  very  low 
levels.  It  was absent  in  all  other oral  samples.  In contrast,  in previous studies it was 
the  second  most  commonly  isolated  tet  gene  using a metagenomic  approach  (Diaz- 
Torres et al.,  2006). As with all genes on the array, the incidence of tet{O) in the oral 
samples  may  appear  reduced  compared  to  previous  studies  as  the  total  DNA 
extracted  includes human  DNA at a high concentration (61.0 %) (Chapter 4), which 
would  dilute the  bacterial  DNA  and  thus  lower the  hybridization  signal.  This could 
also  explain  why  the  hybridisation  intensities  of  the  oral  samples  are  low  in 
comparison to the faecal  samples (The sample of the English faecal library examined 
contained  no  detectable  human  DNA).  This  ‘dilution  effect'  would  mask  genes 
present at low  concentrations in the oral metagenomic DNA.
5.4.1.2  Ery thromycin Resistance
No erm genes were detected in the English oral sample. This is most likely due to the 
high  incidence of human  DNA  in  the  sample masking the presence of genes at  low 
concentrations,  erm  genes  were  found  in  other  samples,  therefore  a  similar  end- 
sequence analysis would  need to be performed to determine if the amount of human 
DNA present in other samples was lower than that in the English sample.  If not, then 
the  incidence  of erm  genes  in  the  English  oral  sample  is  much  lower than  that  for 
other countries.
224The most common erm gene differed between samples.
erm(V) was the most common gene in the Scottish and Italian samples in contrast to 
the culture study  in which it did not feature among the most common genes. erm(V) 
has been  previously  reported  in oral  species (reviewed  in Roberts et al.,  1999b), but 
mobile genetic elements have yet to be characterised that harbour this gene.
erm(B),  erm(E)  and  erm(F)  are  the  most  common  erm  genes  in  the  French, 
Norwegian  and  Finnish  samples,  respectively.  In  the  culture  study  erm(B)  was  the 
most  common,  followed  by  erm{F)  and  erm(E).  Thus  one  determinant  does  not 
predominate, and no obvious difference can be found between the aerobic cultivable 
and total oral  microbiota.  The presence of erm(F) in the common erm genes may be 
in part explained by the fact that it has commonly been found in the same oral isolate 
as tet{Q) (Chung et al.,  2002) which has been identified as the second most common 
tetracycline resistant gene. erm{F) and tet(Q) have been found together in up to 48% 
of oral  B.  forsythus,  P.  ginigivalis  and  P.  intermedia  isolates,  however,  any genetic 
support that links the two has yet to be characterised (Chung et al.,  2002).
5.4.2  Resistance in the Faecal Microbial Metagenome
5.4.2.1  Tetracycline Resistance
5.4.2.1.1 tet( W)
In  the  faecal  metagenome,  tet(W)  was  the  most  common  tet  gene,  occurring  at 
between 2.08 % (Scotland) -  6.90 % (Italy) of the  16S rDNA hybridisation intensity. 
/c?/(W) was only  found  in  2.6 % of the culture  isolates.  Previous studies  have  found 
tet{W)  is  common  among  anaerobic  isolates  (Masco  et  al.,  2006;  Kastner  et  al..
2252006;  Stanton  et  al.,  2004)  which  the  current  culture  study  (Chapter  3)  did  not 
isolate.
5.4.2.1.2 tet(O)
tet(O) is the second most common tet gene in the total faecal DNA and in the culture 
study.  It  is  harboured  by  both  aerobic  and  anaerobic  species.  As  with  the  culture 
study,  its  wide-spread  presence  is  likely  to  be  due  to  it  being  contained  on  mobile 
genetic elements.  Only two of these have been characterised, pTet and pCC31  from 
C. jejuni.  which transfer tet(O) between Campylobacter jejuni strains (Avrain et al., 
2004).  However,  tet(O)  has  also  been  linked  to  mef{A)  in  Streptococci:  in  the  S. 
pyogenes  genome  a  single  260  kb  band  hybridised  with  both  the  tet(O)-  and  the 
we/(A)-specific  probe  in  Southern blot analysis (Giovanetti  et al., 2003),  suggesting 
the presence of tet(O) on an integrative mobile element.
5.4.2.1.3 Other tet Genes
tet(Q)  and  tet(32)  were  also  common  in  the  metagenomic  DNA.  They  are  less 
common among the cultivated  isolates suggesting they are more wide-spread among 
the  uncultivated  /  obligately  anaerobic  species.  Evidence  supporting  this  theory 
includes the fact that tet(Q) is wide-spread among anaerobic Bacteroides spp., (up to 
80 % of isolates  have  been  found  to  harbour it  (Shoemaker et al.,  2001)) which  are 
present  in  large  numbers  in  the  human  colon  (Lepine  et al.,  1993),  and  tet(32)  has 
only  been  found  in  relatively  few  species,  one  of which  is  the  Clostridium-related 
human colonic anaerobe K10 (Melville et al.,  2001).  Furthermore, sequence analysis 
of Bacteroides tet(Q) genes  implicates horizontal  gene transfer in both  its inter- and
226inta-generic spread (Nikolich et a l 1994a). Virtually identical tet(Q) sequences were 
found  in  B. fragalis and B.  thethaiotaomicron (99 % identity) and in B.  fragalis and 
the  distantly  related  Prevotella  ruminocola.  Furthermore,  Shoemaker et  al.,  (2001) 
demonstrated the tet(Q) gene from  10 different Bacteroides spp. and the tet(Q) from 
the conjugative transposon CTnDOT showed between 96-100 % identity, implicating 
the element in its spread.
tet(M) is below the detection  level  of the array for the faecal  metagenomic samples, 
but  is  common  in  the  cultivables.  The  same  is  true  for  the  Tn916  integrase, 
suggesting  that  these  genes  are  more  common  among  the  cultivable  aerobic  / 
facultative anaerobic species of the faecal microbiota which are out numbered 300:1 
by the obligate anaerobes (Blaut et al.,  2002).  Furthermore, the faecal  microbiota is 
thought  to  be  composed  of up  to  80  %  uncultivable  species  (Duncan  et  al.,  1993; 
Hayashi  et  al..  2002:  Suau  et  al.,  1999)  therefore,  the  high  incidence  of tet(M)  and 
Tn916  in  the  cultivable  flora  does  not  mean  that  it  is  as  common  in  the  total 
microbiota.
Interestingly.,  tet(A)  and  tet(B)  have  been  found  in  up  to  51  %  of  tetracycline 
resistant  faecal  E.  coli  strains  (Karami  et  al.,  2006),  but  are  only  detected  at  low' 
levels in the  English and  French  libraries, respectively.  Although it is estimated that 
E.  coli only make up 0.1  % of the total microbiota (Blaut et al.,  2002), tet(A) resides 
on the plasmids pRASl  and pIE420 (Rhodes et al.,  2000) and the transposon Tn 1721 
(Allmeier et al.,  1992). all  of which  have been shown to spread to Salmonella  sp.,  a 
common inhabitant of the colon (Upreti et al.,  2004). tet(B) resides on Tn/0 (Kimura 
et  al.,  1998).  Therefore  the  potential  for  these  genes  to  spread  in  the  faecal 
microbiota is evident.
2275.4.2.2 Erythromycin Resistance
As with the oral  DNA,  erm genes are present at low concentrations compared to  tet 
genes and the most common erm gene differed from country to country.
erm(B)  is  commonly  detected  in  all  samples.  erm(B)  is  a  common  macrolide 
resistance  determinant  among  eneterococci  and  streptococci  which  both  inhabit  the 
human colon (Min et al.,  2003). As with the cultivable isolates, the high incidence of 
erm(B)  is  probably  due  to  its  presence  on  mobile  genetic  elements,  including 
Tn539<S\  a  mobilisable  non-conjugative  element  (Farrow  et  al.,  2001),  and  Tn916- 
like  elements  (Giovanetti  et  al.,  2003).  Furthermore,  the  in vitro  transfer of erm(B) 
from  C.  difficile  to  B.  fibrisolvens  (both  common  components  of  the  faecal 
microbiota  (Blaut  et  al.,  2002)  has  been  demonstrated  (Spigaglia  et  al.,  2005a), 
suggesting it might also occur in the gut. Also common in the metagenome is erm(F) 
which  is  also  maintained  on  mobile  genetic  elements  (Table  1.6).  erm(F)  is 
harboured by the Bacteroides spp.  plasmids pBF4 (Shoemaker et al.,  1985),  pBI136 
(Smith  &  Macrina.  1984)  and  pBFTMIO  (Tally  et  al.,  1982)  and  the  conjugative 
transposon  CTnDOT  (Whittle  et  al.,  2001)  which  are  all  capable  of intra-generic 
transfer.  Since  Bacteroides  spp.  are  major  components  of  the  faecal  microbiota 
(Blaut et al..  2002;  Upreti et al.,  2004) it is possible that the spread of these elements 
is responsible for the high incidence of erm(F).
5.4.2.3 Integrase / Recombinase Genes
The  recombinase  gene of Tn4451  was  commonly  found  in  the  faecal  microbiota of 
all  countries,  and  the  integrase  of  Tn 1549  in  all  but  the  Italian  sample.  Tn4451
228harbours  a  chloramphenicol  resistance  genes  and  is  found  among  Clostridium  spp. 
(Abraham &  Rood.  1987;  Crellin &  Rood,  1998), which goes towards explaining its 
high incidence  in the  faecal  samples since Clostridia are amongst the most common 
species in this environment (Mueller et al.,  2006).
Tn 1549 was  first  isolated  from  an  enterococcal  isolate (Gamier et al.,  2000).  It  is  a 
34  Kb  transposon,  organised  similarly  to  the  Tn916  family  of CTns,  however,  the 
vanB2  operon  replaces  the  tet(M)  gene  in  the  central  region  and  the  conjugation 
region shows differences (Figure  1.10) (Burrus et al., 2002).  It is surprising that the 
Tn 1549  integrase  is  so  common  considering  that  no  Gram  positive  isolates  were 
found to be vancomycin resistant (Chapter 3). However, since tet(W) is harboured on 
the  TnBI230 conjugative  transposon  which  encodes transfer proteins with  up to  67 
%  identity to some encoded  by  Tn 1549 (Melville et al.,  2004) it is possible that the 
probe  cross  hybridised  to  the  tet(W)  support,  especially  since  tet(W )  was  the  most 
common  resistance  determinant  found  in  the  faecal  microbiota.  Also  it  is  possible 
that there  is a common genetic  element  present  in this  metagenome which  is  as  yet 
uncharacterised  as  it  may  not contain  a  readily  selectable  marker.  Further sequence 
information  of  the  two  integrase  genes  would  be  needed  before  this  can  be 
concluded.
5.4.3  Metagenomic Libraries
5.4.3.1  Clone Stability
Having  initially  found  32  tetracycline  resistant  BAG  clones,  only  four  grew  on 
tetracycline  following storage at -70°C  in glycerol  stocks.  It is possible that some of 
these clones contained mobile elements which are highly unstable and were lost over 
the  period  of storage  (approximately  10  weeks).  This  has  been  reported  before  for
229Tn916 (Garwon-Burke et al., 1984), and for Jn4451 (Abraham & Rood,  1987). Since 
all  the  clones  retained  chloramphenicol  resistance,  the  BAC  vector  must  still  be 
contained  in  the  E.  coli  host.  It  is  also  possible  that  BACs  do  not  always  stably 
maintain  inserts  despite  the  presence  of  the  par  operon  (Easter et al.,  1998).
Furthermore,  various  groups  have  reported  a  similar  phenomenon  (Karen  Scott,
personal communication 2005;  Arnfinn Sundsfjord, personal  communication, 2005). 
In  future work this problem could be overcome by immediate sub-cloning to  isolate 
resistance  genes  in  the  absence  of  the  complete  mobile  element,  and  immediate 
plasmid isolation.
In comparison to  the  Diaz-Torres  study (2006)  which  screened -27.78  Mb of insert 
DNA  and  found  58  tetracycline  resistant  clones  (21  contained  known  resistant 
determinants),  the  current  study  screened  5713  Mb  and  found  only  32  tetracycline 
resistant clones. This difference may be explained by the use of different vectors and 
their associated  ability  to  maintain  inserts  stably,  discussed  above.  Furthermore  the 
copy number of BAC is one-two per cell (Shizuya et al,  1992) compared to -700 for 
pUC19. This may influence expression since cloned DNA in pUC will have a higher 
gene dosage, i.e.  more Tet protein would be produced which would exert more of an 
effect on the host cell.  In addition, due to the small insert size in pUC clones, the tet 
genes would be in close proximity to the strong pUC promoters, compared to HMW 
BAC  inserts.  If the promoter on a  BAC  insert does not  function  in the heterologous 
host and the tet gene is located far from the BAC  promoter, the gene may not express
(Rondon et al..  1999; Gabor et al.,  2004).
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The  tet(S)  gene  from  E. faecium  EfcTnl  does  not  express  in  E.  coli.  Previously  it 
was widely  thought that  genes  from  a Gram  positive host would express  in  E.  coli, 
however, this proves that not to be the case.  More studies of this kind are required to 
establish  which  tetracycline  resistance  genes  express  in  E.  coli.  Various  shuttle 
vectors are  now  used  in order to  screen  metagenomic  libraries  in a variety  of hosts. 
These  studies  have  found  different  expression  patterns  depending  on  the  host 
(Martinez  et  al..  2004).  pDL278  is  a  shuttle  vector  capable  of  maintenance  and 
replication  in  a  variety of Gram  negative and  Gram  positive hosts.  English oral  and 
faecal  libraries  were constructed  in this  vector and transformed  into S.  mutans even 
though  -25 -Mb  of each  library  was  screened  no  tetracycline  resistant  clones  were 
found.  However,  this  is  not  surprising  since  the  incidence  of resistant clones  in  the 
BAC library is one per  178.5 Mb. and the insert size in the pDL278 library is -10 kb 
(cf.  25-30  Kb  in  BACs).  Further  screening  of  these  libraries  would  allow  a 
comparison to be made  between the determinants expressed  in a Gram positive host 
and those expressed in E.  coli.
5.4.3.3 Tetracycline Resistant Clones
5.4.3.3.1  SFtetCIO (tet(M) Clone)
End-sequencing of the Scottish faecal clone that hybridised to the tet{M) array probe 
revealed  the  insert  to  be  novel  and  likely  from  a  previously  unsequenced  strain, 
possibly  an  uncultured  bacterium  (end-sequences  showed  no  homology  to  anything 
in the databases), further extending the support range of the tet{M) determinant.  PCR 
analysis  revealed  the  sequences  immediately  flanking  tet(M)  are  from  Tn916, 
suggesting the  /e/(M)  is contained on  at  least a fragment of this element.  However.
231the clone did not hybridise to the Tn916 int probe. teti}A) is maintained on numerous 
mobile  elements,  some  of  which  are  composite  elements  (Table  1.6),  including 
In 5397  which  differs  from  Tn916  in  that  it  has  a  different  integration/excision 
module  and  contains  a  group  II  intron  (Roberts  et  al.,  2001a).  The  evolution  of 
mobile  elements  in  discussed  in  Chapter  1   where  it  is  explained  that  they  can 
exchange  functional  modules  including  integrase genes.  It is possible that  SFtetCIO 
harbours  a  Tn5397  derivative  or  another  unknown  element.  Alternatively,  Tn916 
could  have  been  responsible  for  the  transfer  of tet(M)  to  the  host  strain  and  the 
integrase subsequently lost.  Sub-cloning and sequencing of the insert would allow us 
to determine the genetic  support of this gene.  The sequence of which could then be 
used  to  design  novel  probes  for  the  array  so  that  it's  incidence  in  the  faecal 
metagenome could be determined.
5.4.3.3.2  NFtetCl  (tet(O) Clone)
The other tetracycline resistant clone that hybridised to an array probe was found to 
contain an insert from a Clostridium sp. and to harbour a tet(O) gene showing 98 % 
identity to the tet(O)  from Streptococcus pneumoniae.  tet{O) has been  found  on the 
C. jejuni  plasmids  pTet  and  pCC31,  and  it  has  been  found  to  transfer  rapidly  and 
without antibiotic selection between  C. jejuni strains in the laboratory (Avrain et al., 
2004).  It has also been commonly found  in  Streptococci  where it has been  linked  to 
either  mef(A)  or  erm(A)  (Giovanetti  et  al.,  2003).  To  obtain  information  about  the 
tet(O) support primers were designed  in order to sequence out from the tel(O)  gene. 
The results of these experiments are discussed in Chapter six.
2325.4.3.3.3 IStetC2 and FRStetCll (Unknown Determinants)
Two clones were found to be tetracycline resistant in functional screens, but failed to 
hybridise  to  any  probes  on  the  array.  The  array  does  not  contain  probes  for  all 
tetracycline  resistance  determinants,  so  the  genes  conferring resistance  could  either 
be rare (/e/(K), tet{L), /e/(V), tet(31), tet{33), tet(35), tet{38), tet(39), tet,  tcr3, otr(A), 
o/r(B) and otr(C)) or previously unreported.
End  sequencing  analysis  has  found  the  IStetC2  clone  is  likely  to  originate  from  a 
Salmonella  sp..  IStetC2  had  an  insert of 90.2  Kb,  and  was  sub-cloned  into  pUC19. 
Sequencing  reactions  into  the  insert  were  performed  on  one  tetracycline  resistant 
subclone  using  M l3  primers.  The  insert  of 8.5  KB  was not fully  sequenced  due  to 
time constraints.
The  5'  end  of the  insert  (1496  bp  sequence)  was  found  to  have  99  %  identity  at 
nucleotide  level  to  pRSB107  from  an  uncultured  bacterium  which  contains  tet(D). 
tet(C), tet(A) tet(R).  It also shows 99 % homology to 44 other sequences from Gram 
negative organisms, including a multidrug resistance locus from Acinetobacter sp., a 
pathogenicity island from Shigella sp., and plasmids from Klebsiella sp., Serratia sp.. 
and  Escherichia  sp.,  showing that this  sequence  is common among Gram  negatives 
and potentially transfers as a functional module between mobile genetic elements.
The 3' end of the insert (2640 bp sequence) was found to have 99 % identity to the S. 
typhimurium plasmid R64 which also harbours tet(A), and the E.  coli plasmids p300 
and pAPEC-01-Col  which do  not  harbour a tetracycline  resistance  gene.  It  is  likely 
that the insert is a natural chimera which has evolved through the recombination and 
/ or exchange of functional modules.
233Therefore  it  is  possible  that  IStetC2  contains  tet(A)  or  one  of the  other  tet  genes 
harboured  by  pRSB107  (tet(C),  tet(D)  and  /e/(R)).  If this  is the  case,  the  tet  genes 
were probably missed by the array due to sequence divergence in the region probed. 
This could be confirmed by sequencing the whole insert.  It illustrates the constraints 
of the array in that some genes may not be detected if their sequence differs from that 
of the probe.  Therefore all clones that do not hybridise to probes on the array should 
be  checked  by  PCR  to  determine  their  presence.  The  same  problem  has  been 
encountered'before  when  using  arrays.  Frye  et  al.,  (2006)  found  that  some  tet(A) 
genes were  not detected  from control  strains due to the fact that their sequence was 
divergent  from that  used  to construct the probes on the array.  This finding suggests 
that the  levels  of some  genes,  certainly  tet(A),  in  the  metagenomes  investigated  in 
this study may be higher than suggested by the array results.
However, probes for tet(A), tet(C), tet(D) and tet(R) are used in the array anaylsis of 
the  clones.  Therefore,  another  possibility  is  that  the  natural  chimera  cloned  in 
IStetC2  harbours a novel  tetracycline resistance gene.  To establish the genetic  basis 
for resistance, the entire insert of the subclone should be sequenced.
An  alternative  explanation  for  the  apparent  chimera  is  that  it  is  a  cloning  artefact. 
Sequencing  the  complete  insert  and  looking  for  an  abrupt  change  at  a  Hindlll  site 
would allow its identification.
No  tetracycline  resistant  sub-clones  of  the  FRStetCll  BAC  were  found.  Partial 
digestion  of  the  original  clone  was  performed  in  order  to  create  the  sub-clones 
suggesting the lack of resistant sub-clones is not due to choice of restriction enzyme. 
Further  rounds  of  sub-cloning  would  need  to  be  performed  in  order  to  isolate  a
234tetracycline resistant sub-clone for sequencing. This clone should be fully sequenced 
to determine which tetracycline resistance gene is present.
2355.5 Conclusions
In this part of the study metagenomic analysis has established that culture studies do 
not  reflect  the  levels  of  tetracycline  resistance  genes  in  the  total  microbial 
metagenome of the human oral and faecal microbiota.
The  most  common  tetracycline  resistance  determinants  in  the  oral  microbial 
metagenome  are  tet{M),  tet(Q)  and  tet{30)  (cf.  tet{M),  tet(O)  and  tet(W)  in  the 
culture  study):  and  are  tet(W),  tet{O),  tet(Q)  and  tet(32)  in  the  faecal  microbial 
metagenome (cf. tet(M). tet(O) and tet(Q) in the culture study).
The  most common erythromycin  resistance  genes  in the oral  microbial  metagenome 
are erm(B). erm(V) and erm(E) (cf. erm(B) and erm(F) in the culture study); and are 
£V/m(B).  erm(V) and crm(F)  in the  faecal  microbial metagenome (cf.  erm(B), erm{F) 
and crm{K) in the culture study).
This  suggests  that  some  determinants  are  more  common  among  obligate  anaerobic 
species and/or unculitvables.
Not  all  tetracycline  resistance determinants  express  in  the  E.  coli host (for example 
the tct{S)  gene cloned  from  E. faecium 664:1 HI),  therefore construction of libraries 
in  alternative  hosts  is  required  in  order  to  obtain  a  full  description  of genes  if a 
functional screen is used as the assay for their presence.
Tetracycline  resistant  BAC  clones  have  been  found  that  contain  tet(O)  from  which 
the sequence of the genetic support is described in Chapter six; tet{M) supported on a 
Tn9/6-like  element;  and  two  rare  or novel  tetracycline  resistance determinants,  one 
of which appears to be  supported on a chimearic element.
236CHAPTER SIX
C haracterisation of the te*(0)-Containing BA C Clone Insert
2376.1  Introduction
The tetracycline resistance determinant tet(O) was first isolated from a 
Campylobacter coli strain in  1987 (Sougakoff et al.,  1987), and has since been found 
to have a broad host range (Table  1.4) (reviewed in Roberts, 2005). 
tet(0) encodes a ribosomal protection protein of 638-640 aa (Nikolich et al.,  1992) 
which binds to the  16S ribosomal subunit at the *A site’ causing a conformational 
change in the  16S subunit that prevents the binding of tetracycline (Chapter 1; 
Section  1.1.1.2.2.2). It has varying sequence identity to other RPP genes (Table 6.1)
%  identitiy to tet(O) Reference
tet( M) 76% Wang & Taylor, 
1991
tet( W) 6 8 % Barbosa et al., 
1999
tet{ 0/32/0) 76%
100 % similarity to tet(O) over the first 243 nucleotides 
and 97.7 % identity to tet{O) from nucleotide  1263-1920
Melville et al., 
2001
/e/(0/W /0)
Megasphaera 
elsdenii strain 
7-11
78%
100 % similarity to the tet{O) gene over the first 225 
nucleotides and 99.7 % similarity from nucleotide  1311- 
1920
Stanton & 
Humphrey, 2003
tet( O/W/O)
Megasphaera 
elsdenii strain 
14-14
72.5 %
100 % similarity to tet{O) over the first 243 nucleotides 
and 99.3 % similarity from nucleotide  1635-1920
Stanton & 
Humphrey, 2003
Table 6.1: Sequence similarity of tet(0) to other RPP and mosaic genes.
238tet(O) is commonly cited as one of the most common tetracycline resistance 
determinants in the human microbial metagenome (Diaz-Torres et al., 2006; 
Villedieu et al.. 2003).  In this study it was the second most common tet gene in both 
the oral and faecal aerobic / facultative anaerobic Gram positive cultivable flora 
(Chapter three), and in the total faecal microbial metagenome (Chapter five). It was 
the third most common tet gene in the total oral microbial metagenome.
Its wide-spread distribution suggests it resides on one or more mobile genetic 
elements. The pCC31  plasmid from Campylobacter coli CC31  and pTet from 
Campylobacter jejuni strain 81 -176 both harbour the tet{ O) gene (Batchelor et al., 
2004).  In addition tet(O) has been linked to the tnpV gene (Scott et al.,  2002), and 
the upstream region of the E.  coli tet(0) has  shown homology to the sequences 
upstream of /e/(M) from Tn916. Tn 1545. and in the recently sequenced genomes of 
S.  aureus,  C.  coli and  Ureaplasma urealycum (Wang & Taylor,  1991).
In this part of the study. NFtetCl. the tetracycline resistant BAC clone which 
hybridised to the tet(O) probe on the macroarray is sequenced in full in order to 
determine the genetic support of the tet(Q) gene in this clone.
2396.2 Materials and Methods
All methods used in this part of the study are described in Chapter two.
2406.3  Results
6.3.1  Isolation of the tet(O) gene and the relatedness of the predicted Tet(O) 
protein to that found  in S. pneumoniae.
A tetracycline resistant BAC clone, NFtetCl, was isolated upon functional screening 
of a Norwegian faecal metagenomic library, macroarray analysis showed it to 
harbour a tet(O) gene which was confirmed by PCR (Chapter five). The sequence of 
the isolated /<?/(O) gene was determined. The gene can encode a protein which has 99 
% homology Tet(O) from S. pneumoniae (Table 6.2 and Figure 6.1).
Homologues of BAC/e/(0), based 
on BlastX searches
Accession
number
% Identity % Similarity
tet{0) S. pneumoniae CAA69103.1
98
99
tet{O) S. Pyogenes YP  600745.1
98
tet(O) E. faecalis AAV80411.1
tet(O) C. jejuni ZP_01072284.1
tet(0) Actinobacillus 
pleuropneumoniae
AAY54279.1
tet{O) Megasphaera elsdenii AAR29970.1
tet(0) C. coli YP  063396.1 96 94
Table 6.2: Closest matches to the tet(O) gene from  BAC clone NFtetCl. Homology is at the 
protein level, as determined by BlastX searches.
241S.pneumoniae Tet(O) 
S.pyogenes Tet(O) 
BAC Tet(O)
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV  60 
MKI  INLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV  45 
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV  60
S.pneumoniae Tet(O) 
$ .pyogenes Tet(O) 
BAC Tet(O)
S.pneumoniae Tet(O) 
S.pyogenes Tet(O) 
BAC Tet(O)
S.pneumoniae Tet(O) 
S.pyogenes Tet(O) 
BAC Tet  (O)
S.pneumoniae Tet(O) 
S.pyogenes Tet(O) 
BAC Tet(O)
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TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK  120 
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK  105 
TSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMK  120
I  PTIFFINKIDQEGIDLPMVYQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIM  180 
IPTI  FFINKI  DQEGI  DLPMVYQEMKAKLSSEI  I  VKQKVGQHPHINVTDNDDMEQWDAVIM  165 
I  PT  I  FFINKI  DQEGI  DLPMVYQEMKAKLSSEI  I  VKQKVGQHPHINVTDNDDMEQWDAVIM  180
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS  240 
GNDELLEKYMSGKPFKMSELEQEENRKFQTGTLFPVYHGSAKNNLGIRQLKKGIASKFYS  225 
GNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYS 240 
★  ***********************  *  ★  . * ■   *  ^   **  *  *★  *  *****  *  ★  ******  *  .   *******
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG  300 
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG 285 
STPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIKISEKEKIKITEMCVPTNG  300
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI  360 
ELYSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRKFIENPLPMLQTTIAVKKSEQREI  345 
ELCSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRTFIENPLPMLQTTIAAKKSEQREI  360
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY  420 
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIY  405 
LLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVEAEIKEPTVIY  420
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG  480 
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG  4  65 
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG  4  80
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL  540 
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL  525 
VLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYL  540
HFEIYAPQEYLSRAYHDAPRYCADIVSTQVKNDEVILKGEIPARCIQEYRNDLTYFTNGQ  600 
HFEIYAPQEYLSRAYHDAPRYCADIVSTQVKNDEVILKGEIPARCIQEYRNDLTYFTNGQ 585 
HFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQ  600
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA  639 
GVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA 624
GVCLTELKGYQPATGKLICQPRR------------------- 623
* * * * * * * * * * * * *   * * * * * * * * *
Figure 6.1: Amino Acid Alignment of the NFtetCl  BAC clone tet(O) with closest matches in the 
database (tet(O) from S. pneumoniae (accession number CAA69I03.1) and tet(O) from S. pyogenes 
(accession number YP  600745.1) using the ClustalW program.
2426.3.2 Characterisation of the Genetic Organisation of the tet(O) Support
The entire insert was sequenced which produced 9.3 Kb of sequence information (1.5 
Kb upstream and 5.9 Kb downstream of the tet(O)).
Of 11  open reading frames (ORFs) that were found (Table 6.2; Figure 6.2), six 
(ORFs 3, 5, 6, 7, 9 and  10) have the same direction of transcription as tet(O) gene. 
BlastX searches were performed on these ORFs (Table 6.2).
ORF Length
of
predicted
protein
(aa)
Closest protein match in 
the database
Accession
Number
%
identity
E value
1 51 Hypothetical protein 
from C. difficile
ZP_01229423.1 82 8e-17
2 94 Hypothetical protein 
from C. difficile
ZP_01229424.1 40 le-06
3 56/57 Tn9/(5-like (Orf6) 
protein from E. faecalis / 
Cpp2 from C. jejuni
YP  133685.1 / 
AAR29536.1
68/98 2e-17 / 
2e-27
4 639 Tet(O) from S. 
pneumoniae
CAA69103.1 98 0.0
5 105 TnpV from C. difficile AAF66227.1 42 9e-19
6 80 Hypothetical protein 
from Rickettsia sp.
AAL03447.1 27 1.1
7 436 Rlx-like protein from E. 
faecalis
AAF72355.1 43 4e-89
8 84 MmcQ-like protein from
Mannheimia
succiniciproducens
AAU37184.1 57 le-24
9 197 DNA binding protein 
from Listeria 
monocytogenes
YP013142.1 43 2e-09
10 231 Hypothetical 
transcriptional regulator 
from Streptococcus 
thermophilus
CAC67535.1 29 5e-18
11 414 DNA directed DNA 
polymerase from C. 
thermocellum
ZP00504582 55 2e-131
Table 6.2:  Homologues to the ORFs flanking tet(O) in the BAC clone, NFtetCl.
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Figure 6.2: Genetic organisation of the tet( O) flanking DNA. Arrowed boxes represent the ORFs with proposed direction of transcription shown by the arrow. The 
ORFs are labelled above. The thick black line indicates scale.
2446.3.3  Comparison of TnpV from NFtetCl with those found through end- 
sequencing of BAC isolates
The tet(O) gene was immediately downstream from a gene encoding TnpV. The 
BAC end-sequence analysis of the English faecal library revealed six clones which 
exhibited amino acid sequence homology to the TnpV protein (Chapter four). The 
sequences were aligned (Appendix  12) and the TnpV from NFtetCl  was found to be 
distantly related to those from the end-sequencing approach (Figure 6.3), but closely 
related to the TnpV from S. pyogenes (Figure 6.4).
  [
H
BACTnpVCIone: 0.07170 
SpyogenesTnpV: 0.04734 
Tn4453TnpV: 0.00000 
Tn4451TnpV: 0.00000 
BACTnpVI: 0.01503 
BACTnpV3:  0.01503 
BACTnpV6:0.00982 
CcoliTnpV: 0.05707 
BACTnpV2:0.03237 
BACTnpV4:0.05302 
BACTnpV5:0.00669
Figure 6.3 Cladogram showing the phylogenetic relationship between the translated tnpVgenes
found by  end-sequencing (BACTnpVI-6), known TnpV proteins in the database and the TnpV 
recovered from the tet(O) containing BAC clone (BACTnpVclone).
TnpVBAC
r.en  Tr;p'V
TnpVBAC
A.pyognnen  TnpV
TnpV  BAf'
A .   pyogoner,  TnpV
Figure 6.4: Alignment of TnpV amino acid sequences from S. pyogenes and the TnpV found in the 
tetracycline resistant BAC clone harbouring tet(O) (NFtetC l). The proteins are predicted to be 88 % 
idendical.
MVQSIFEEMGGRYERQGEYILPCLTIPPEKEQSIDLFGRRHLDYLREYRKITYTNLLTSG  60 
MAKS  LFEELGGKYERQGDYLIPCLTVPAEEEQAIGIWGQRHLDYLKQYRKVTYTNLLTSG  60
RLNAYLADIDRQA0EHFERLIEGMKQAQGITECLKEENALEWTGRTNNI  RACAREIVEKE  120 
RLNAYLADIDRQAQEHFERLIEGMKQAQGITECLKEENALEWTGRTNNIRACAREIVEKE  120
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2456.4 Discussion 
6.4.1  Sequence analysis of tet(O) and it’s comparison to other tet(0) genes
The tet(O) gene isolated in this study shows 99% amino acid similarity to that from
S.  pneumoniae, and 98 % amino acid similarity to a number of other tet{O) 
sequences in the database (Table 6.1). The insert does not contain any genes 
commonly used as phylogenetic markers so it is impossible to confidently identify 
the original host. The sequence comparisons from one end of the insert (Figure 6.2) 
suggests the DNA may originate from a Clostridium sp., although previous studies 
have suggested that this end sequencing method of phylogenetic assignment is only 
between 57 - 96 % accurate (Nesbo et al.,  2005). tet(O) has not been previously 
found in Clostridia spp.(M Roberts, 2002). It is possible that the tet{O) transferred 
from S. pneumoniae to a Clostridium sp. on a mobile genetic element. However, it 
may  be more likely that the gene has transferred from (or to) S. pyogenes (98 % 
homology), especially considering the adjacent tnpV is also closely related to the 
tnp I' from S. pyogenes (92 % homology at the protein level).
6.4.2 Evolution of the tet(0) support
Mobile elements have been shown to exchange genes responsible for particular 
functions in modules. This can influence the host range of the element (Burrus et al.,
2002). The genes encoded by the clone insert that are associated with mobile 
elements are discussed below.
In order to obtain the complete sequence of the putative element the library will be 
probed with end sequences obtained from this study to obtain an ordered series of
246clones covering the entire element and would enable phylogenetic markers to be 
discovered leading to the determination of the original host.
Furthermore, a macroarray probe, specific to this region of DNA could then be made 
to determine the extent to which it is spread among the faecal microbiota.
6.4.2.1  tnpV
The tnpV gene is harboured by the mobilisable transposon Tn4451 from C. 
per  fr ingens and Tn4453a and b from C.  difficile. It encodes a protein of unknown 
function (Bannam et al.,  1995). In the clostridal transposons the gene overlaps by 73 
bp with tnpX. which encodes a site-specific recombinase responsible for the precise 
excision of Tn4-L5/-like transposons (Adams et al.,  2002; Lyras & Rood, 2000;
Lyras et al.,  2004). tnpV\\as also been associated with the chloramphenicol 
resistance determinant catP in the absence of the rest of the element (Shultz et al.,
2003).  In NFtetCl  the tnpV gene is immediately downstream of the tet( O) gene, an 
association previously observed by Scott (2002) in a B. fibrisolvens isolate. 
Interestingly, the tet(O) gene in the B. fibrisolvens isolate showed greatest homology 
to the tet(O) from S. pneumoniae, as did the NFtetCl  tet{O) (Table 6.1). Therefore, it 
is possible that the tnpV and tet(O) are transferred as one functional module, and that 
both elements are related to one or more as yet uncharacterised streptococcal 
elements.
Six translated BAC end-sequences (derived from the English faecal library) showed 
homology to TnpV. these sequences were not linked to tet(O) or other tetracycline 
resistance determinants, and were picked up at random. They were found to be 
distantly related to that from NFtetCl, suggesting the genes have diverged from the
247same ancestor over time. This study illustrates that InpVgenes are common and can 
be isolated from different sources, suggesting that they are commonly located on 
mobile elements.
6A.2.2 Cpp2 / Tn9/6-like Protein
Upstream from the tet{O) gene, orf3 encodes a protein with 98 % homology to the 
Cpp2 protein from the C. jejuni plasmid pTet. This plasmid is closely related to the 
C. jejuni plasmid pCC31  and both harbour tet{O). In the plasmids the ccp2 gene is 
located immediately downstream of the tet{O) suggesting that the tet{O) and ccp2 
may be transferred as part of a functional module. The tet(O) gene in the C. jejuni 
plasmids is identical to that from C. jejuni P10952 (Batchelor et al,  2004).
Therefore, since the BAC tet{0)'s closest homologue is tet(O) from S. pneumoniae 
(as in the B. jihrisolvens isolate) it is more likely the tet(O) is transferred with the 
tnpV rather than the cpp2 from pTet.
Although the function of Cpp2 from pTet has yet to be determined, it shows 82 % 
similarity to ORF6 from Tn916 which may be involved in mobility of the element. In 
this study the Cpp2-like protein harboured by the BAC clone shows 68 % similarity 
to the I'n9/6 orf6 suggesting a common ancestor for this protein and a likely function 
in mobility (Flannagan el al..  1994).
6.4.2.3  Rlx-like Protein
Upstream from the tnpV gene, orf? encodes a protein with 43 % similarity to the Rlx- 
like protein from E. faecalis. The protein is probably required for relaxation complex
248formation and plasmid mobilisation by conjugative plasmids (Gamier et al.,  2000).
In E. faecal  is the gene is present on the transposon Tn1549 which harbours the 
vanB2 operon for vancomycin resistance (Gamier et al.,  2000), therefore its presence 
in the BAC insert suggests it has a possible role in the mobilisation and spread of the 
tet{O) gene, and further serves to illustrate the role of the recombination between 
different elements in the evolution of mobile elements.
6.4.2.4  Hypothetical Transcriptional Regulator
Another putative o//identified in the BAC clone which has homology to genes 
associated with MGEs is orflO which has 29 % similarity to the hypothetical 
transcriptional regulator from S.  thermophilus. This gene has been found on various 
insertion sequences including IS 1191  and iso-IS981  (Guedon et al.,  1995), and the 
integrative conjugative element ICEStl  from S.  thermophilus (Burrus et al.,  2000).
2496.5 Conclusions
The tet(O) found in this study by screening metagenomic BAC libraries was found to 
be flanked by a number of genes associated with mobile genetic elements. This 
represents a new' genetic support for tet(O).
It is likely that tet(O) and tnpV are transferred together, and that the rest of the 
support is a mosaic of genes from a number of different commensal and pathogenic 
species. Previous studies have shown the human gut to be conducive for gene 
transfer and the support characterised in this study may be involved in the spread of 
tet(O) throughout this environment.
250C H A P T E R  SE V E N  
F inal D iscussionThe  threat  of antibiotic  resistant  bacteria to  public  health  is  of great concern  to  the 
European  Union  and  other  international  bodies  (Degener,  1999,  McCaig,  1995, 
Hoiby,  2000.  Fish.  1995).  Studies  into the  molecular mechanisms of resistance  and 
their mode  of spread  are considered  essential  in order to  stay one step ahead  of the 
pathogens (Mills,  2006;  Monaghan  &  Barrett,  2006).  Such  investigations,  including 
this study, gamer information on the most prevalent resistance determinants and their 
targets  and  allow  the  effective  use  of  antibiotics  against  certain  bacteria  in  the 
clinical setting (Manfedi, 2005; Sinclaire et al.,  2005).
The  work  in  this  study  has  contributed  to  the  understanding  of the  prevalence  of 
tetracycline and  erythromycin resistant bacteria not only in the cultivable portion of 
the  human  oral  and  faecal  microbiota,  but  also  the  microbial  metagenome  isolated 
from these environments.
The  culture  study  demonstrated  that  tetracycline  and  erythromycin  resistance  is 
wide-spread-among the aerobic cultivable Gram positive flora and identified the most 
common  resistance  determinants  implicated.  The  samples  were  taken  from  healthy 
subjects  who  had  not  received  antibiotics  in  the  previous  three  months.  All  sample 
sets  harboured  tetracycline and  erythromycin resistance determinants suggesting the 
genes  are  stable  to  some  degree.  Resistant  bacteria were  isolated  from  all  countries 
for both samples (saliva and  faecal), however, no significant differences were found 
in  the  incidence  of resistance  between  the  countries  under  investigation.  The  most 
likely explanation for the differences reported is sample variation.
252The  previously  reported  linkage  of tet(M)  and  int  from  Tn916  (Flanagan  et  al., 
1994) was evident from the data obtained from the array, although further analysis of 
individual  isolates would be required to determine if these genes were harboured by 
the same mobile element rather than just being present in the same cell. However, the 
prevalence  of int  illustrates  the  extent  to  which  mobile genetic  elements  are  spread 
among  the  human  microbiota.  Previous  studies  have  shown  that  dental  plaque 
(Marsh, 2005; Roberts et al., 2001a) and biofilms in the human intestine (Licht et al., 
1999) facilitate the exchange of such elements by holding bacteria in close proximity 
to each other.
The  prevalence  of  different  resistance  determinants  generally  agreed  with  other 
studies of this kind (Diaz-Torres et al., 2006;  Lancaster et al.,  2003, 2005;  Villedieu 
et  al.,  2003;  Olsvik.  1995;  Walker  et  al.,  2000;  Karami  et  al.,  2006).  Difference 
could be due to the fact that this study concentrated on Gram positive organisms, and 
strict anaerobes  were  not cultured  due to constraints with  sample transportation  and 
laboratory  equipment.  The  study  would  be  enhanced  by  a complete  analysis  of the 
total  cultivable  flora  to  allow  a  more  accurate  comparison  between  cultivable  and 
total microbiota for each environment.
Of the  tetracycline  resistant  Gram  positive  isolates,  two  streptococci  (SStetl5  and 
FRStetl2) did not hybridise to any probes on the array. The study would benefit from 
an  expansion  of the array  to  include  all  known  tet  genes.  This  would  eliminate  the 
need  to  investigate  the  isolates  further  using  PCR.  This  was  not  possible  in  the 
present  study  due  to  lack  of positive  controls  or  genes  sequence  in  the  database 
(tet(34).  te/(35))  (preventing  the  design  of appropriate  primers).  The  SStetl5  and
253FRStetl2  isolates  need  to  be  sequenced  to  determine  the  gene  responsible  for 
tetracycline resistance which could possibly be novel.
I he  culture  study  also  identified  a  streptococcus  which  hybridised  to  the  tet(32) 
probe, but not the tet(O) probe (isolate FStetl2).  All other isolates that hybridised to 
the  tet{32)  probe  also  hybridised  to  the  tet(O)  probe  suggesting  that  these  isolates 
contain mosaic genes (Stanton & Scott, 2005). The FStetl2 was sub-cloned in both a 
Gram positive and a Gram negative host, however, no resistant colonies were found. 
To investigate the genetic basis of resistance in this isolate colony blots using a probe 
derived from a tet(32) PCR product should be performed. The genetic support of the 
gene  can  then  also  be  determined.  tet(32)  was  first  found  in  a  Clostridium-like 
ruminant,  K10  (Melville  et  al.,  2001)  and  subsequent  studies  have  found  it  in  oral 
Eubacterium  sp.  and Streptococcus sp.  isolates (Lancaster et al.,  2005).  The genetic 
supports  of the  tet(32)  genes  were  found  to  differ  significantly  and  analysis  of the 
support of the FStetl2 tet{32) would give an insight into its origin.
The  study  also  investigated  the  use  of  metagenomic  libraries  to  access  the 
uncultivable portion of the oral and faecal microbiota. It was found that -60 % of the 
saliva libraries consisted of clones harbouring human DNA. No attempt was made to 
remove eukaryotic  DNA  in this study since various eukaryotic organisms have been 
reported  in  the  oral  microbiota.  However,  future  studies  of this  kind  would  benefit 
from  an  attempt to  remove  most of the human contamination.  This would cut down 
the amount of library required to be screened in order to gain a representative picture 
of the tetracycline resistance determinants present. Of the clones that did not harbour
254human DNA, 74.8 % of faecal and 67.2 % of oral clones which showed homology to 
sequences  in  the  database  harboured  DNA  from  anaerobic  species  illustrating  the 
ability of  the  libraries to  include  sequences from organisms not found in the culture 
study.  Furthermore, 60.7 % of faecal and 56.8 % of oral clones showed no significant 
similarity to any sequences in the databases, suggesting that the uncultivated portion 
of the microbiota is represented in each.
A  study  by  Nesbo  et  al.,  (2005)  discovered  that  the  end-sequencing  and  blastX 
homology search approach used here only gives an accurate species identification in 
approximately  76.5  %  of  clones  (ranging  from  57-96  %  depending  on  species). 
Therefore the results are not definitive. This approach masks horizontal gene transfer 
since only short sequences are analysed rather than known phylogenetic markers.  To 
improve  the’accuracy  of clone  analysis,  only  those  clones  containing  phylogenetic 
markers such as  16S rRNA genes should be used.
The  study  would  also  benefit  from  similar  end-sequence  analysis  for  each  library 
constructed. The hybridisation of total metagenomic DNA illustrated the incidence of 
tetracycline  and  erythromycin  resistance  determinants  in  the  total  microbiota, 
however,  in the saliva DNA since ~60 % of DNA was human, the presence of some 
determinants appears to have been masked.  In particular, the English samples shows 
a lack of erm genes, however, the samples from other countries exhibit higher levels 
of carriage.  End-sequencing  analysis  would  allow  us to  determine  if the  incidences 
found  are  truly  representative  or a  result of the  'dilution  effect'  of different  human 
DNA contents  in each  library.  Another way to compare the  incidences of resistance 
between countries would  be to quantify the array.  In this study, genes are given as a 
percentage hybridisation signal of the  16S rDNA control, however, different species
255harbour  different  numbers  of  16S  rRNA  genes  (Schloss  &  Handelsman,  2004).  In 
order to quantify resistance,  a different control could be used such as the sodA  gene 
which  has  been reported to occur only once  in the genomes of most species (Poyart 
et al.,  1995a).
The metagenomic study highlighted the differences between the predominant tet and 
erm  genes  in  the  cultivable  portion  and  total  microbiota.  In  the  oral  microbial 
metagenome  tet{M),  tet(Q)  and  tet{30) are the most common (cf.  tet(M),  tet(O)  and 
tet(W)  in  the  culture  study  and  differing  from  a  similar  study  conducted  by  Diaz- 
Torres et al., (2006) which found te/(M), tet(O) and tet(Q) to predominate). The most 
common tetracycline resistance determinants in the faecal microbial metagenome are 
tet{W). tet(O), tet(Q) and tet(32)  (cf.  tet(M), tet(O) and tet(Q) in the culture  study). 
The  most common  erythromycin  resistance genes  in the oral microbial  metagenome 
are erm(B). erm {\) and erm(E) (cf. erm{B) and erm(F) in the culture study); and are 
erm(B). erm(W) and erm{F)  in the faecal  microbial  metagenome (cf.  erm{B), erm(F) 
and  erm{E)  in  the  culture  study).  These  results  are  important  since  most  previous 
studies  have  only  concentrated  on  cultivable  flora.  If the  results  from  those  studies 
are  used to design clinical  responses to disease, the treatment may prove  ineffective 
if those genes that are predominant in the uncultivable portion of the microbiota are 
not considered.
Screening  of  the  metagenomic  libraries  for  tetracycline  resistance  resulted  in  32 
tetracycline  resistant clones.  Only 4 grew on tetracycline (10 pg/ml) after storage  in 
glycerol  stocks  at  -70  °C.  Discussions  with  other  groups  (K.  Scott  personal 
communication  2005;  A.  Sundesfjord  personal  communication  2005)  revealed
256similar  stability  problems  when  using  the  pCClBAC  vector.  However,  the  loss  of 
tetracycline  resistance  could  also  be  due  to  the  carriage  of the  tet  genes  on  highly 
unstable  mobile  elements.  To  establish  which  it  is,  end  sequencing  of  the  non­
tetracycline  resistant  clones  should  be  performed  to  see  if  any  insert  sequence 
remains.  All  tetracycline  resistant  clones  should  be  immediately  sub-cloned,  and 
plasmids extractions performed to prevent loss of resistance determinants. 
tet{S)  of  E.  faecium  664:1 HI  was  found  not  to  express  in  E.  coli,  thus  not  all 
tetracycline  resistance  genes  can  be  found  using  this  approach.  Therefore,  the 
pDL278 vector (Dunny et al.,  1991) was used to construct small insert metagenomic 
libraries in S.  mutans.  These were screened, but no tetracycline resistant clones were 
found,  however,  calculations  suggest  that  a  greater  amount  of library  needs  to  be 
screened.  This  study  would benefit  from this  since the predominant tet genes  found 
in a Gram negative host could be compared to those found in a Gram positive host. It 
is likely that the genes found would be different demonstrating the need for different 
hosts when using a metagenomic approach.
Of the 4 viable tetracycline resistant BAC clones one hybridised to the tet(M) probe 
on the array,  but not the  int probe (SFtetCIO).  PCR analysis revealed the sequences 
immediately Hanking the tet{M) gene amplified with primers specific for Tn916.  It is 
possible that the element has lost the int gene since transferring into the original host, 
or that it may have acquired a different int gene. The exchange of functional modules 
involved in integration and conjugation can occur between different mobile elements, 
and  this  probably  plays  a  significant  part  in  the  host  specificity  of  the  elements 
(Burrus et al.,  2002;  Frost et al.,  2005;  Osborn & Boltner, 2002).  By sequencing the 
entire  SFtetCIO  insert  it  would  be  possible  to  characterise  the  mobile  element  and
257determine if it harbours an alternative integrase gene. If so, filter mating experiments 
would determine its host range.
The tetracycline resistance clones IStetCl  and FRStetCl 1   did not hybridise to any of 
the  probes  on  the  array.  Both  were  sub-cloned  into  pUC19,  however,  FRStetCll 
failed  to  yield  any  tetracycline  resistant  colonies.  End-sequence  analysis  of 
FRStetCll  revealed  it  to  be  of unknown  origin.  Previous  studies  have  shown  that 
some  human  DNA  encoded  protein  conferred  resistance  on  the  host  through  an 
unknown mechanism (Diaz-Torres et al.,  2006), however, this can be ruled out since 
the  entire  human  genome  is  in  the  database  and  homology  searches  would  have 
revealed  it to  be the  insert.  As with the  streptococcal  isolates  Sstetl5  and  FRStetl2 
this clone could harbour a novel resistance determinant (the tet genes absent from the 
array  would  need to  be checked  by  PCR or sequencing) and would need to be fully 
sequenced in order to characterise the gene.
The  IStetCl  BAC  clone did not hybridise to any probes on the array, however, end- 
sequencing analysis revealed the clone to harbour what is possibly a natural chimera 
of two tetracycline resistance plasmids pRSB107 (accession number AP005147) and 
pR64  (accession  number  AJ851089)  which  both  harbour  tet(A).  Sequence 
divergence  m  the  probe  target  region  could  have  resulted  in  the  tet(A)  probe  not 
hybridising  to  the  clone,  however,  the  tetracycline  resistance  determinant  may  also 
be  novel.  Full  sequencing  of the  IStetCl  insert  would  allow  confirmation  of the 
tetracycline resistance determinant.
The  final  tetracycline  resistant  BAC  clone,  NFtetCl,  hybridised  to  the  tet(O)  probe 
on the array. Sequence analysis found it to be 98 % homologous to the tet{O) from S.
258pneumoniae.  The  entire  BAC  insert  was  sequenced.  Only  two  genetic  supports  of 
tet(O) have been previously characterised: pTet and pCC31  from C. jejuni (Batchelor 
et  al.,  2004).  The  NFtetCl  insert  was  not  homologous  to  either of these  plasmids, 
except  for  the  cpp2  gene  immediately  upstream  of  the  tet{O).  tnpV  was  found 
downstream ol tet(O) (this has been reported before in a B. fibrisolvens isolate (Scott, 
2002)).  and  both  genes  are of streptococcal  origin  suggesting the element cloned  is 
related to streptococcal elements.
It  is  unlikely  that  the  insert  contained  an  entire  mobile  element  since  there  are  no 
genes  present  that  are  involved  in  transfer,  however,  filter-mating  studies  would 
determine if the tet{ O) in NFtetCl  is transferable.
Tetracycline and  erythromycin resistant bacteria are present at relatively high  levels 
in the  human  oral  and  faecal  microbiota.  The  findings in this study further illustrate 
the limitations of the therapeutic use of these antibiotics. Tetracycline is widely used 
in  the  treatment  of  atypical  pneumonia,  cholera,  periodontal  infection,  acne  and 
many  other  genital,  local  and  systemic  infections  (reviewed  in  M  Roberts,  2004). 
Erythromycin  is  used  against  lung  infections,  infections  of  the  throat  and  some 
sexually transmitted infections (reviewed in Goldman & Scaglione, 2004). Therefore 
the  increasing  incidence  of resistance  to  these  drugs  over  the  past  decades  has  a 
major effect on the treatment of the above infections.
The policies  introduced to halt the spread of antibiotic resistance may not be enough 
to  combat  the  problem.  The  carriage  of resistance  determinants  on  mobile  genetic 
elements allows the rapid dissemination of resistance across genera barriers, and this 
study  has  proven  them  to  be  common  in  the  absence  of a  selective  pressure  (all
259samples came  from  individuals that have not received antibiotic therapy in the three 
months prior to sampling).
The  study  also  demonstrates  that  most  investigations  up to now have not described 
the full picture.  Investigations into resistance need to include the uncultivable portion 
of the microbiota.  Studies such as this are essential in order to identify the molecular 
basis  of  resistance,  and  the  mechanisms  of  transfer  of  resistance  genes.  This 
information  can  then  be  used  to  investigate  potential  novel  drug  targets,  and  to 
groom the clinical response appropriately.
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324Appendix 1: Composition of Buffers and Solutions
Buffer, Solution, Medium Per Litre
LB (Luria-Bertani) medium 1.5% Tryptone (Oxoid)
0.5% Yeast extract (Oxoid)
1.0% NaCl
(5.0% Technical Agar 3) (Oxoid)
DNA Extraction Buffer 100 mM Tris-HCL [pH 8.0]
100 mM sodium EDTA [pH 8.0]
100 mM sodium phosphate [pH 8.0] 
1.5 M NaCl 
1% CTAB
50 x TAE 242g Tris base
57.1  ml Glacial acetic Acid
18.6 g EDTA
dH20  to  1L
Hybridisation Solutions: 
Depurination solution 250 mM HC1
Denaturation solution 1.5 M NaCl 
0.5 M NaOH
Neutralization solution 1.5 M NaCl 
0.5 M TrisHCl 
pH adjusted to 7.5
SSC x 20 0.3 M Na3 citrate 
3.0 M NaCl 
pH 7.0
Primary wash buffer 0.4% SDS 
0.5 x SSC 
Urea
325Reduced Transport Fluid (RTF) 
Stock Solution  1 Dibasic potassium phosphate 
Sterile dH20  to
0.6 g
100 ml
MgS04 Stock Solution M gS04
Sterile dH20  to
2.5 g 
100 ml
Stock Solution 2 Potassium Chloride  1.2 g 
Ammonium Sulphate  1.2 g 
Monobasic potassium phosphate  0.6 g 
MgSC> 4  stock solution  1.0 ml 
Sterile dH20   99 ml
Sodium Carbonate Solution Sodium carbonate 
Sterile dH20
0.8 g
10 ml
Preparation for 100 ml: Stock 1   7.5 ml 
Stock 2  7.5 ml 
Sodium carbonate  0.5 ml 
Sterile dH20   80 ml 
Autoclave, once cool add Filter sterilised solution 
of DTT (0.02 g in 5 ml dH20). Solution is stable 
for one week.
All chemicals are from Sigma Aldrich unless otherwise stated.
326Appendix 2:  Profile of Subjects from whom Oral and Faecal Samples 
Taken.
English Volunteers
Number Age Gender
SI 45+ M
S2 45+ M
S3 41-45 M
S4 36-40 F
S5 45+ M
S6 31-35 M
S7 31-35 M
S8 21-25 F
S9 26-30 F
S10 21-25 M
S ll 21-25 M
S12 21-25 F
S13 36-40 F
S14 31-35 F
S15 26-30 F
S16 26-30 M
S17 31-35 M
S18 21-25 F
S19 21-25 F
S20 26-30 M
French Volunteers
Number Age Gender
SI 26-30 M
S2 26-30 M
S3 31-35 M
S4 21-25 F
S5 45+ M
S6 36-40 M
S7 26-30 M
S8 45+ F
S9 36-40 F
S10 21-25 M
S ll 21-25 M
S12 31-35 F
S13 41-45 F
S14 21-25 F
S15 26-30 F
S16 21-25 M
S17 26-30 M
S18 26-30 FS19 31-35 F
S20 26-30 M
Finnish Volunteers
Number Age Gender
SI 45+ M
S2 36-35 F
S3 35-40 F
S4 41-45 F
S5 41-45 F
S6 45+ F
S7 26-30 F
S8 26-30 M
S9 31-35 F
S10 36-40 F
S ll 41-45 F
S12 41-45 F
S13 41-45 F
S14 31-35 F
S15 45+ F
S16 21-25 M
S17 31-35 F
S18 31-35 M
S19 45+ M
S20 45+ F
Italian Volunteers
Number Age Gender
SI 36-40 F
S2 36-40 F
S3 26-30 F
S4 31-35 M
S5 36-40 M
S6 45+ M
S7 31-35 M
S8 26-30 F
S9 36-40 M
S10 26-30 M
S ll 26-30 M
S12 45+ M
S13 26-30 M
S14 26-30 F
S15 26-30 F
S16 21-25 M
328S17 26-30 F
S18 26-30 F
S19 26-30 F
S20 26-30 F
Norwegian Volunteers
Number Age Gender
SI 21-25 F
S2 31-35 F
S3 36-40 F
S4 45+ F
S5 26-30 F
S6 31-35 F
S7 41-45 F
S8 45+ F
S9 31-35 F
S10 36-40 F
Sll 26-30 M
S12 26-30 M
S13 41-45 M
S14 26-30 M
S15 26-30 M
S16 31-35 M
S17 36-40 M
S18 36-40 M
S19 45+ M
S20 41-45 M
Scottish Volunteers
Number Age Gender
SI 21-25 F
S2 21-25 F
S3 26-30 F
S4 26-30 F
S5 26-30 F
S6 31-35 F
S7 36-40 F
S8 36-40 F
S9 45+ F
S10 45+ F
S ll 41-45 F
S12 41-45 F
S13 26-30 M
S14 26-30 MS15 36-40 M
S16 36-40 M
S17 31-35 M
S18 41-40 M
S19 45+ M
S20 45+ M
330Appendix 3: Instructions to Volunteers 
Explanation of why we are taking these samples and what we will do with them
Thank you for agreeing to supply a stool and saliva sample. These will be used as part 
of a European Commission funded study, the major aim of which is to determine what 
type of antibiotic resistance genes are contained within bacteria in the human 
gastrointestinal tract and if these genes are likely to be able to spread to other bacteria. 
As you probably know there has been a recent increase in the levels of antibiotic 
resistant bacteria in our environment and this has consequently hampered our ability 
to treat diseases caused by bacteria. In order to combat this problem we need to have a 
deeper understanding of the mechanisms involved in transfer of these resistance genes 
and to know in what type of bacteria the genes reside. We also need to know if 
antibiotic resistant bacteria are more common in certain parts of Europe.
What will happen to the Sample?
After you have provided the stool and saliva sample a courier will transfer these to the 
Eastman Dental Institute in London. Here the samples will be split into two, with one 
sample being used to determine what type of antibiotic resistant bacteria are capable 
of growing under laboratory conditions. As it is well known that not all bacteria can 
be grown under conditions obtainable in the lab, the other half of the sample will be 
used to isolate DNA from all the bacteria in the sample. By using the techniques of 
genetic manipulation it should be possible to determine what antibiotic resistant genes 
are present in the total sample (both from laboratory-cultivable and non-cultivable).
Once the antibiotic resistance genes have been isolated the mechanisms used for 
transmission of these genes between different bacteria and the transmission of the 
genes between different environments will be determined. The results of this study 
will be published in scientific literature and at scientific meetings.
331Volunteers
1). A total of 20 volunteers must be used -  preferably (but not essentially) the same 
volunteers for both the saliva samples and the stool samples.
2). These should be healthy adults (between 18 and 60 years of age).
3). They may be male or female -  ideally there should be equal numbers of each -  but 
this is not essential. They must NOT all be exclusively male or female.
4). They must NOT have taken antibiotics during the three months prior to sampling.
5). The samples MUST be collected and couriered to the Eastman on the same day.
Faecal Specimen Collection
1). Each volunteer must pass their stool into a disposable paper container (picture). A 
portio of this then needs to be transferred to the faecal sample container (a plastic 
container with a brown lid) while wearing the disposable gloves provided.
2). The sample container is opened and small portions of the stool are transferred to 
the container using the small spatula attached to the lid until the container is a quarter 
full.
3). The quarter-full container is then given to the person responsible for collecting the 
specimens.
4). The person responsible for collecting the specimens must add an equal volume of 
Cary Blair medium -  the container should now be approximately half full. This 
should be done in a microbioloical safety cabinet while wearing disposable gloves.
5). Replace the lid and secure tightly.
6). Ensure the container is wiped clean.
7). Label the samples with the date and time of collection.
8). Place the sample container into the plastic transportation tube ( a plastic tube 
containing absorbant paper). Please note that the base of the faecal sample container is 
slotted into the lid of the transport container to prevent the movement of the sample 
container during transport.
9). Place each of the twenty transport containers into the box supplied by the courier 
(DHL).
10). Courier the samples to the Eastman to arrive before 12am the following day. 
Email the courier reference to the Eastman 1.Sevi 1  le@eastman.uel.ac.uk
Paraffin Wax Stimulated Saliva Collection
1). Each volunteer places a lg piece of paraffin wax into their mouth and chews.
2). At intervals the volunteers leans forward and spits into the sterile saliva collection 
container (avoid dribbling as this will result in sample contamination with bacteria 
present on the lips and chin).
3). After 5 mis have been collected, the lid should be replaced and secured tightly.
4). The container is then wiped clean and given to the person responsible for 
collection of the specimens.
5). The container is opened (in a microbiological safety cabinet) and an equal volume 
of reduced transport fluid should be added (this transport fluid has a limited life-time
332and will be sent to each centre on the Monday of the week in which the samples are to 
be taken).
6). Replace the lid and secure tightly.
7). Ensure that the container is wiped clean.
8). Label the sample with the date and time of collection.
9). Place each sample container into the plastic transportation tube (a plastic tube 
containing absorbant paper). Please note that the base of the saliva sample container is 
slotted into the lid of the transport container to prevent the movement of the sample 
container during transport.
10). Place each of the twenty transport containers into the box supplied by the courier 
(DHL).
11). Courier the samples to the Eastman to arrive before  12am the following day. 
Email the courier reference to the Eastman l.Seville@eastman.ucl.ac.uk
333Appendix 4: Primers used in this study
Primer Name Primer Sequence Reference
16S rRNA gene
27F
357F
1492R
5'-AGA GTT TGA TCM TGG CTC AG-3’ 
5’-CTC CTA CGG GAG GCA GCA G-3’ 
5’-TAC GGY TAC CTT GTT ACG ACT T-3’
Lane,
1996
Tet determinants 
tet{ M)F 
/er(M)R
tet(  0)F 
te/(0)R
5’-GTG GAC AAA GGT AC  A ACG AG-3’ 
5’-CGG TAA AGT TCG TCA CAC AC-3’
5’-A  AC TTA GGC ATT CTG GCT CAC-3’ 
5’-TCC CAC TGT TCC ATA TCG TCA-3’
Ng, 2001 
Ng, 2001 
Ng, 2001
tet{  S)F 
fef(S)R
5’-CAT AGA CAA GCC GTT GAC C-3’ 
5’-ATG TTT TTG GAA CGC CAG AG-3’
Melville 
etal. 2001
tet( 32)F 
tet{  32)R
5’-GAA CCA AGA TGC TGC TCT T-3’ 
5’-CAT AGC CAC GCC CAC ATG AT-3’
Roberts et 
al. 2006
tet(S)F complete 
gene
tet{S)R complete 
gene
5’-ATA AAG AAT CCC TTA TCA AC-3’ 
5’-TTA TAA AGG ATA TCA AGA AC-3’ Aminov,
2001
Universal RPP-F 
Universal RPP-R
5’-GGM CAY RTG GAT TTY WTI GC-3’ 
5’-TCI GMI GGI GTR CTI RCI GGR C-3’
Tn916 
Intxis 1  
Intxisl
5’-CGC CAA AGG ATC CTG TAT ATG-3’ 
5’-GCT GTA GGT TTT ATC AGC TTT TGC-3’
Roberts et 
al.  2001
RT1
RT2
5’-CTC TAT CCT ACA GCG ACA GC-3’ 
5’-ATA TAC GAG TTT GTG CTT GT-3’
Roberts
(thesis)
RT3
RT4
5’-CCT GCT CGG TGT ATT CAA GA-3’ 
5’-TCT TTG CGT CTG GCT CTG TA-3’
Roberts
(thesis)
M13F
M13R
5’-CGC CAG GGT TTT CCC AGT CAC GAC-3’ 
5’-AGC GGA TAA CAA TTT CAC ACA GGA-3’
Invitrogen
pCClBAC-F
pCClBAC-R
5 ’ -GG  ATGTGCTGC AAGGCG  ATT  A AGTTGG-3 ’ 
5’-CTCGTATGTTGTGTGGAATTGTGAGC-3’
Epicentre
334Appendix 5: Antibiotic Working/Stock Concentrations.
Antibiotic
(all Sigma Aldrich)
Solvent 
(100% AnalaR 
BDH diluted 
with dH20)
Stock
Concentration
Working concentration
Tetracycline 50% ethanol 10 mg/ml 2 pg/ml for screening for 
resistant isolates.
10 fig/ml for screening 
BAC clones
Erythromycin 70% ethanol 10 mg/ml 1   pg/ml for screening 
isolates
Vancomycin Sterile distilled 
water
10 mg/ml 8 pg/ml for screening 
isolates
Ampicillin 1M Sodium 
hydroxide
100 mg/ml 50 pg/ml for selection of 
pUC19
Spectinomycin 70% ethanol 1000 mg/ml 50 pg/ml for selection of 
pDL278 in E. coli 
800 pg/ml for selection of 
pDL278 in S. mutans
Chloramphenicol 100% ethanol 12.5 mg/ml 12.5 fig/ml for selection of 
pCClBAC
335Appendices 6, 7 and 8 are on the CDRom provided in the front cover of this 
thesis
Appendix 9: SFtetCIO (tet(M) BAC Clone) End-Sequencing Results
>SFtC10_pCClF_D10 sequence exported from chromatogram file
CGACGTTGTAAAACGACGGCCAGTGNATTGTAATACGACTCACTATAGGGCGAATTCGAG
CTCGGCACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTCTTCCAGGGAAA
GACCGTCTTTGGCAAGCAGCCGTTCCATTTCGTTGAACGCCGCTCAAATTTTCTGTTTGCTC
CGGCCATGGCCGTTTCCGGGTCGATTCCTTTTTTCCTGCACAGGTTGACTACGGAAAACAG
AAGATCCCCCAATTCTTCCGCGACGCGGGGGTCTTCCTCCGGTGCGGAAAGAATTTCCCCG
CATTCCGCGGTTTCTTCCTTCACCTTGTCAAGGGCGCCTTGGGCGTCCGCCCAGTCAAATC
CTACTTTGGCGGCTTTTTTCTGGAGCTTCCATGCCTGGAGCATGGGCGGCAGCCCCTTGCC
TGTTCCATGCAGGTATGGGGTTGTTTCCGCCCCCTTTTCCCGGCGTTTGATCTTGTCCCACT
GAGCTAATACGGCATCCGTCGTGTCCGCCTTGGACTGGGCAAATACATGGGGATGGCGGC
GGACGAGTTTTTCGCTTACTTCCGCAGCCACGTCATTGAAATCGAAACGCCCTGCTTCCTG
GGCAATCTCCGCATGAAAAACCACTTGAAGCAAAACATCGCCCAATTCTTCCCTCAGCTG
CGTCCAGTCATTCCGCTGAATGGTGTCCACGACTTCATAGGCTTCCTCAATCATATTGGAA
ATCAGGGAATGGTGGGTTTGTTCCGCGTCCCAGGGGCAGCCGTGGGGGGCGCGCAGACGT
TTNATGATGGCGATGAGGCGCTGCATTTGAAGGGCAGGCTCGCGGCATTCGATCATTTCA
GTGTCGTTCATGACNGAGCCATACTAATCGCGCA
>SFtC10_PCCIR  E 10 SEQUENCE EXPORTED FROM CHROMATOGRAM FILE
GTGAGACTATAGAATACTCAAGCTTTACAAGGGTAACGTCATGTACGCCGGACGCCGTTC
CCCTCAGTCCCTGTATTCCGAAGAAATCGCCACGATGGAAGGCGGCCACGAGGAACTGTA
CAACCAGAACGACGCGGAAGGGTTCATCCACCTCAACGGATTGCGCCTGAAGCAATTCAG
CCGCGTCAATAAACCCTACGGCAATTAAGCGCCCGTAACGGAGCCGCTCTTTATCAAACC
GTCCGGAAAAGGTATTCCGGACGGTTTTTTCTTTGCAATAACCTTTTCCTTTCCTGCGTAGT
AACCGTTATGGGATTTCTTTCATACGCATTTCTGGCGGCTGCATTTTCGCTTTCCCCGTTTT
TGGCATCCGCCACGGCCTTCAAACCCAATATCATTTTTATTTATGCGGATGACCTGGGCAT
GGGCATGCTGGGCTGCTATGGCCAGAAAATCGTGAAAACACCCAATATCGACCGCCTGGC
CAGCCAGGGCATCATGTTCACCCGGTGCTACAGCAGCCAATATTGCTGCCCGGCGCGCGC
TTCCCTGCTTATGGGCGTGCACGACAGCCACTCCCATTCCTACACCCAGACAGCGGGAGCC
CTGGTCATCACGGCGGAACGGGAAGGCTGGTCCAATGAGCAACTGGAAGAGAGAGCGGC
ACGGGCAGCACGCATCAAGGCCGCCGAGGGAGAAGTGTTCCTCCCGGAATTGCTGAAAA
AGGCCGGATACGTCACGGGACAGTTCGGCAAGCTGGAATGGGGATTCACCACCTGGCACG
GAGAATTGAAAAAGACACGGCTGGGACCGCTATGTAGGGTACATG
336Appendix 10: NFtetCl (tet(O) BAC Clone) Insert Sequence
>N F C lT etO _M 134 8R _C 07  L S E .0 .1 1
AGCTATTTAGGTGAGACTATAGAATACTCAAGCTAATTCAAAAATTAGAGCACCACAAAA
ACAAGAAATGGTTGCGTTCAAACATCAATTAGAGCAAACAGGACTTGAAGTTACCATGAG
AGTTTCTCATGGTAGAGAGATTAAAGCAGCTTGTGGACAGTTAGCTAATACATATAATAA
AGCCAAAAAACAACAGAAATAATTTAATTAAAAGAGCCAGACGCACAGACGCAGAGCCGA
TAATATGCAGTTTGAAATACTGCTGTTATCGGCTCTTTTTTGATTTTAATTTGTGCCCCT
AATAACCATATTGGAGCAAAATCAGAACTGTTGCTTGTCGTTCTTTGATTTCCGCAGCAG
CTTTGAAAAATCAAAGCCGCCGTTTCTTTTTATCTTCTAATGAAATGACGCGGTATCACT
GTTGAAATCGGCGGCTAAAGGAGGTAGCCGCCATGAAGCAAAAAGCATATCGACAAAATC
CGACAGTTATTGACTTATCAAAAAAAGCCCGCCCACCACCGGGGGAAACTACGCTTATAT
ATATGAACTGTCTAATCATCTGGATACTGCTTACAATGCCTATGCGCCCGTCCGGGCTTT
TCGGACGGGCGCATTTTGTACGTTCAAAAAATTTTTGAAGAAATTTCAAAAAATCTTCGG
CGTTTTTGAAAAACGCCGTATTGCCCCGCGAAAAGGGGGGAAGCACCACCAACTTTCCAA
CGAGAAAGGAGGTGAGAATGTGGAACCTAATAGCAGGGAGTTTTACAAACAGTGTGCTTT
TCAGAAGTTTTGTAATACGGTATTGCACAATGAAGCTTGCGACACCCATAGAGAACTTCG
CAGACACAAGGCAAAGGAAGTGACCTTTTCCGACATGACCTTAGACGAAGCGCGGCAGCT
TCATACGTTTGATGAATATTTCAAACGTGAAGCCGCCGAAACCGTCTTTGAGAAAGCCGG
GAAGAAAATCACGCCAAAGCTGCTTCTTGAAGCAATCCGTACTTTGCCGGAAGAAAAGCG
CAAAGCCATATTGCTGTATTACTTCGAGGGAATATAAGCAGATGGGCAACCGCCCGAAAA
AAGGAACATAAAAACCCTCCAAATTTAAAAACAAATTCAGAGGGTAATTTAGGGTATAAC
AAAATAACCCACCCGAATATCGTTTTTTCTATTTGGTGAGTTTGTTCTTTCAAATACGAA
ACAAAAAGAGCCGATGATTCGTGAATTGTTCCACAATTTCATCGGCTCTGCGTCTTAAGC
GTCTGGCTCTTTGATGACAGTTATCTTCAAGTTGTCAACTTTAATCAATCTTTCTTGTCT
GCATTTTGGACAATAAAGGGGATAATTCTTCAAAACAGTGTCCTTCCTAATTTTATTACG
GGTTTTGCTCCCACAAACAGGACATAATATCCATTCGCATTTCATCATAATTAGCTTCTA
ATCCTTTCAAATCTCATTTTATACGACTTATGCAAGCTGTTAGGCTAACTTGTGGAACAT
ATGCCGAACCTTATCTATACGGCTATTCGGGCGGCGGGGTTGGCAAATAAGTTTACCAGT
AGCTGGCTGGTATCCTTTTAACTCTGTCAAGCAGACTCCCTGCCCATTTGTGAAATAAGT
TAAATCGTTCCTGTATTCTTGAATACATCTAGCAGGGATTTCTCCTTTCAGAATGACCTC
GTCATTCTTTATCTGAGTACTTACAATATCTGCACAATACCTTGGAGCATCATGATACGC
CCGTGAGAGATATTCCTGCGGTGCATAAATTTCAAAGTGGAGATATGGCTCTAATAGTTC
TGTCCCTGCTTTTTTTAAAGCCTGCTCCAATACGATAGGGGAAAGCAGCCGAAAGTCTGC
GGGGGTACTTACAGGACTATAATACAATCCATATTCAAAACAGATTTTACAGTCTGTCAC
TTTCCATCCATACAGCCCCTGCTCGCAGCCATAAAGAACCCCCTCCATAACCGCATTTTG
GAACGATTGGTTTAAATATCCAAGTGAAACTCTGCTTTCATACTGCACTCCACTTCCAAT
AGGGAGCGGCTCTATGGACAACCCGACAGAAGCCCAGAAAGGATTTGGCGGGACTTCTAT
GTGGATGGTATATTCTGCTTTTCTAAGCGGTCTTTCCATATATATAACAGTAGGCTCTTT
TATTTCTGCCTCCACATGATATTTTTCCTCAAGGATGGCACAAATGACTTCCATCTGCAC
TTTCCCCAAAAAAGAAAGTATAATCTCATGCGTTGTAGTATCCACATAATATTTTAAAAG
AGGGTCGCCATCTGAAATTTCTGTAAGTGCCCCAAGCAATATTTCCCGCTGTTCAGATTT
CTTTGCTGCAATCGTTGTTTGGAGCATAGGGAGAGGATTTTCAATAAATGTTCTCTGCGG
CAACAGCATTTCGTTCCCCAAAATACTGTTTAGCTGCAAAACATCATTTGGTAAAATTAC
AATATCACCAGAGCAGGCTGTATCGGATGAACATAATTCACCGTTTGTCGGAACACACAT
CTCTGTGATTTTTATTTTCTCTTTTTCAGATATTTTAATAACATCCCTCAAATGCAATGT
TCCGCTATATATACGCACATAAACAAAACGCCGCCTTTTCTCTGAATATTCAATCTTAAA
AACCTGCCCGCATAGTTCAGATTGACCTTCAGGCGTTGATGAATAAAACTTACTGGCAAT
CACTTCTATAAGCTGCCGAATCCCCAGATTGTTTTTAGCGCTTCCGTGATAAACGGGAAA
TAACGTTCCGTTTTGGAATCTCCTGTTTTCTTCCTGTTCCAGTTCTGACATTTTAAACGG
TTTCCCTGACATATATTTCTCTAATAGTTCATCGTTTCCCATAATTACCGCATCCCACTG
TTCCATATCGTCATTGTCCGTTACATTTATATGAGGATGCTGCCCAACCTTTTGCTTCAC
TATAATTTCCGAAGAAAGCTTTGCTTTCATTTCTTGATATACCATTGGCAAATCAATCCC
CTCTTGGTCAATTTTATTGATGAAAAAAATTGTCGGAATCTTCATTGTCTGTAGTGCATG
AAACAGTATACGGGTCTGTGCCTGTATGCCATCCTTTGCAGAAACTAATAATACTGCTCC
GTCTAATACGGATAAAGAACGGTATACTTCCGCCAAAAAATCCATATGGCCTGGCGTATC
TATAATGTTGACTTTTACATCCTCCCACTGAAAAGATGTCACTGCTGTCTGGATAGTGAT
TCCCCTTTGACGCTCCAAATTCATTGTATCTGTCCTTGTTGTGCCTTTATCTACGCTCCC
TGGTTCTGCAATTGCACCACTGGTATACAATAAACTCTCCGTTAATGTTGTCTTTCCTGC
GTCAACGTGAGCCAGAATGCCTAAGTTAATTATTTTCATGTGATTTTCCTCCTATCAACA
CCCAAAAAAGGGCATAAAAATACCCAGTGATAAATACTCCTATCACTGGGTAAATAACTCCAATAGCCCCAAAACACTTATATGTTTTCGGGCATATAAAATTACATGATAAAAGTATTC 
TTAAACTGGGTACAAAAAACTAAGCCCCATATTAAAAGTGAAACGGGACTGCTACTTTTT 
GTTCCCACTATCAAATTGACAGTTTATTTAAGAATACCTTGCCGCATATTTATTAACTCC 
TTGTATAATACTGAATCTAATTATATTCCTTAACCCTTTATTTGTCAAGCTGACAAACTA 
AAGCAGAAAAAGCGGCAGGATTTCCCCCTGCCACTAATCATCTGTTTATGCAAAAATAAT 
TTCCTTTTCCACAATCTCCCTCGCACAAGCCCTTATGTTATTCGTTCTTCCAGTCCATTC 
TAAGGCGTTTTCTTCCTTTAGGCATTCCGTTATGCCCTGTGCTTGCTTCATGCCCTCTAT 
GAGCCGTTCAAAGTGTTCCTGTGCCTGTCTGTCAATGTCGGCAAGGTAAGCATTGAGCCT 
GCCGCTTGTGAGAAGATTGGTGTATGTAATTTTGCGGTACTCCCGCAGATAGTCCAAGTG 
CCGCCGTCCGAATAAGTCTATCGACTGTTCCTTTTCGGGTGGTATGGTAAGGCAGGGTAA 
AATGTATTCGCCTTGCCGTTCGTATCTGCCGCCCATTTCCTCAAAGATTGATTGTACCAT 
TTGTTTTTCCTCCAAATAAGATATTCACTCCATACTCATGTCTGCTATCATTAACACAAT 
TTACGTTTTCTCCTTATCTGGTTTCATACATCTGTGAAAAATAAAGAAATTTCTGTGCAG 
ATAAAAGCAACAGTGGAAAATGACAGTCAGATGTACAAACTGAAATTACATACGCTGTGG 
TCGCCTATGAAGAAAGATGTATGAATAGGAATTATCGGTTTTTTTGAAATGGCAAAATAA 
GTATGAAGATTATAAATATAGAGTGTATGGAATCAATCAAATTCATATGCTCTTTTTCTT 
TTTTGATTGAAATAAGTATGCGTGGACTACTTTTGGGTGCGAGTGTGATAGGGTAGCGCA 
AGAATAGAT TAGAT G GAAAG GAAGAG G CAC C G T TAAG TAG G TACC T CTTCTTTT TAAAGA 
GCTAGCTCTTTTCCTGATACGGGAACTTGCATCTCTGGAGCATTAAGCAGTGATGTGAAA 
TTCTGCCGAATGATATCAAGTGTCTTTTGCTTTTTCTGCAGCTCCTGTTTTTCTCGGACG 
GTAGCAGCCTGTTCAGATTCAAGATTTTCAATCTGCTTCTGGATTTTATTAGAGCTTGGG 
ATTTTGGTAACGCCGAGATCCTGAAGCTCTTTTTTTAGTGAATCGTGTAGCTGGTATTCT 
GCCTGATGCTTGGTACGGTAAGCTTTTGGATTTTTAGCAGATTTGCAATCTTCAATCACT 
TTTCGGCAGAGCCGATAAGAATCACAGTGCTTTTGAATGACTTTCTGTGTGCTCAGCTCA 
CTGTTGATTTGTGCTATTTTTTGGTCGGCAACTTTCACAGAAACTTCAATGTCAGATACA 
TGCTGCTTGAAATCCTCATAATTCAACAGGTTATTTTCGGAAAGATAGTTAAAGGTGCGG 
GCTGCCTCTTTCAGATTATTGAGCTTTGCCCATCGTTCAAATCCTTCTCGATTGCCGGTC 
GTAACATAAGTGGAAATATTGATATACAGGCGAGCTTCTCTGGACAGATGCTTCGGAGTT 
TTCACTTTGTTACGATTTTTAGCCAGGCGAATGCGAACATTTTCTTCTGAATAATAGCTT 
CCGAGAGATTTCATATAAGTGAAGTTTTTCTGTTCAGGCGCACGGAAGGATAGGTGCTTT 
CCTTGGCGGATTTCGTATCCGGCTAACTGCATTTTTTGTAGAAATTCCTCATAGTTGATG 
GAAGTCCAGATTGCTTTATCAACTGCAACACGTAGCTTGGCTTTCCAACTGGTGCCACGA 
TGGTATTCCATGTTCTCTTTATAGCTTTTACCTTTTTCTCCGGTTGGCATACTGGTGGCA 
AGTCCATTTTCATGGCAGATACGATTACTGATCCGGCAGATTTTATGGTAGCTCCGCTTA 
TTG G  AAAT  AT AT T T GT G  AT GAT C  AAC  AAAAC T TGC T G CAT T  AAAG  AT GAT G T GG T TAT G  A 
ATGTGGTTTTTGTCAACATGGGTACTAATCACGTATTCATATTTTCCTTTCAGTACTTCG 
TCTGCAAATTGTTGCCCTAAGCGATGGGCAGTTTCGGCATCAACTTCTCCAGGTTTAAAT 
GACTGGATCAGATGAAATGCCAGGTTATCACCTTTGTCCATTCCATTCTTTTTTGCCATT 
TCTCTTGTCATAGAAAATTCAAGATCTGCAGTTTCCGGGGAACAGCCAAAACTGGAAACT 
AACAGTTTTTCATCAGTCTTATCAGGATTCGTAATATAGTCCAGAGCTTTCTTGTCTGTT 
ACTTTAATGGGGAAGATCTTAAGATACGCCATAATTCTTTCACCATCTCTTTCAATTCTT 
GCATTTCTTCCGGATATAGATCTCCGGTGCTGTTTACTTTTTTCGCAATCTGATTAATAT 
TCACACCAATCTTATGCATTTCCTCATACTGTTTCTTCAGTGGAGTAGTATCGGTGTTGA 
CGATGTAACCGTCGATTGCCATTTTACGAAGATAAGCTCCCATGTTTTTGGTCTTTGATT 
CAATCATCTTTCTGCGGATAAGCTTCCGTTCTTCTTCTGTGACATAGAAATGGATTTCTT 
TGCTTCTCTTTCTTTCAGCCATTGGCGTGTTCTCCTTTCTGAGAAGGTAGTAGTATCGTT 
GCTTTCAGCTTTTTTCAATTTAGGGCAGGGTTCCCTAAATTGGGATTTCCCGGAAGTGTA 
TCCTCACTTCCTGTCCTTGCTGTTTTACCCCTCTATTAGCTAAAGTCAGAAGAATAAGAG 
AAATGCAAAAGAATTTGGCAGGTAGTATGGCATACAAAAATGTGGTATGATTAGGGGCAG 
GAT  AT CAG  AAG  AAT CAG GAG T T G  AAT  AG AT TGT G  AAG  AAAG  AAG  AAAT T T T T GAAT AT G T 
GCAGAAACAGTATGGCACGATTCCGGAATATTTATGGAGTAAACTACCGGACAGTGCAGT 
ACTTCGACATAAGAATGGGAAATGGTATGCAGTGATCATGACGGTTGAAAAATCGAAACT 
GGGATTAGAGGGAAATGATCTGGTTGACATCATGGATGTAAAGTGCGATCCAGAAATGAC 
CAGCATGATTATTCAGACTTATGGATTTTTACCTGGATACCATATGAACAAAGCGGCACT 
GGATTACGATTTTACTGGATGGTTCGTTCAGTGAAGCAAAGATACTGGACTTTTTGGATA 
TGAGTTATGACCTGATTGATGGAGCAGGCAGAAAAGAAGAAAATGTAAGTGGTTTACAGT 
GATTTTTGAGCAAAAGGGAAACCGGGGATTTTACTCCTCGGTTTTTCGGCTGTTATGCTT 
CAGTCTTCAACTTGAAAAATATCTTCTACAGGCACTTTCAGGTAATGGGCCAGCCGGATT 
GCAATCTCAAGAGAGGGATTACGTTCTCCACGTTCGATGCGGCCTATAGTCTGGCTGCAG 
GAACCTATGGCTTCAGCCAAATCTGCTTGAATGAGATTCCGTTCTTCACGAATATCTTTT 
AATGTATTATTGATTGCCATTCAATCACTTCCTTTGCTTATTGTTATCAGCAGGATCATGAACCTGCTGTTGAAATCTAATGAAATCCCGGAATTTCTGCACCTTTGCATTTCCCGATTA 
CTTTTCCAAAAATTTTAAAAGAGTCAGATTCCAAAACCTGGATAGGACGATATTTTTGAT 
TTAAAGAGATCAGATAAACACCATCTGGCTCATCGTGTAATTCCTTGATGTAAGTATTGC 
CG T T GAGATAGAAGAT T CCAAT T T CAC CAT TAGCAAGAGAAT CTTTTTTCT GAAT C CAT G 
CAACATCATCTGTATGATAAAGTGGCTCCATACTATCACCGGAGATCCGTACACCAAAGT 
CAGTCTGCTCAGGAGCAAGATGTCCTACGTCATAGGTTTCTTTTACAGAATCTTCCAGGT 
AATTTCCAGTACCAGCAGAAACTGGTTCCCAGGTAATTTCTACAGGATGATGGAATGGGA 
TAAT C T T T G CAGAT AG T G GAGAAAAC T T T T TAGAAG C T T T T AAAAT AT CAG CAAAT T CAA 
TCAATTTATTTCTGCCTTCTTCATTCAATCCACTCATAATGTTATAGGGGTTTTCTCCAA 
AGAAGGATTCATATATATCTTCGATATCAAGTAACTGGCAAAGTGTCAGGAAAACATGTA 
AAGCTGGTTCTCGTGCATTGGTCTCCCATTTGGAGATTGCTTTTGTAGTGACCTGAATAC 
CTTCCTGAGAAAGCAGGTCTACCAGATCTGATTGAGAGTATCCTTTCTTTTTTCTATTTT 
CTGCTAATATTTCCCCGAAATCGTGCATTTGTTCGCCTCATTTCTATTTGAATTTTCTAT 
AT GCAT TATACCG TAT G T TAGAAATAAAAT CAACAATAAT C T CC G  AAAT G GAGAAAATAC 
AACCAAGATGTTACTTGACTATCTCCAAAATGTCGATATATACTAAACATACAGAAATTG 
ATAAAACATCATGTTGAAAGAAGCAGCTGGGAGGTGAAAAGTTTGAGTGAGCGTGTGATC 
CTGCATAGTGATATGAACTGTTTTTATGCCAGTGTAGAAATGCTGCATCATCCGGAATTT 
GCCGGAATGCCTCTTGCAGTTGGCGGTGATCCGGAAGCTCGGCATGGAATAGTGCTAACA 
GCAAATTATATTGCAAAGCGAAAAGGTGTAAAGACCGGAATGGCATTATGGCAGGCAAAA 
CAGATTTGTCCGGAAATCATTTTTGTGCCACCACGAATGGACTTGTATTTGAGATTTTCA 
CAGATGGCAAGAGAAATCTATTCGGAGTATACGGACAAGATCGAGCCATATGGGATTGAT 
GAAGCCTGGCTGGATGTATCGGACAGCAGAAATCTGAAAGGAAGCGGAATGACGATTGCA 
AGAGAAATCAGCCATCGGATTAAATACGAACTGGGTGTAACGGTAAGTATCGGAATTTCC 
TGGAATAAGATTTATGCGAAACTTGGTTCAGATTACAAAAAGCCGGATGCAATCACAGAG 
TTTAATCGAGAAAATTATAAAGACAGGATATGGCAGCTTCCAGCATCAGATTTGCTTTAT 
GTCGGAAGGCAGACAAATAAGAAATTGCAAAAACTTGGAATCCGGACAATCGGGCAACTT 
GCGGAATCAGACGAAAAGTTGTTAGAGAGCCATTTTGGAAAAATAGGAAATGTATTATGG 
ACTTTCGCAAATGGCTGGGATGAAGATCCGGTTTGCAAGGAAGGGTATGAAGCACCAGTA 
AAGTCGATAGGTAATGGCACCACAACACCGAGAGATCTGGAAAATGATCTGGATGTCTGG 
ATCATTCAAATAGCATTGGCAGAAAGTGTAGCTGCACGATTGCGGAAACATGGATTTAAA 
TG C  AAAAC  AG TAGAAAT TAC  AG T TC G  AG  AT  AAT G GAT T G TAT AG T T T T T C CAG  AC  AG  AT A 
CATTTACGACAGCCAACGAATATTACAAACGAGATTGTAACTGCAGCATTTCAGCTATTT 
AAAGATAATTATAAATGGGAACATCCTATTAGAAGCCTGGGAATCCGAGCTGCGGATCTT 
GTGTTAGATGATATTCCCGTGCAGTTGGATTTATTTGGAAATCAGGAGAAAAAGGAAAAG 
TTAGAGAAGCTGGATCGTACTGTAGATGAGATCAGACGACGGTTTGGTTATTTCAGTATA 
CAGCGAGCGGCAATGTATCAAGATAAAGTCTTATCCCACTTAGACGCTGGTACGCACACG 
ATCCATCCACAC  AG T TAT T T TC  ATGGGT AAT T GGAGGGAT  AGAT T T G  AAAAAAGC  AT TAA 
CC  AGAAAAC  AGAAAG  AAAG T TAT C  AAT G TAT TTT G  AAT TAT  AT GAAG GAGC  AT GG  AT  ACC 
CGCCGACAGTCCGGGAATTTGGAGAGTTGATCGGGGTGAAATCAACATCATCTGCTTTTT 
CCAGAATCAAGCAGTTGGAGCAAAATGGATATATCCGCAGAATCCCGGCATCGCCAAGAG 
CAATCGAGATTTTATAGTGAGGTGTCGGTATGAACAAAGTGGTATGTAGATGTAGTGGCA 
GAGTTTCGGAAAGACGGGCAGGAppendix 11: IStetC2 (tet(A) / unknown BAC Clone) Subclone Sequence
> ls tC ls u b 8 _ p U C 1 9 F _ G 0 4 .a b l  L S E s u b 8 .0 .1
GTAACGGCACCTGANTCCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTG
TTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTG
AATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACG
GTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCA
ATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCG
CCCCCGTTTTCACCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGG
CGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAAT
TACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAATTTTTTTAAGGCAGTTATTGGT
GCCCTTAAACGCCTGGTTGCTACGCCTGAATAAGTGATAATAAGCGGATGAATGGCAGAA
ATTCGAAAGCAAATTCGACCCGGTCGTCGGTTCAGGGCAGGGTCGTTAAATAGCCGCTTA
TGTCTATTGCTGGTTTACCGGTTTATTGACTACCGGAAGCAGTGTGACCGTGTGCTTCTC
AAATGCCTGAGGCCAGTTTGCTCAGGCTCTCCCCGTGGAGGTAATAATTGACGATATGAT
CATTTATTCTGCCTCCCAGAGCCTGATAAAAACGGTTAGCGCCGGGGTTGGATTTTTCAG
CGTTCCAGCTAAGGCTAAGGCATTCCTGTTCAAGCGCAAGCCGGGCTATAAAGCGCATTA
TCGCTTTACCCGTGCCCTTATTTCGATCGCACTGAGAAACATACAGCTCTTTAATATGCA
GCTGACCGCTGTATCGGGGCGAGGGATAAAGAATATTGCAACATGCCAGGCCAGTAATGT
TATTGCCGCAGCGCGCTCTGATCACCAGGGTACCGGAAAGCCGGTTGAATAACTTTTTAC
AGAGATAATCCTTCATCAACGCTTCCTGAATGATACCTTCGCCATAATAGGGGTCGTCTC
AGAAAACGGAAAATAAAGCACGCTAAGCCGGTTGCAGAGGCCGTAGCGGCCTGAACTTCC
CCGCGCCGATCTTGGCGCTGCTGCGCCATAGGTAATCACCGGTCAGGTTGATGTGCTCCC
AGCCGAGTGGCGACAGGTACTGCAATAGCGAGTCATCGACGGCATGACCATTGCCGCGCA
ACGCATGCGCCGCACGCTCCAGGTAGACCGTGTTCCACAGCACGATGGCCGCCGTCACCA
GGTTGAGGCCGCTGGCCCGGTAGCGCTGCTGCTCGAAACTGCGGTCACGGATTTCACCAA
GGCGGTTGAA
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TTACGCCAGCCTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCCGGGTACCGAGCTCGA
ATTCTGCGCCCGCCTCGATGCCATCCTGCCCTGGGATCGCGCCGCAGTAGACGCCACCAC
GAAGATTAAAGTGGCACTGCGGCTGGCCGGGACGCCGATCGGCCCGAACGACACGGCGAT
TGCCGGGCACGCCATCGCCGCCGGGGCGATACTGGTAACGAATAATACAAGAGAATTTGA
GCGAGTGCCTGACCTGGTGCTGGAAGACTGGGTGAAGTAAGACACTCTTTTCAAAGTCAG
GAGATAAGGGCACCAAGAAACAGCCCGTATACGGGCTGTTTTAACAGATATCTACAGTAA
GCGGTCCTAAACTGTAGGGTATCTTCGAAGATCAGACTATCAGGGAGCTAAAGCCTATCT
TCCGGCGGCAAAAACAGTGGCTCAAGCGATACGGGCAACCGAGCTCTGGTTTGCTGCCGG
TGGCAGGGCGATGAGCTTGTCACATTCCATAATCACGTACTCCGGGATGAGATCGAATCT
GGACGGATCTAGTTGACAGATGAACTCATTTTCAATGTGGTACGTTTCGTTAACGAATTT
TCGTATTACCGGATGGTCCTGATCCAGTTCCAGTAAACGGAATACCTGCAGTTTTTCATA
GCCGTTACGACAGCGACGGTACAGGTTTTTTATTTCATCTGGGCTGCTGACGAGAGCCTG
AAGTCGCGGGTAATCAAAACTGTCCACATACTCCCGGATATCCCGCAAGGCCTGCTGAAT
TTTCTCAGGAGCCATTTTGGGATAGCCCGAGCCCGCAGCGGCAGGCTCGCGATAATCCAG
CGGGACGACGCGTCGATGGAATAGATTGGATAGAAGCTGATAAGCATCACCACGTTCGTC
AACGATTTCAAAGTAGCGACGAAGATAGATGAGCTTAATGATCTCCTCACAGTCTGCTGA
CGCGGTGATGGATTTGCAGATCTGCATGAATGTCATGATATCGCCGTCGTTAACAGGTAA
TTCTTCTATGACTCCAGCAGACAGGCGCAGGCAGGAGGCGGTCACCTGATTACTGAACAA
CCTTCTGACTGACTTCAGCGTGTCAATCACAGGCTCCACGTCATGCGTCAGCATAAGTAC
AGTCCGGTTCTTCAGGCATTCACCACTTGCACGTCTGAACAGCATTTCAAGAATGGCAAA
CTTCTTGTTTTTATCAAAAGAAGATATGGGATCATCAAGGATAATCAGTCCCGGGTTTTT
TGACAGGCATTCATACATGAATAACACAATCGCAAAGGCGTTCCGTTCTCCATAGCTGAG
ATGCTGGCTACCGCCGCTGACGTACCCGTCAAAATCTATGTGTCGTAGCCTGAGTTTTCT
CTGCTCTCCCTCGCCGGCTATATCCACCCTGTATTTATAGCCTGCATAAGTGAGGAAATT
ATTGATGTTTGTTTTGTGCTGTGCGATCAGCCGGATCATGCTGTCCCGGTGCCGGTTAAT
TTTTCCCTGCAGCGGTCCGGCAAGGTTTATCAGGTCCATAAGGGCCGCGTTCAGTCTGTC
GGTGATCCCCTGCATGAGTTCGGATTGCAGATCAGGGAAGAACTGCAGGTCAATCAACCT
GGCAGTGAGCACCTCCCGAACGTTCTGCTGTTCCTGCAGGCTGAAAACATTCAGGCCTCT
CAGCGCAGTGAGTTTCTCTGTCAGCGTATCGGTCTGGCGTTTCAACGCCACTAGGTACTCGATATGTTCGGCTTCCGGACCGTTCTGAAGCATAGTAATGGCCAGAAGGCGTTCTCTGGC
GCTCTCCGTCAGGTAATTACCGAGGTTTTCCACCAGTCTGATGATAGCGGTCAGGTTTTT
AATGGTGGATTTATCGTATTCCTCTCTGACTTGGCGAATTTGTGCTTCCTTTCCCGTGAT
ATCACCGGTACAGAACGGACAGCAGCCATCCGAAAGGGGCGAAAACTCGAGTCCCTTTGT
CTGCCAGTCAATCCATTCCACGCGGCGTTCACTGCGGATGTAGGGTTGATAGTTCTCAAG
ACCAGCCGGAATGTGGTGTATTTTATTTCCGCCTGACAGACCTCTCATGCCGGTTGAAGA
ACGTGAAATCCCGGAACTGGTTGATCTGAAAGCATTACTGAGTTCCTGTAGATGGTCTAT
CAGAGAGTTCAGCTCAGTGTGATCCGTGAAAACAGCCCGGATCTTTTGCGTCATTTCTTC
TATTTCACGCTCTCTTTCCGCATGGGCTTGATTGCGGATAAGAATATTAAAGCTATCACT
GATGAGCTCGTCCGGTTGGAACGTAAACTGACTGACGTACTCCTCGTTGAAGCACATCAC
GTCCCCAATCCCGTCAGCACCGATGACAATGGGCCCGGTGCTATCGGGGTTTTCTCCGCG
CAGCCGGAAGGGCATCAGTGCCTGTAGTCCCTGAATGTCGTCCCGCGCCGCACAGCTTAT
GGCCCGTGACAGCGTACTTTTTCCAGTACCATTTGGCGCAAACTTAATGTTCAGTTTATC
GGCAGTGAGGGTGATATGTGCTCGACGATGTTATTGCAGGGGCGATTTCAATGTCCATTT
ATCTGTCCCTTGGCCAGTTATTCCGGGGGGATTCATATCCTTCCGCAAAATGGGCCCGCAAppendix 10: CLUSTAL W multiple sequence alignment of TnpV/Tet(0) BAC 
clone with TnpV sequences from BAC end-sequencing results (chapter four) and 
TnpV sequences from the databases.
BACTnpVl
BACTnpV3
BACTnpV6
CcoliTnpV
BACTnpV  4
BACTnpV5
BACTnpV2
Tn4453TnpV
Tn4451TnpV
BACTnpVClone
SpyogenesTnpV
BACTnpVl
BACTnpV3
BACTnpV6
CcoliTnpV
BACTnpV4
BACTnpV5
BACTnpV2
Tn4453TnpV
Tn445lTnpV
BACTnpVClone
SpyogenesTnpV
BACTnpVl
BACTnpV3
BACTnpV6
CcoliTnpV
BACTnpV4
BACTnpV5
BACTnpV2
Tn4453TnpV
Tn4451TnpV
BACTnpVClone
SpyogenesTnpV
  PLGHYGRLRKAYLEMHRPILFNELVLS  27
-------------------------------------PLGHYGRLRKAYLEMHRPILFNELVLS  27
-------------------------------------PLGHYGRLRKAYLEMHRPILFNELVLS  27
--------- MNITYTQNGDYLIPNI11— RKTKPLGHYGRLRKAYLEMHRPILFNELVLS  4  9
-----------------------------------------YGRVRKAYLEMRRPILFDELVLS 23
------------------------------------ PLGHYGRVRKAYLEMRRPILFDELVLS 27
------------------------------------ PLGHYGRLRKAYLEMRRPILFDELVLS 27
MQRFITDERTGIRYELIGDYYYPCLTA--EEKPLLSRYGRMRERYLKEHKRVLYYTLMTS  58 
MQRFITDERTGIRYELIGDYYYPCLTA--EEKPLLSRYGRMRERYLKEHKRVLYYTLMTS  58
--------------------------------------------- HLDYLREYRKITYTNLLTS  19
-MAKSLFEELGGKYERQGDYLIPCLTVPAEEEQAIGIWGQRHLDYLKQYRKVTYTNLLTS  59
★   *   . . .   *   .   *
DKLFEHCAEIDEAARNRMELIVRSLAEQNGVTEQLKAKNQM-------ACGAADEQ  76
DKLFEHCAEIDEAARNRMELIVRSLAEQNGVTEQLKAKN------------------------ 66
DKLFEHCAEIDEAARNRMELIVRSLAEQNGVTEQLKAKNQM-------EWVRQTSS  7  6
DKLFEHCAEIDEAARNRMELIVPELVKRNGVTEQLRAENQMEWVRQMNACKAQAEEWKA 109
DKLFERCGEIEEAARNRMELIARALADQNGGT-QLGAKNQM-------GWVR---------- 67
DKLFERCGEIEEAGRNRMELIVRALADQNGVT-QLKAKNQM-------GWVR---------- 71
DKLFERCGEIDEAGRNRMELIVRALADQNGGT-QLKAKNQR-------GWVR---------- 71
GKLYEHLAEIDTSAC  DMAEYLIREMARKQGVTEQLKAVDMMRWIGLMNNIRACVDEIVLN 118 
GKLYEHLAEIDTSAC  DMAEYLIKEMARKQGVTEQLKAVDMMRWIGLMNNIRACVDEIVLN  118 
GRLNAYLADIDRQAQEH  FERLIEGMKQAQGITECLKEENALEWTGRTNNIRACAREIVEK 7  9 
GRLNAYLADINRQVQERFERLIEGMKQAQGITEQLKAENALEWTGYLNNIRACAREIVEK  119 
_.*  .:*•  •   *   •   .* * *
ELIYD 114
DIVYS  123 
DIVYS  123 
ElIFA 84 
ElIFA  124
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